id	sid	tid	token	lemma	pos
cuesj-811	1	1	tx_1	tx_1	PROPN
cuesj-811	1	2	~	~	X
cuesj-811	1	3	abs	ab	NOUN
cuesj-811	1	4	:	:	PUNCT
cuesj-811	1	5	at	at	ADP
cuesj-811	1	6	/	/	SYM
cuesj-811	1	7	add	add	VERB
cuesj-811	1	8	:	:	PUNCT
cuesj-811	1	9	tx_2	tx_2	PROPN
cuesj-811	1	10	~	~	NOUN
cuesj-811	1	11	abs	ab	NOUN
cuesj-811	1	12	:	:	PUNCT
cuesj-811	1	13	at	at	ADP
cuesj-811	1	14	1	1	NUM
cuesj-811	1	15	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-811	1	16	cuesj	cuesj	NOUN
cuesj-811	1	17	2023	2023	NUM
cuesj-811	1	18	,	,	PUNCT
cuesj-811	1	19	7	7	NUM
cuesj-811	1	20	(	(	PUNCT
cuesj-811	1	21	1	1	NUM
cuesj-811	1	22	):	):	PUNCT
cuesj-811	1	23	1	1	NUM
cuesj-811	1	24	-	-	SYM
cuesj-811	1	25	7	7	NUM
cuesj-811	1	26	research	research	NOUN
cuesj-811	1	27	article	article	NOUN
cuesj-811	1	28	age	age	NOUN
cuesj-811	1	29	of	of	ADP
cuesj-811	1	30	women	woman	NOUN
cuesj-811	1	31	as	as	ADP
cuesj-811	1	32	a	a	DET
cuesj-811	1	33	parameter	parameter	NOUN
cuesj-811	1	34	affecting	affect	VERB
cuesj-811	1	35	ca-125	ca-125	PROPN
cuesj-811	1	36	,	,	PUNCT
cuesj-811	1	37	tsh	tsh	NOUN
cuesj-811	1	38	,	,	PUNCT
cuesj-811	1	39	and	and	CCONJ
cuesj-811	1	40	cbc	cbc	NOUN
cuesj-811	1	41	:	:	PUNCT
cuesj-811	1	42	a	a	DET
cuesj-811	1	43	correlation	correlation	NOUN
cuesj-811	1	44	study	study	NOUN
cuesj-811	1	45	muhsin	muhsin	PROPN
cuesj-811	1	46	h.	h.	PROPN
cuesj-811	1	47	ubeid1	ubeid1	PROPN
cuesj-811	1	48	,	,	PUNCT
cuesj-811	1	49	ameena	ameena	PROPN
cuesj-811	1	50	s.	s.	PROPN
cuesj-811	1	51	m.	m.	PROPN
cuesj-811	1	52	juma1	juma1	PROPN
cuesj-811	1	53	,	,	PUNCT
cuesj-811	1	54	tanya	tanya	PROPN
cuesj-811	1	55	s.	s.	PROPN
cuesj-811	1	56	salih2	salih2	PROPN
cuesj-811	1	57	,	,	PUNCT
cuesj-811	1	58	shilan	shilan	PROPN
cuesj-811	1	59	s.	s.	PROPN
cuesj-811	1	60	kamel1	kamel1	PROPN
cuesj-811	1	61	,	,	PUNCT
cuesj-811	1	62	shakir	shakir	PROPN
cuesj-811	1	63	m.	m.	PROPN
cuesj-811	1	64	al	al	PROPN
cuesj-811	1	65	-	-	PUNCT
cuesj-811	1	66	awqati3	awqati3	PROPN
cuesj-811	1	67	1department	1department	NUM
cuesj-811	1	68	of	of	ADP
cuesj-811	1	69	medical	medical	ADJ
cuesj-811	1	70	microbiology	microbiology	NOUN
cuesj-811	1	71	,	,	PUNCT
cuesj-811	1	72	college	college	NOUN
cuesj-811	1	73	of	of	ADP
cuesj-811	1	74	science	science	NOUN
cuesj-811	1	75	,	,	PUNCT
cuesj-811	1	76	cihan	cihan	VERB
cuesj-811	1	77	university	university	NOUN
cuesj-811	1	78	-	-	PUNCT
cuesj-811	1	79	erbil	erbil	PROPN
cuesj-811	1	80	,	,	PUNCT
cuesj-811	1	81	kurdistan	kurdistan	PROPN
cuesj-811	1	82	region	region	NOUN
cuesj-811	1	83	,	,	PUNCT
cuesj-811	1	84	iraq	iraq	PROPN
cuesj-811	1	85	,	,	PUNCT
cuesj-811	1	86	2department	2department	NUM
cuesj-811	1	87	of	of	ADP
cuesj-811	1	88	physiotherapy	physiotherapy	NOUN
cuesj-811	1	89	,	,	PUNCT
cuesj-811	1	90	cihan	cihan	VERB
cuesj-811	1	91	university	university	NOUN
cuesj-811	1	92	-	-	PUNCT
cuesj-811	1	93	erbil	erbil	PROPN
cuesj-811	1	94	,	,	PUNCT
cuesj-811	1	95	kurdistan	kurdistan	PROPN
cuesj-811	1	96	region	region	NOUN
cuesj-811	1	97	,	,	PUNCT
cuesj-811	1	98	iraq	iraq	PROPN
cuesj-811	1	99	,	,	PUNCT
cuesj-811	1	100	3department	3department	NUM
cuesj-811	1	101	of	of	ADP
cuesj-811	1	102	nutrition	nutrition	NOUN
cuesj-811	1	103	and	and	CCONJ
cuesj-811	1	104	dietetics	dietetic	NOUN
cuesj-811	1	105	,	,	PUNCT
cuesj-811	1	106	cihan	cihan	VERB
cuesj-811	1	107	university	university	NOUN
cuesj-811	1	108	-	-	PUNCT
cuesj-811	1	109	erbil	erbil	PROPN
cuesj-811	1	110	,	,	PUNCT
cuesj-811	1	111	kurdistan	kurdistan	ADJ
cuesj-811	1	112	region	region	NOUN
cuesj-811	1	113	,	,	PUNCT
cuesj-811	1	114	iraq	iraq	PROPN
cuesj-811	1	115	abstract	abstract	VERB
cuesj-811	1	116	one	one	NUM
cuesj-811	1	117	of	of	ADP
cuesj-811	1	118	the	the	DET
cuesj-811	1	119	cancer	cancer	NOUN
cuesj-811	1	120	’s	’s	PART
cuesj-811	1	121	antigens	antigen	NOUN
cuesj-811	1	122	is	be	AUX
cuesj-811	1	123	the	the	DET
cuesj-811	1	124	ca125	ca125	NOUN
cuesj-811	1	125	,	,	PUNCT
cuesj-811	1	126	which	which	PRON
cuesj-811	1	127	is	be	AUX
cuesj-811	1	128	a	a	DET
cuesj-811	1	129	protein	protein	NOUN
cuesj-811	1	130	antigen	antigen	ADV
cuesj-811	1	131	,	,	PUNCT
cuesj-811	1	132	found	find	VERB
cuesj-811	1	133	at	at	ADP
cuesj-811	1	134	excessively	excessively	ADV
cuesj-811	1	135	high	high	ADJ
cuesj-811	1	136	levels	level	NOUN
cuesj-811	1	137	in	in	ADP
cuesj-811	1	138	females	female	NOUN
cuesj-811	1	139	characterized	characterize	VERB
cuesj-811	1	140	with	with	ADP
cuesj-811	1	141	ovarian	ovarian	ADJ
cuesj-811	1	142	cancer	cancer	NOUN
cuesj-811	1	143	.	.	PUNCT
cuesj-811	2	1	it	it	PRON
cuesj-811	2	2	is	be	AUX
cuesj-811	2	3	suggested	suggest	VERB
cuesj-811	2	4	for	for	ADP
cuesj-811	2	5	ovarian	ovarian	ADJ
cuesj-811	2	6	cancer	cancer	NOUN
cuesj-811	2	7	screening	screening	NOUN
cuesj-811	2	8	of	of	ADP
cuesj-811	2	9	women	woman	NOUN
cuesj-811	2	10	that	that	PRON
cuesj-811	2	11	are	be	AUX
cuesj-811	2	12	at	at	ADP
cuesj-811	2	13	higher	high	ADJ
cuesj-811	2	14	risk	risk	NOUN
cuesj-811	2	15	to	to	PART
cuesj-811	2	16	get	get	VERB
cuesj-811	2	17	the	the	DET
cuesj-811	2	18	disease	disease	NOUN
cuesj-811	2	19	,	,	PUNCT
cuesj-811	2	20	despite	despite	SCONJ
cuesj-811	2	21	its	its	PRON
cuesj-811	2	22	limited	limited	ADJ
cuesj-811	2	23	sensitivity	sensitivity	NOUN
cuesj-811	2	24	and	and	CCONJ
cuesj-811	2	25	specificity	specificity	NOUN
cuesj-811	2	26	.	.	PUNCT
cuesj-811	3	1	this	this	DET
cuesj-811	3	2	study	study	NOUN
cuesj-811	3	3	is	be	AUX
cuesj-811	3	4	conducted	conduct	VERB
cuesj-811	3	5	to	to	PART
cuesj-811	3	6	identify	identify	VERB
cuesj-811	3	7	possible	possible	ADJ
cuesj-811	3	8	correlations	correlation	NOUN
cuesj-811	3	9	between	between	ADP
cuesj-811	3	10	ca125	ca125	NOUN
cuesj-811	3	11	and	and	CCONJ
cuesj-811	3	12	thyroid	thyroid	VERB
cuesj-811	3	13	stimulating	stimulate	VERB
cuesj-811	3	14	hormone	hormone	NOUN
cuesj-811	3	15	(	(	PUNCT
cuesj-811	3	16	tsh	tsh	NOUN
cuesj-811	3	17	)	)	PUNCT
cuesj-811	3	18	levels	level	NOUN
cuesj-811	3	19	with	with	ADP
cuesj-811	3	20	parameters	parameter	NOUN
cuesj-811	3	21	of	of	ADP
cuesj-811	3	22	hematological	hematological	ADJ
cuesj-811	3	23	origin	origin	NOUN
cuesj-811	3	24	among	among	ADP
cuesj-811	3	25	women	woman	NOUN
cuesj-811	3	26	of	of	ADP
cuesj-811	3	27	different	different	ADJ
cuesj-811	3	28	ages	age	NOUN
cuesj-811	3	29	.	.	PUNCT
cuesj-811	4	1	this	this	DET
cuesj-811	4	2	study	study	NOUN
cuesj-811	4	3	included	include	VERB
cuesj-811	4	4	44	44	NUM
cuesj-811	4	5	healthy	healthy	ADJ
cuesj-811	4	6	looking	look	VERB
cuesj-811	4	7	females	female	NOUN
cuesj-811	4	8	,	,	PUNCT
cuesj-811	4	9	and	and	CCONJ
cuesj-811	4	10	20	20	NUM
cuesj-811	4	11	individuals	individual	NOUN
cuesj-811	4	12	as	as	ADP
cuesj-811	4	13	control	control	NOUN
cuesj-811	4	14	group	group	NOUN
cuesj-811	4	15	most	most	ADJ
cuesj-811	4	16	but	but	CCONJ
cuesj-811	4	17	not	not	PART
cuesj-811	4	18	all	all	DET
cuesj-811	4	19	patients	patient	NOUN
cuesj-811	4	20	were	be	AUX
cuesj-811	4	21	from	from	ADP
cuesj-811	4	22	erbil	erbil	PROPN
cuesj-811	4	23	.	.	PUNCT
cuesj-811	5	1	the	the	DET
cuesj-811	5	2	study	study	NOUN
cuesj-811	5	3	revealed	reveal	VERB
cuesj-811	5	4	that	that	SCONJ
cuesj-811	5	5	,	,	PUNCT
cuesj-811	5	6	ca125	ca125	NOUN
cuesj-811	5	7	and	and	CCONJ
cuesj-811	5	8	tsh	tsh	NOUN
cuesj-811	5	9	levels	level	NOUN
cuesj-811	5	10	were	be	AUX
cuesj-811	5	11	not	not	PART
cuesj-811	5	12	associated	associate	VERB
cuesj-811	5	13	.	.	PUNCT
cuesj-811	6	1	furthermore	furthermore	ADV
cuesj-811	6	2	,	,	PUNCT
cuesj-811	6	3	the	the	DET
cuesj-811	6	4	elevation	elevation	NOUN
cuesj-811	6	5	of	of	ADP
cuesj-811	6	6	the	the	DET
cuesj-811	6	7	ca125	ca125	NOUN
cuesj-811	6	8	levels	level	NOUN
cuesj-811	6	9	in	in	ADP
cuesj-811	6	10	the	the	DET
cuesj-811	6	11	females	female	NOUN
cuesj-811	6	12	could	could	AUX
cuesj-811	6	13	be	be	AUX
cuesj-811	6	14	related	relate	VERB
cuesj-811	6	15	to	to	ADP
cuesj-811	6	16	other	other	ADJ
cuesj-811	6	17	non	non	ADJ
cuesj-811	6	18	-	-	ADJ
cuesj-811	6	19	cancerous	cancerous	ADJ
cuesj-811	6	20	factors	factor	NOUN
cuesj-811	6	21	such	such	ADJ
cuesj-811	6	22	as	as	ADP
cuesj-811	6	23	menstrual	menstrual	ADJ
cuesj-811	6	24	cycle	cycle	NOUN
cuesj-811	6	25	,	,	PUNCT
cuesj-811	6	26	or	or	CCONJ
cuesj-811	6	27	postmenopausal	postmenopausal	NOUN
cuesj-811	6	28	.	.	PUNCT
cuesj-811	7	1	furthermore	furthermore	ADV
cuesj-811	7	2	,	,	PUNCT
cuesj-811	7	3	wbc	wbc	PROPN
cuesj-811	7	4	parameters	parameter	NOUN
cuesj-811	7	5	and	and	CCONJ
cuesj-811	7	6	hb	hb	PROPN
cuesj-811	7	7	levels	level	NOUN
cuesj-811	7	8	were	be	AUX
cuesj-811	7	9	not	not	PART
cuesj-811	7	10	affected	affect	VERB
cuesj-811	7	11	by	by	ADP
cuesj-811	7	12	ca125	ca125	PROPN
cuesj-811	7	13	.	.	PUNCT
cuesj-811	8	1	the	the	DET
cuesj-811	8	2	only	only	ADJ
cuesj-811	8	3	parameter	parameter	NOUN
cuesj-811	8	4	that	that	PRON
cuesj-811	8	5	was	be	AUX
cuesj-811	8	6	affected	affect	VERB
cuesj-811	8	7	by	by	ADP
cuesj-811	8	8	ca125	ca125	NOUN
cuesj-811	8	9	elevation	elevation	NOUN
cuesj-811	8	10	was	be	AUX
cuesj-811	8	11	rbcs	rbc	NOUN
cuesj-811	8	12	.	.	PUNCT
cuesj-811	9	1	the	the	DET
cuesj-811	9	2	research	research	NOUN
cuesj-811	9	3	recorded	record	VERB
cuesj-811	9	4	a	a	DET
cuesj-811	9	5	significant	significant	ADJ
cuesj-811	9	6	difference	difference	NOUN
cuesj-811	9	7	of	of	ADP
cuesj-811	9	8	rbc	rbc	PROPN
cuesj-811	9	9	between	between	ADP
cuesj-811	9	10	patient	patient	NOUN
cuesj-811	9	11	group	group	NOUN
cuesj-811	9	12	and	and	CCONJ
cuesj-811	9	13	control	control	NOUN
cuesj-811	9	14	group	group	NOUN
cuesj-811	9	15	.	.	PUNCT
cuesj-811	10	1	also	also	ADV
cuesj-811	10	2	recorded	record	VERB
cuesj-811	10	3	,	,	PUNCT
cuesj-811	10	4	no	no	DET
cuesj-811	10	5	difference	difference	NOUN
cuesj-811	10	6	to	to	PART
cuesj-811	10	7	be	be	AUX
cuesj-811	10	8	considered	consider	VERB
cuesj-811	10	9	as	as	ADP
cuesj-811	10	10	an	an	DET
cuesj-811	10	11	indication	indication	NOUN
cuesj-811	10	12	related	relate	VERB
cuesj-811	10	13	to	to	ADP
cuesj-811	10	14	the	the	DET
cuesj-811	10	15	difference	difference	NOUN
cuesj-811	10	16	in	in	ADP
cuesj-811	10	17	women	woman	NOUN
cuesj-811	10	18	age	age	NOUN
cuesj-811	10	19	.	.	PUNCT
cuesj-811	11	1	keywords	keyword	NOUN
cuesj-811	11	2	:	:	PUNCT
cuesj-811	11	3	cancer	cancer	NOUN
cuesj-811	11	4	antigen	antigen	NOUN
cuesj-811	11	5	125	125	NUM
cuesj-811	11	6	,	,	PUNCT
cuesj-811	11	7	thyroid	thyroid	NOUN
cuesj-811	11	8	stimulating	stimulate	VERB
cuesj-811	11	9	hormone	hormone	NOUN
cuesj-811	11	10	,	,	PUNCT
cuesj-811	11	11	white	white	ADJ
cuesj-811	11	12	blood	blood	NOUN
cuesj-811	11	13	cells	cell	NOUN
cuesj-811	11	14	,	,	PUNCT
cuesj-811	11	15	red	red	ADJ
cuesj-811	11	16	blood	blood	NOUN
cuesj-811	11	17	cells	cell	NOUN
cuesj-811	11	18	,	,	PUNCT
cuesj-811	11	19	pregnant	pregnant	ADJ
cuesj-811	11	20	women	woman	NOUN
cuesj-811	11	21	introduction	introduction	NOUN
cuesj-811	11	22	identified	identify	VERB
cuesj-811	11	23	women	woman	NOUN
cuesj-811	11	24	with	with	ADP
cuesj-811	11	25	ovarian	ovarian	ADJ
cuesj-811	11	26	cancer	cancer	NOUN
cuesj-811	11	27	are	be	AUX
cuesj-811	11	28	likely	likely	ADJ
cuesj-811	11	29	to	to	PART
cuesj-811	11	30	have	have	VERB
cuesj-811	11	31	the	the	DET
cuesj-811	11	32	cancer	cancer	NOUN
cuesj-811	11	33	protein	protein	NOUN
cuesj-811	11	34	antigen	antigen	ADJ
cuesj-811	12	1	ca125	ca125	NOUN
cuesj-811	12	2	at	at	ADP
cuesj-811	12	3	excessively	excessively	ADV
cuesj-811	12	4	high	high	ADJ
cuesj-811	12	5	levels	level	NOUN
cuesj-811	13	1	their	their	PRON
cuesj-811	13	2	blood	blood	NOUN
cuesj-811	13	3	of	of	ADP
cuesj-811	13	4	yurkovetsky	yurkovetsky	NOUN
cuesj-811	13	5	et	et	NOUN
cuesj-811	13	6	al.[1	al.[1	NOUN
cuesj-811	13	7	]	]	PUNCT
cuesj-811	13	8	sikaris[2	sikaris[2	PRON
cuesj-811	13	9	]	]	PUNCT
cuesj-811	13	10	stated	state	VERB
cuesj-811	13	11	that	that	SCONJ
cuesj-811	13	12	the	the	DET
cuesj-811	13	13	serosal	serosal	ADJ
cuesj-811	13	14	epithelial	epithelial	ADJ
cuesj-811	13	15	cells	cell	NOUN
cuesj-811	13	16	produce	produce	VERB
cuesj-811	13	17	ca125	ca125	ADV
cuesj-811	13	18	naturally	naturally	ADV
cuesj-811	13	19	.	.	PUNCT
cuesj-811	14	1	and	and	CCONJ
cuesj-811	14	2	this	this	DET
cuesj-811	14	3	product	product	NOUN
cuesj-811	14	4	can	can	AUX
cuesj-811	14	5	be	be	AUX
cuesj-811	14	6	found	find	VERB
cuesj-811	14	7	in	in	ADP
cuesj-811	14	8	both	both	CCONJ
cuesj-811	14	9	malignant	malignant	ADJ
cuesj-811	14	10	and	and	CCONJ
cuesj-811	14	11	benign	benign	ADJ
cuesj-811	14	12	serosal	serosal	ADJ
cuesj-811	14	13	fluids	fluid	NOUN
cuesj-811	14	14	.	.	PUNCT
cuesj-811	15	1	meanwhile	meanwhile	ADV
cuesj-811	15	2	,	,	PUNCT
cuesj-811	15	3	bast	bast	NOUN
cuesj-811	15	4	et	et	NOUN
cuesj-811	15	5	al.[3	al.[3	PROPN
cuesj-811	15	6	]	]	PUNCT
cuesj-811	15	7	advocated	advocate	VERB
cuesj-811	15	8	in	in	ADP
cuesj-811	15	9	a	a	DET
cuesj-811	15	10	small	small	ADJ
cuesj-811	15	11	segment	segment	NOUN
cuesj-811	15	12	of	of	ADP
cuesj-811	15	13	diseased	diseased	ADJ
cuesj-811	15	14	patients	patient	NOUN
cuesj-811	15	15	that	that	PRON
cuesj-811	15	16	the	the	DET
cuesj-811	15	17	ascending	ascending	NOUN
cuesj-811	15	18	of	of	ADP
cuesj-811	15	19	the	the	DET
cuesj-811	15	20	ca125	ca125	NOUN
cuesj-811	15	21	levels	level	NOUN
cuesj-811	15	22	facilitated	facilitate	VERB
cuesj-811	15	23	the	the	DET
cuesj-811	15	24	triggering	triggering	NOUN
cuesj-811	15	25	of	of	ADP
cuesj-811	15	26	transvaginal	transvaginal	ADJ
cuesj-811	15	27	sonography	sonography	NOUN
cuesj-811	15	28	.	.	PUNCT
cuesj-811	16	1	further	far	ADV
cuesj-811	16	2	,	,	PUNCT
cuesj-811	16	3	yurkovetsky	yurkovetsky	PROPN
cuesj-811	16	4	et	et	NOUN
cuesj-811	16	5	al.[1	al.[1	PROPN
cuesj-811	16	6	]	]	PUNCT
cuesj-811	16	7	stated	state	VERB
cuesj-811	16	8	that	that	SCONJ
cuesj-811	16	9	the	the	DET
cuesj-811	16	10	blood	blood	NOUN
cuesj-811	16	11	serum	serum	NOUN
cuesj-811	16	12	of	of	ADP
cuesj-811	16	13	a	a	DET
cuesj-811	16	14	large	large	ADJ
cuesj-811	16	15	segment	segment	NOUN
cuesj-811	16	16	of	of	ADP
cuesj-811	16	17	healthful	healthful	ADJ
cuesj-811	16	18	females	female	NOUN
cuesj-811	16	19	contained	contain	VERB
cuesj-811	16	20	levels	level	NOUN
cuesj-811	16	21	lower	low	ADJ
cuesj-811	16	22	than	than	ADP
cuesj-811	16	23	35	35	NUM
cuesj-811	16	24	units/µl	units/µl	NUM
cuesj-811	16	25	of	of	ADP
cuesj-811	16	26	ca125	ca125	PROPN
cuesj-811	16	27	.	.	PUNCT
cuesj-811	17	1	besides	besides	ADV
cuesj-811	17	2	,	,	PUNCT
cuesj-811	17	3	there	there	PRON
cuesj-811	17	4	were	be	VERB
cuesj-811	17	5	indicators	indicator	NOUN
cuesj-811	17	6	of	of	ADP
cuesj-811	17	7	noncancerous	noncancerous	ADJ
cuesj-811	17	8	origin	origin	NOUN
cuesj-811	17	9	contributed	contribute	VERB
cuesj-811	17	10	to	to	ADP
cuesj-811	17	11	the	the	DET
cuesj-811	17	12	elevation	elevation	NOUN
cuesj-811	17	13	of	of	ADP
cuesj-811	17	14	ca125	ca125	NOUN
cuesj-811	17	15	levels	level	NOUN
cuesj-811	17	16	.	.	PUNCT
cuesj-811	18	1	other	other	ADJ
cuesj-811	18	2	scholars	scholar	NOUN
cuesj-811	18	3	stated	state	VERB
cuesj-811	18	4	,	,	PUNCT
cuesj-811	18	5	when	when	SCONJ
cuesj-811	18	6	thyroid	thyroid	NOUN
cuesj-811	18	7	hormons	hormon	NOUN
cuesj-811	18	8	extensively	extensively	ADV
cuesj-811	18	9	exposed	expose	VERB
cuesj-811	18	10	they	they	PRON
cuesj-811	18	11	have	have	VERB
cuesj-811	18	12	the	the	DET
cuesj-811	18	13	tendency	tendency	NOUN
cuesj-811	18	14	to	to	PART
cuesj-811	18	15	influence	influence	VERB
cuesj-811	18	16	ovarian	ovarian	ADJ
cuesj-811	18	17	tumors	tumor	NOUN
cuesj-811	18	18	development.[4	development.[4	X
cuesj-811	18	19	]	]	X
cuesj-811	18	20	in	in	ADP
cuesj-811	18	21	addition,[5	addition,[5	NOUN
cuesj-811	18	22	]	]	PUNCT
cuesj-811	18	23	in	in	ADP
cuesj-811	18	24	their	their	PRON
cuesj-811	18	25	vitro	vitro	X
cuesj-811	18	26	research	research	NOUN
cuesj-811	18	27	illustrated	illustrate	VERB
cuesj-811	18	28	that	that	SCONJ
cuesj-811	18	29	at	at	ADP
cuesj-811	18	30	the	the	DET
cuesj-811	18	31	physiological	physiological	ADJ
cuesj-811	18	32	levels	level	NOUN
cuesj-811	18	33	both	both	PRON
cuesj-811	18	34	hormones	hormone	NOUN
cuesj-811	18	35	3,5,3’-triiodo	3,5,3’-triiodo	NUM
cuesj-811	18	36	-	-	NOUN
cuesj-811	18	37	l	l	NOUN
cuesj-811	18	38	-	-	NOUN
cuesj-811	18	39	thyronine	thyronine	NOUN
cuesj-811	18	40	and	and	CCONJ
cuesj-811	18	41	l	l	NOUN
cuesj-811	18	42	-	-	PUNCT
cuesj-811	18	43	thyroxin	thyroxin	NOUN
cuesj-811	18	44	,	,	PUNCT
cuesj-811	18	45	(	(	PUNCT
cuesj-811	18	46	t3	t3	PROPN
cuesj-811	18	47	)	)	PUNCT
cuesj-811	18	48	and	and	CCONJ
cuesj-811	18	49	(	(	PUNCT
cuesj-811	18	50	t4	t4	PROPN
cuesj-811	18	51	)	)	PUNCT
cuesj-811	18	52	,	,	PUNCT
cuesj-811	18	53	respectively	respectively	ADV
cuesj-811	18	54	,	,	PUNCT
cuesj-811	18	55	were	be	AUX
cuesj-811	18	56	capable	capable	ADJ
cuesj-811	18	57	of	of	ADP
cuesj-811	18	58	the	the	DET
cuesj-811	18	59	expansion	expansion	NOUN
cuesj-811	18	60	and	and	CCONJ
cuesj-811	18	61	improvement	improvement	NOUN
cuesj-811	18	62	of	of	ADP
cuesj-811	18	63	the	the	DET
cuesj-811	18	64	ovarian	ovarian	ADJ
cuesj-811	18	65	cancer	cancer	NOUN
cuesj-811	18	66	cells	cell	NOUN
cuesj-811	18	67	.	.	PUNCT
cuesj-811	19	1	accordingly	accordingly	ADV
cuesj-811	19	2	,	,	PUNCT
cuesj-811	19	3	these	these	DET
cuesj-811	19	4	cells	cell	NOUN
cuesj-811	19	5	were	be	AUX
cuesj-811	19	6	grown	grow	VERB
cuesj-811	19	7	much	much	ADV
cuesj-811	19	8	slower	slow	ADJ
cuesj-811	19	9	when	when	SCONJ
cuesj-811	19	10	exposed	expose	VERB
cuesj-811	19	11	to	to	ADP
cuesj-811	19	12	(	(	PUNCT
cuesj-811	19	13	t3	t3	PROPN
cuesj-811	19	14	)	)	PUNCT
cuesj-811	19	15	and	and	CCONJ
cuesj-811	19	16	(	(	PUNCT
cuesj-811	19	17	t4	t4	PROPN
cuesj-811	19	18	)	)	PUNCT
cuesj-811	19	19	below	below	ADP
cuesj-811	19	20	normal	normal	ADJ
cuesj-811	19	21	serum	serum	NOUN
cuesj-811	19	22	concentrations	concentration	NOUN
cuesj-811	19	23	levels	level	NOUN
cuesj-811	19	24	.	.	PUNCT
cuesj-811	20	1	hence	hence	ADV
cuesj-811	20	2	,	,	PUNCT
cuesj-811	20	3	thyroid	thyroid	NOUN
cuesj-811	20	4	functionality	functionality	NOUN
cuesj-811	20	5	evaluation	evaluation	NOUN
cuesj-811	20	6	would	would	AUX
cuesj-811	20	7	be	be	AUX
cuesj-811	20	8	important	important	ADJ
cuesj-811	20	9	to	to	PART
cuesj-811	20	10	adjudge	adjudge	VERB
cuesj-811	20	11	whether	whether	SCONJ
cuesj-811	20	12	it	it	PRON
cuesj-811	20	13	is	be	AUX
cuesj-811	20	14	an	an	DET
cuesj-811	20	15	elevation	elevation	NOUN
cuesj-811	20	16	in	in	ADP
cuesj-811	20	17	the	the	DET
cuesj-811	20	18	tumor	tumor	NOUN
cuesj-811	20	19	markers	marker	NOUN
cuesj-811	20	20	or	or	CCONJ
cuesj-811	20	21	high	high	ADJ
cuesj-811	20	22	-	-	PUNCT
cuesj-811	20	23	protein	protein	NOUN
cuesj-811	20	24	ascites.[6	ascites.[6	X
cuesj-811	20	25	]	]	X
cuesj-811	20	26	a	a	DET
cuesj-811	20	27	positive	positive	ADJ
cuesj-811	20	28	correlation	correlation	NOUN
cuesj-811	20	29	was	be	AUX
cuesj-811	20	30	found	find	VERB
cuesj-811	20	31	between	between	ADP
cuesj-811	20	32	ca125	ca125	NOUN
cuesj-811	20	33	and	and	CCONJ
cuesj-811	20	34	the	the	DET
cuesj-811	20	35	total	total	ADJ
cuesj-811	20	36	white	white	ADJ
cuesj-811	20	37	,	,	PUNCT
cuesj-811	20	38	neutrophil	neutrophil	ADJ
cuesj-811	20	39	,	,	PUNCT
cuesj-811	20	40	monocyte	monocyte	NOUN
cuesj-811	20	41	and	and	CCONJ
cuesj-811	20	42	neutrophil	neutrophil	ADJ
cuesj-811	20	43	-	-	PUNCT
cuesj-811	20	44	tolymphocyte	tolymphocyte	NOUN
cuesj-811	20	45	ratio	ratio	NOUN
cuesj-811	20	46	(	(	PUNCT
cuesj-811	20	47	nlr	nlr	PROPN
cuesj-811	20	48	)	)	PUNCT
cuesj-811	20	49	counts	count	NOUN
cuesj-811	20	50	.	.	PUNCT
cuesj-811	21	1	but	but	CCONJ
cuesj-811	21	2	conversely	conversely	ADV
cuesj-811	21	3	,	,	PUNCT
cuesj-811	21	4	a	a	DET
cuesj-811	21	5	negative	negative	ADJ
cuesj-811	21	6	correlation	correlation	NOUN
cuesj-811	21	7	recorded	record	VERB
cuesj-811	21	8	with	with	ADP
cuesj-811	21	9	lymphocytes.[7	lymphocytes.[7	NOUN
cuesj-811	21	10	]	]	X
cuesj-811	21	11	the	the	DET
cuesj-811	21	12	current	current	ADJ
cuesj-811	21	13	study	study	NOUN
cuesj-811	21	14	by	by	ADP
cuesj-811	21	15	ceran	ceran	PROPN
cuesj-811	21	16	et	et	PROPN
cuesj-811	21	17	al.[8	al.[8	PROPN
cuesj-811	21	18	]	]	PUNCT
cuesj-811	21	19	demonstrated	demonstrate	VERB
cuesj-811	21	20	that	that	SCONJ
cuesj-811	21	21	the	the	DET
cuesj-811	21	22	rise	rise	NOUN
cuesj-811	21	23	in	in	ADP
cuesj-811	21	24	neutrophil	neutrophil	ADJ
cuesj-811	21	25	and	and	CCONJ
cuesj-811	21	26	platelet	platelet	NOUN
cuesj-811	21	27	counts	count	NOUN
cuesj-811	21	28	,	,	PUNCT
cuesj-811	21	29	nlr	nlr	PROPN
cuesj-811	21	30	,	,	PUNCT
cuesj-811	21	31	along	along	ADP
cuesj-811	21	32	with	with	ADP
cuesj-811	21	33	platelet	platelet	NOUN
cuesj-811	21	34	-	-	PUNCT
cuesj-811	21	35	to	to	ADP
cuesj-811	21	36	-	-	PUNCT
cuesj-811	21	37	lymphocyte	lymphocyte	ADJ
cuesj-811	21	38	ratio	ratio	NOUN
cuesj-811	21	39	(	(	PUNCT
cuesj-811	21	40	plr	plr	NOUN
cuesj-811	21	41	)	)	PUNCT
cuesj-811	21	42	correlated	correlate	VERB
cuesj-811	21	43	to	to	ADP
cuesj-811	21	44	an	an	DET
cuesj-811	21	45	adverse	adverse	ADJ
cuesj-811	21	46	clinic	clinic	NOUN
cuesj-811	21	47	pathological	pathological	ADJ
cuesj-811	21	48	results	result	NOUN
cuesj-811	21	49	subsequent	subsequent	ADJ
cuesj-811	21	50	to	to	ADP
cuesj-811	21	51	various	various	ADJ
cuesj-811	21	52	cancer	cancer	NOUN
cuesj-811	21	53	types	type	NOUN
cuesj-811	21	54	which	which	PRON
cuesj-811	21	55	comprised	comprise	VERB
cuesj-811	21	56	the	the	DET
cuesj-811	21	57	epithelial	epithelial	ADJ
cuesj-811	21	58	ovarian	ovarian	ADJ
cuesj-811	21	59	cancer	cancer	NOUN
cuesj-811	21	60	(	(	PUNCT
cuesj-811	21	61	eoc	eoc	PROPN
cuesj-811	21	62	)	)	PUNCT
cuesj-811	21	63	.	.	PUNCT
cuesj-811	22	1	while	while	SCONJ
cuesj-811	22	2	a	a	DET
cuesj-811	22	3	previous	previous	ADJ
cuesj-811	22	4	study	study	NOUN
cuesj-811	22	5	mentioned	mention	VERB
cuesj-811	22	6	,	,	PUNCT
cuesj-811	22	7	that	that	SCONJ
cuesj-811	22	8	van	van	PROPN
cuesj-811	22	9	derr	derr	PROPN
cuesj-811	22	10	zee	zee	PROPN
cuesj-811	22	11	et	et	PROPN
cuesj-811	22	12	al	al	PROPN
cuesj-811	22	13	.	.	PROPN
cuesj-811	22	14	shown	show	VERB
cuesj-811	22	15	whether	whether	SCONJ
cuesj-811	22	16	the	the	DET
cuesj-811	22	17	ovarian	ovarian	ADJ
cuesj-811	22	18	tumors	tumor	NOUN
cuesj-811	22	19	were	be	AUX
cuesj-811	22	20	malignant	malignant	ADJ
cuesj-811	22	21	or	or	CCONJ
cuesj-811	22	22	benign	benign	VERB
cuesj-811	22	23	the	the	DET
cuesj-811	22	24	elevation	elevation	NOUN
cuesj-811	22	25	in	in	ADP
cuesj-811	22	26	interleukin-6	interleukin-6	NUM
cuesj-811	22	27	level	level	NOUN
cuesj-811	22	28	in	in	ADP
cuesj-811	22	29	cystic	cystic	ADJ
cuesj-811	22	30	fluids	fluid	NOUN
cuesj-811	22	31	is	be	AUX
cuesj-811	22	32	related	relate	VERB
cuesj-811	22	33	to	to	ADP
cuesj-811	22	34	a	a	DET
cuesj-811	22	35	decline	decline	NOUN
cuesj-811	22	36	corresponding	correspond	VERB
cuesj-811	22	37	author	author	NOUN
cuesj-811	22	38	:	:	PUNCT
cuesj-811	22	39	muhsin	muhsin	PROPN
cuesj-811	22	40	h.	h.	PROPN
cuesj-811	22	41	ubeid	ubeid	PROPN
cuesj-811	22	42	,	,	PUNCT
cuesj-811	22	43	department	department	NOUN
cuesj-811	22	44	of	of	ADP
cuesj-811	22	45	medical	medical	ADJ
cuesj-811	22	46	microbiology	microbiology	NOUN
cuesj-811	22	47	,	,	PUNCT
cuesj-811	22	48	college	college	NOUN
cuesj-811	22	49	of	of	ADP
cuesj-811	22	50	science	science	NOUN
cuesj-811	22	51	,	,	PUNCT
cuesj-811	22	52	cihan	cihan	VERB
cuesj-811	22	53	university	university	NOUN
cuesj-811	22	54	-	-	PUNCT
cuesj-811	22	55	erbil	erbil	PROPN
cuesj-811	22	56	,	,	PUNCT
cuesj-811	22	57	kurdistan	kurdistan	PROPN
cuesj-811	22	58	region	region	NOUN
cuesj-811	22	59	,	,	PUNCT
cuesj-811	22	60	iraq	iraq	PROPN
cuesj-811	22	61	.	.	PUNCT
cuesj-811	23	1	e	e	X
cuesj-811	23	2	-	-	NOUN
cuesj-811	23	3	mail	mail	NOUN
cuesj-811	23	4	:	:	PUNCT
cuesj-811	23	5	muhsin.hmeadi@cihanuniversity.edu.iq	muhsin.hmeadi@cihanuniversity.edu.iq	NOUN
cuesj-811	23	6	received	receive	VERB
cuesj-811	23	7	:	:	PUNCT
cuesj-811	23	8	october	october	PROPN
cuesj-811	23	9	16	16	NUM
cuesj-811	23	10	,	,	PUNCT
cuesj-811	23	11	2022	2022	NUM
cuesj-811	23	12	accepted	accept	VERB
cuesj-811	23	13	:	:	PUNCT
cuesj-811	23	14	december	december	PROPN
cuesj-811	23	15	2	2	NUM
cuesj-811	23	16	,	,	PUNCT
cuesj-811	23	17	2022	2022	NUM
cuesj-811	23	18	published	publish	VERB
cuesj-811	23	19	:	:	PUNCT
cuesj-811	23	20	january	january	PROPN
cuesj-811	23	21	30	30	NUM
cuesj-811	23	22	,	,	PUNCT
cuesj-811	23	23	2023	2023	NUM
cuesj-811	23	24	doi	doi	NOUN
cuesj-811	23	25	:	:	PUNCT
cuesj-811	23	26	10.24086	10.24086	NUM
cuesj-811	23	27	/	/	SYM
cuesj-811	23	28	cuesj.v7n1y2023.pp1	cuesj.v7n1y2023.pp1	NOUN
cuesj-811	23	29	-	-	PUNCT
cuesj-811	23	30	7	7	NUM
cuesj-811	23	31	copyright	copyright	NOUN
cuesj-811	23	32	©	©	PROPN
cuesj-811	23	33	2023	2023	NUM
cuesj-811	23	34	muhsin	muhsin	PROPN
cuesj-811	23	35	h.	h.	PROPN
cuesj-811	23	36	ubeid	ubeid	PROPN
cuesj-811	23	37	,	,	PUNCT
cuesj-811	23	38	ameena	ameena	PROPN
cuesj-811	23	39	s.	s.	PROPN
cuesj-811	23	40	m.	m.	PROPN
cuesj-811	23	41	juma	juma	PROPN
cuesj-811	23	42	,	,	PUNCT
cuesj-811	23	43	tanya	tanya	PROPN
cuesj-811	23	44	s.	s.	PROPN
cuesj-811	23	45	salih	salih	PROPN
cuesj-811	23	46	,	,	PUNCT
cuesj-811	23	47	shilan	shilan	PROPN
cuesj-811	23	48	s.	s.	PROPN
cuesj-811	23	49	kamel	kamel	PROPN
cuesj-811	23	50	,	,	PUNCT
cuesj-811	23	51	shakir	shakir	PROPN
cuesj-811	23	52	m.	m.	PROPN
cuesj-811	23	53	al	al	PROPN
cuesj-811	23	54	-	-	PUNCT
cuesj-811	23	55	awqati	awqati	PROPN
cuesj-811	23	56	.	.	PUNCT
cuesj-811	24	1	this	this	PRON
cuesj-811	24	2	is	be	AUX
cuesj-811	24	3	an	an	DET
cuesj-811	24	4	open	open	ADJ
cuesj-811	24	5	-	-	PUNCT
cuesj-811	24	6	access	access	NOUN
cuesj-811	24	7	article	article	NOUN
cuesj-811	24	8	distributed	distribute	VERB
cuesj-811	24	9	under	under	ADP
cuesj-811	24	10	the	the	DET
cuesj-811	24	11	creative	creative	ADJ
cuesj-811	24	12	commons	common	NOUN
cuesj-811	24	13	attribution	attribution	NOUN
cuesj-811	24	14	license	license	NOUN
cuesj-811	24	15	(	(	PUNCT
cuesj-811	24	16	cc	cc	NOUN
cuesj-811	24	17	by	by	ADP
cuesj-811	24	18	-	-	PUNCT
cuesj-811	24	19	nc	nc	VERB
cuesj-811	24	20	-	-	PROPN
cuesj-811	24	21	nd	nd	PRON
cuesj-811	24	22	4.0	4.0	NUM
cuesj-811	24	23	)	)	PUNCT
cuesj-811	24	24	cihan	cihan	VERB
cuesj-811	24	25	university	university	NOUN
cuesj-811	24	26	-	-	PUNCT
cuesj-811	24	27	erbil	erbil	PROPN
cuesj-811	24	28	scientific	scientific	ADJ
cuesj-811	24	29	journal	journal	NOUN
cuesj-811	24	30	(	(	PUNCT
cuesj-811	24	31	cuesj	cuesj	PROPN
cuesj-811	24	32	)	)	PUNCT
cuesj-811	24	33	cihan	cihan	VERB
cuesj-811	24	34	university	university	NOUN
cuesj-811	24	35	-	-	PUNCT
cuesj-811	24	36	erbil	erbil	PROPN
cuesj-811	24	37	scientific	scientific	ADJ
cuesj-811	24	38	journal	journal	NOUN
cuesj-811	24	39	(	(	PUNCT
cuesj-811	24	40	cuesj	cuesj	ADJ
cuesj-811	24	41	)	)	PUNCT
cuesj-811	24	42	ubeid	ubeid	NOUN
cuesj-811	24	43	,	,	PUNCT
cuesj-811	24	44	et	et	PROPN
cuesj-811	24	45	al	al	PROPN
cuesj-811	24	46	.	.	PUNCT
cuesj-811	24	47	:	:	PUNCT
cuesj-811	25	1	parameter	parameter	PROPN
cuesj-811	25	2	affecting	affect	VERB
cuesj-811	25	3	ca-125	ca-125	PROPN
cuesj-811	25	4	,	,	PUNCT
cuesj-811	25	5	tsh	tsh	NOUN
cuesj-811	25	6	,	,	PUNCT
cuesj-811	25	7	and	and	CCONJ
cuesj-811	25	8	cbc	cbc	NOUN
cuesj-811	25	9	2	2	NUM
cuesj-811	25	10	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-811	25	11	cuesj	cuesj	NOUN
cuesj-811	25	12	2023	2023	NUM
cuesj-811	25	13	,	,	PUNCT
cuesj-811	25	14	7	7	NUM
cuesj-811	25	15	(	(	PUNCT
cuesj-811	25	16	1	1	NUM
cuesj-811	25	17	):	):	PUNCT
cuesj-811	25	18	1	1	NUM
cuesj-811	25	19	-	-	SYM
cuesj-811	25	20	7	7	NUM
cuesj-811	25	21	in	in	ADP
cuesj-811	25	22	the	the	DET
cuesj-811	25	23	hemoglobin	hemoglobin	NOUN
cuesj-811	25	24	level	level	NOUN
cuesj-811	25	25	and	and	CCONJ
cuesj-811	25	26	an	an	DET
cuesj-811	25	27	inclination	inclination	NOUN
cuesj-811	25	28	in	in	ADP
cuesj-811	25	29	platelet	platelet	NOUN
cuesj-811	25	30	count.[9,10	count.[9,10	NOUN
cuesj-811	25	31	]	]	PUNCT
cuesj-811	25	32	based	base	VERB
cuesj-811	25	33	on	on	ADP
cuesj-811	25	34	lengye	lengye	PROPN
cuesj-811	25	35	study	study	NOUN
cuesj-811	25	36	,	,	PUNCT
cuesj-811	25	37	the	the	DET
cuesj-811	25	38	ovary	ovary	ADJ
cuesj-811	25	39	cell	cell	NOUN
cuesj-811	25	40	transformation	transformation	NOUN
cuesj-811	25	41	occur	occur	VERB
cuesj-811	25	42	due	due	ADJ
cuesj-811	25	43	to	to	ADP
cuesj-811	25	44	ovarian	ovarian	ADJ
cuesj-811	25	45	carcinoma	carcinoma	NOUN
cuesj-811	25	46	that	that	PRON
cuesj-811	25	47	is	be	AUX
cuesj-811	25	48	consequent	consequent	ADJ
cuesj-811	25	49	to	to	ADP
cuesj-811	25	50	genetic	genetic	ADJ
cuesj-811	25	51	and	and	CCONJ
cuesj-811	25	52	epigenetic	epigenetic	ADJ
cuesj-811	25	53	alterations.[11	alterations.[11	PROPN
cuesj-811	25	54	]	]	PUNCT
cuesj-811	25	55	ovarian	ovarian	ADJ
cuesj-811	25	56	cancer	cancer	NOUN
cuesj-811	25	57	etiology	etiology	NOUN
cuesj-811	25	58	is	be	AUX
cuesj-811	25	59	still	still	ADV
cuesj-811	25	60	not	not	PART
cuesj-811	25	61	verified	verify	VERB
cuesj-811	25	62	.	.	PUNCT
cuesj-811	26	1	however	however	ADV
cuesj-811	26	2	,	,	PUNCT
cuesj-811	26	3	the	the	DET
cuesj-811	26	4	incessant	incessant	PROPN
cuesj-811	26	5	ovulation	ovulation	NOUN
cuesj-811	26	6	theory	theory	NOUN
cuesj-811	26	7	is	be	AUX
cuesj-811	26	8	one	one	NUM
cuesj-811	26	9	of	of	ADP
cuesj-811	26	10	the	the	DET
cuesj-811	26	11	models	model	NOUN
cuesj-811	26	12	to	to	PART
cuesj-811	26	13	explain	explain	VERB
cuesj-811	26	14	the	the	DET
cuesj-811	26	15	issue	issue	NOUN
cuesj-811	26	16	.	.	PUNCT
cuesj-811	27	1	it	it	PRON
cuesj-811	27	2	states	state	VERB
cuesj-811	27	3	that	that	SCONJ
cuesj-811	27	4	women	woman	NOUN
cuesj-811	27	5	have	have	VERB
cuesj-811	27	6	a	a	DET
cuesj-811	27	7	continual	continual	ADJ
cuesj-811	27	8	ovulation	ovulation	NOUN
cuesj-811	27	9	regardless	regardless	ADV
cuesj-811	27	10	to	to	ADP
cuesj-811	27	11	age.[12	age.[12	NOUN
cuesj-811	27	12	]	]	X
cuesj-811	27	13	another	another	DET
cuesj-811	27	14	proponents	proponent	NOUN
cuesj-811	27	15	stated	state	VERB
cuesj-811	27	16	that	that	SCONJ
cuesj-811	27	17	high	high	ADJ
cuesj-811	27	18	contributors	contributor	NOUN
cuesj-811	27	19	to	to	ADP
cuesj-811	27	20	ovary	ovary	ADJ
cuesj-811	27	21	carcinoma	carcinoma	NOUN
cuesj-811	27	22	were	be	AUX
cuesj-811	27	23	,	,	PUNCT
cuesj-811	27	24	that	that	ADV
cuesj-811	27	25	is	is	ADV
cuesj-811	27	26	,	,	PUNCT
cuesj-811	27	27	infertility	infertility	NOUN
cuesj-811	27	28	alongside	alongside	ADV
cuesj-811	27	29	to	to	PART
cuesj-811	27	30	menopause	menopause	VERB
cuesj-811	27	31	age	age	NOUN
cuesj-811	27	32	.	.	PUNCT
cuesj-811	28	1	yet	yet	ADV
cuesj-811	28	2	,	,	PUNCT
cuesj-811	28	3	determinants	determinant	NOUN
cuesj-811	28	4	particularly	particularly	ADV
cuesj-811	28	5	hysterectomy	hysterectomy	ADJ
cuesj-811	28	6	,	,	PUNCT
cuesj-811	28	7	pregnancy	pregnancy	NOUN
cuesj-811	28	8	,	,	PUNCT
cuesj-811	28	9	and	and	CCONJ
cuesj-811	28	10	tubal	tubal	ADJ
cuesj-811	28	11	ligation	ligation	NOUN
cuesj-811	28	12	showed	show	VERB
cuesj-811	28	13	to	to	PART
cuesj-811	28	14	diminish	diminish	VERB
cuesj-811	28	15	such	such	ADJ
cuesj-811	28	16	risk.[13,14	risk.[13,14	NOUN
cuesj-811	28	17	]	]	X
cuesj-811	28	18	abdominal	abdominal	ADJ
cuesj-811	28	19	size	size	NOUN
cuesj-811	28	20	,	,	PUNCT
cuesj-811	28	21	bloating	bloat	VERB
cuesj-811	28	22	,	,	PUNCT
cuesj-811	28	23	urinary	urinary	ADJ
cuesj-811	28	24	symptoms	symptom	NOUN
cuesj-811	28	25	,	,	PUNCT
cuesj-811	28	26	and	and	CCONJ
cuesj-811	28	27	pelvic	pelvic	ADJ
cuesj-811	28	28	pains	pain	NOUN
cuesj-811	28	29	are	be	AUX
cuesj-811	28	30	the	the	DET
cuesj-811	28	31	symptoms	symptom	NOUN
cuesj-811	28	32	that	that	PRON
cuesj-811	28	33	were	be	AUX
cuesj-811	28	34	frequently	frequently	ADV
cuesj-811	28	35	informed	inform	VERB
cuesj-811	28	36	by	by	ADP
cuesj-811	28	37	women	woman	NOUN
cuesj-811	28	38	prior	prior	ADV
cuesj-811	28	39	diagnosing	diagnose	VERB
cuesj-811	28	40	them	they	PRON
cuesj-811	28	41	with	with	ADP
cuesj-811	28	42	ovarian	ovarian	ADJ
cuesj-811	28	43	cancer	cancer	NOUN
cuesj-811	28	44	.	.	PUNCT
cuesj-811	29	1	such	such	ADJ
cuesj-811	29	2	symptoms	symptom	NOUN
cuesj-811	29	3	are	be	AUX
cuesj-811	29	4	likely	likely	ADJ
cuesj-811	29	5	indicators	indicator	NOUN
cuesj-811	29	6	causing	cause	VERB
cuesj-811	29	7	cancer	cancer	NOUN
cuesj-811	29	8	more	more	ADJ
cuesj-811	29	9	than	than	ADP
cuesj-811	29	10	benign	benign	ADJ
cuesj-811	29	11	.	.	PUNCT
cuesj-811	30	1	yet	yet	ADV
cuesj-811	30	2	,	,	PUNCT
cuesj-811	30	3	distinguishing	distinguish	VERB
cuesj-811	30	4	cancer	cancer	NOUN
cuesj-811	30	5	symptoms	symptom	NOUN
cuesj-811	30	6	from	from	ADP
cuesj-811	30	7	those	those	PRON
cuesj-811	30	8	associating	associate	VERB
cuesj-811	30	9	with	with	ADP
cuesj-811	30	10	benign	benign	ADJ
cuesj-811	30	11	is	be	AUX
cuesj-811	30	12	difficult	difficult	ADJ
cuesj-811	30	13	.	.	PUNCT
cuesj-811	31	1	consequently	consequently	ADV
cuesj-811	31	2	,	,	PUNCT
cuesj-811	31	3	results	result	NOUN
cuesj-811	31	4	,	,	PUNCT
cuesj-811	31	5	regardless	regardless	ADV
cuesj-811	31	6	how	how	SCONJ
cuesj-811	31	7	sensitive	sensitive	ADJ
cuesj-811	31	8	and	and	CCONJ
cuesj-811	31	9	specific	specific	ADJ
cuesj-811	31	10	pelvic	pelvic	ADJ
cuesj-811	31	11	examinations	examination	NOUN
cuesj-811	31	12	that	that	PRON
cuesj-811	31	13	were	be	AUX
cuesj-811	31	14	carried	carry	VERB
cuesj-811	31	15	out	out	ADP
cuesj-811	31	16	to	to	PART
cuesj-811	31	17	detect	detect	VERB
cuesj-811	31	18	asymptomatic	asymptomatic	ADJ
cuesj-811	31	19	ovarian	ovarian	ADJ
cuesj-811	31	20	cancer	cancer	NOUN
cuesj-811	31	21	recorded	record	VERB
cuesj-811	31	22	poor	poor	ADJ
cuesj-811	31	23	also	also	ADV
cuesj-811	31	24	,	,	PUNCT
cuesj-811	31	25	not	not	PART
cuesj-811	31	26	supporting	support	VERB
cuesj-811	31	27	the	the	DET
cuesj-811	31	28	physical	physical	ADJ
cuesj-811	31	29	examination	examination	NOUN
cuesj-811	31	30	in	in	ADP
cuesj-811	31	31	same	same	ADJ
cuesj-811	31	32	way	way	NOUN
cuesj-811	31	33	as	as	SCONJ
cuesj-811	31	34	the	the	DET
cuesj-811	31	35	screening	screening	NOUN
cuesj-811	31	36	method.[15	method.[15	PROPN
cuesj-811	31	37	]	]	PUNCT
cuesj-811	31	38	according	accord	VERB
cuesj-811	31	39	to	to	ADP
cuesj-811	31	40	national	national	ADJ
cuesj-811	31	41	academies	academy	NOUN
cuesj-811	31	42	of	of	ADP
cuesj-811	31	43	sciences	science	NOUN
cuesj-811	31	44	and	and	CCONJ
cuesj-811	31	45	medicine	medicine	NOUN
cuesj-811	31	46	women	woman	NOUN
cuesj-811	31	47	and	and	CCONJ
cuesj-811	31	48	their	their	PRON
cuesj-811	31	49	designated	designate	VERB
cuesj-811	31	50	health	health	NOUN
cuesj-811	31	51	care	care	NOUN
cuesj-811	31	52	providers	provider	NOUN
cuesj-811	31	53	repeatedly	repeatedly	ADV
cuesj-811	31	54	look	look	VERB
cuesj-811	31	55	upon	upon	SCONJ
cuesj-811	31	56	as	as	SCONJ
cuesj-811	31	57	such	such	ADJ
cuesj-811	31	58	symptoms	symptom	NOUN
cuesj-811	31	59	(	(	PUNCT
cuesj-811	31	60	ovarian	ovarian	ADJ
cuesj-811	31	61	cancers	cancer	NOUN
cuesj-811	31	62	)	)	PUNCT
cuesj-811	31	63	as	as	ADP
cuesj-811	31	64	non	non	ADJ
cuesj-811	31	65	-	-	ADJ
cuesj-811	31	66	specific	specific	ADJ
cuesj-811	31	67	and	and	CCONJ
cuesj-811	31	68	not	not	PART
cuesj-811	31	69	referring	refer	VERB
cuesj-811	31	70	to	to	ADP
cuesj-811	31	71	critical	critical	ADJ
cuesj-811	31	72	illness	illness	NOUN
cuesj-811	31	73	until	until	SCONJ
cuesj-811	31	74	they	they	PRON
cuesj-811	31	75	are	be	AUX
cuesj-811	31	76	dramatically	dramatically	ADV
cuesj-811	31	77	worsen	worsen	ADJ
cuesj-811	31	78	or	or	CCONJ
cuesj-811	31	79	developed.[16	developed.[16	PROPN
cuesj-811	31	80	]	]	PUNCT
cuesj-811	31	81	which	which	PRON
cuesj-811	31	82	concurrent	concurrent	ADJ
cuesj-811	31	83	with	with	ADP
cuesj-811	31	84	rauh	rauh	PROPN
cuesj-811	31	85	-	-	PUNCT
cuesj-811	31	86	hain	hain	PROPN
cuesj-811	31	87	et	et	NOUN
cuesj-811	31	88	al.[17	al.[17	PROPN
cuesj-811	31	89	]	]	PUNCT
cuesj-811	31	90	who	who	PRON
cuesj-811	31	91	suggested	suggest	VERB
cuesj-811	31	92	that	that	SCONJ
cuesj-811	31	93	70	70	NUM
cuesj-811	31	94	%	%	NOUN
cuesj-811	31	95	of	of	ADP
cuesj-811	31	96	women	woman	NOUN
cuesj-811	31	97	with	with	ADP
cuesj-811	31	98	ovarian	ovarian	ADJ
cuesj-811	31	99	cancer	cancer	NOUN
cuesj-811	31	100	were	be	AUX
cuesj-811	31	101	diagnosed	diagnose	VERB
cuesj-811	31	102	at	at	ADP
cuesj-811	31	103	late	late	ADJ
cuesj-811	31	104	stages	stage	NOUN
cuesj-811	31	105	of	of	ADP
cuesj-811	31	106	the	the	DET
cuesj-811	31	107	disease	disease	NOUN
cuesj-811	31	108	hence	hence	ADV
cuesj-811	31	109	,	,	PUNCT
cuesj-811	31	110	these	these	DET
cuesj-811	31	111	women	woman	NOUN
cuesj-811	31	112	have	have	VERB
cuesj-811	31	113	a	a	DET
cuesj-811	31	114	high	high	ADJ
cuesj-811	31	115	fatality	fatality	NOUN
cuesj-811	31	116	rate	rate	NOUN
cuesj-811	31	117	and	and	CCONJ
cuesj-811	31	118	have	have	VERB
cuesj-811	31	119	a	a	DET
cuesj-811	31	120	5	5	NUM
cuesj-811	31	121	year	year	NOUN
cuesj-811	31	122	survival	survival	NOUN
cuesj-811	31	123	rates	rate	NOUN
cuesj-811	31	124	with	with	ADP
cuesj-811	31	125	advanced	advanced	ADJ
cuesj-811	31	126	illness	illness	NOUN
cuesj-811	31	127	ranging	range	VERB
cuesj-811	31	128	between	between	ADP
cuesj-811	31	129	20	20	NUM
cuesj-811	31	130	%	%	NOUN
cuesj-811	31	131	and	and	CCONJ
cuesj-811	31	132	30	30	NUM
cuesj-811	31	133	%	%	NOUN
cuesj-811	31	134	.	.	PUNCT
cuesj-811	32	1	in	in	ADP
cuesj-811	32	2	contrast	contrast	NOUN
cuesj-811	32	3	,	,	PUNCT
cuesj-811	32	4	early	early	ADV
cuesj-811	32	5	diagnosed	diagnose	VERB
cuesj-811	32	6	women	woman	NOUN
cuesj-811	32	7	as	as	SCONJ
cuesj-811	32	8	the	the	DET
cuesj-811	32	9	disease	disease	NOUN
cuesj-811	32	10	is	be	AUX
cuesj-811	32	11	encompassed	encompass	VERB
cuesj-811	32	12	within	within	ADP
cuesj-811	32	13	the	the	DET
cuesj-811	32	14	ovary	ovary	NOUN
cuesj-811	32	15	the	the	DET
cuesj-811	32	16	cure	cure	NOUN
cuesj-811	32	17	percentage	percentage	NOUN
cuesj-811	32	18	were	be	AUX
cuesj-811	32	19	70–90	70–90	NUM
cuesj-811	32	20	%	%	NOUN
cuesj-811	32	21	.	.	PUNCT
cuesj-811	33	1	more	more	ADJ
cuesj-811	33	2	into	into	ADP
cuesj-811	33	3	this	this	PRON
cuesj-811	33	4	,	,	PUNCT
cuesj-811	33	5	due	due	ADP
cuesj-811	33	6	to	to	ADP
cuesj-811	33	7	an	an	DET
cuesj-811	33	8	association	association	NOUN
cuesj-811	33	9	between	between	ADP
cuesj-811	33	10	the	the	DET
cuesj-811	33	11	disease	disease	NOUN
cuesj-811	33	12	stage	stage	NOUN
cuesj-811	33	13	and	and	CCONJ
cuesj-811	33	14	survival	survival	NOUN
cuesj-811	33	15	,	,	PUNCT
cuesj-811	33	16	early	early	ADJ
cuesj-811	33	17	detection	detection	NOUN
cuesj-811	33	18	provides	provide	VERB
cuesj-811	33	19	higher	high	ADJ
cuesj-811	33	20	hope	hope	NOUN
cuesj-811	33	21	to	to	PART
cuesj-811	33	22	reduce	reduce	VERB
cuesj-811	33	23	mortality	mortality	NOUN
cuesj-811	33	24	besides	besides	SCONJ
cuesj-811	33	25	long	long	ADJ
cuesj-811	33	26	-	-	PUNCT
cuesj-811	33	27	term	term	NOUN
cuesj-811	33	28	disease	disease	NOUN
cuesj-811	33	29	control	control	NOUN
cuesj-811	33	30	.	.	PUNCT
cuesj-811	34	1	globally	globally	ADV
cuesj-811	34	2	,	,	PUNCT
cuesj-811	34	3	the	the	DET
cuesj-811	34	4	ovarian	ovarian	ADJ
cuesj-811	34	5	cancer	cancer	NOUN
cuesj-811	34	6	is	be	AUX
cuesj-811	34	7	ranked	rank	VERB
cuesj-811	34	8	the	the	DET
cuesj-811	34	9	7th	7th	ADJ
cuesj-811	34	10	disease	disease	NOUN
cuesj-811	34	11	that	that	PRON
cuesj-811	34	12	is	be	AUX
cuesj-811	34	13	commonly	commonly	ADV
cuesj-811	34	14	diagnosed	diagnose	VERB
cuesj-811	34	15	cancer	cancer	NOUN
cuesj-811	34	16	while	while	NOUN
cuesj-811	34	17	,	,	PUNCT
cuesj-811	34	18	it	it	PRON
cuesj-811	34	19	is	be	AUX
cuesj-811	34	20	classified	classify	VERB
cuesj-811	34	21	the	the	DET
cuesj-811	34	22	8th	8th	NOUN
cuesj-811	34	23	among	among	ADP
cuesj-811	34	24	cancer	cancer	NOUN
cuesj-811	34	25	diseases	disease	NOUN
cuesj-811	34	26	causing	cause	VERB
cuesj-811	34	27	death	death	NOUN
cuesj-811	34	28	.	.	PUNCT
cuesj-811	35	1	239,000	239,000	NUM
cuesj-811	35	2	women	woman	NOUN
cuesj-811	35	3	were	be	AUX
cuesj-811	35	4	diagnosed	diagnose	VERB
cuesj-811	35	5	with	with	ADP
cuesj-811	35	6	this	this	DET
cuesj-811	35	7	illness	illness	NOUN
cuesj-811	35	8	in	in	ADP
cuesj-811	35	9	2012	2012	NUM
cuesj-811	35	10	,	,	PUNCT
cuesj-811	35	11	152,000	152,000	NUM
cuesj-811	35	12	did	do	AUX
cuesj-811	35	13	not	not	PART
cuesj-811	35	14	survive.[18	survive.[18	VERB
cuesj-811	35	15	]	]	PUNCT
cuesj-811	35	16	yet	yet	ADV
cuesj-811	35	17	,	,	PUNCT
cuesj-811	35	18	the	the	DET
cuesj-811	35	19	disease	disease	NOUN
cuesj-811	35	20	mortality	mortality	NOUN
cuesj-811	35	21	rates	rate	NOUN
cuesj-811	35	22	and	and	CCONJ
cuesj-811	35	23	its	its	PRON
cuesj-811	35	24	frequencies	frequency	NOUN
cuesj-811	35	25	vary	vary	VERB
cuesj-811	35	26	from	from	ADP
cuesj-811	35	27	one	one	NUM
cuesj-811	35	28	region	region	NOUN
cuesj-811	35	29	to	to	ADP
cuesj-811	35	30	another	another	PRON
cuesj-811	35	31	.	.	PUNCT
cuesj-811	36	1	and	and	CCONJ
cuesj-811	36	2	the	the	DET
cuesj-811	36	3	variance	variance	NOUN
cuesj-811	36	4	is	be	AUX
cuesj-811	36	5	due	due	ADJ
cuesj-811	36	6	to	to	ADP
cuesj-811	36	7	genetic	genetic	ADJ
cuesj-811	36	8	factors	factor	NOUN
cuesj-811	36	9	and	and	CCONJ
cuesj-811	36	10	environmental	environmental	ADJ
cuesj-811	36	11	influences.[19	influences.[19	NOUN
cuesj-811	36	12	]	]	PUNCT
cuesj-811	36	13	moradi	moradi	NOUN
cuesj-811	36	14	et	et	PROPN
cuesj-811	36	15	al	al	PROPN
cuesj-811	36	16	.	.	PROPN
cuesj-811	36	17	stated	state	VERB
cuesj-811	36	18	that	that	SCONJ
cuesj-811	36	19	iran	iran	PROPN
cuesj-811	36	20	is	be	AUX
cuesj-811	36	21	witnessing	witness	VERB
cuesj-811	36	22	an	an	DET
cuesj-811	36	23	inclination	inclination	NOUN
cuesj-811	36	24	in	in	ADP
cuesj-811	36	25	ovarian	ovarian	ADJ
cuesj-811	36	26	cancer	cancer	NOUN
cuesj-811	36	27	cases	case	NOUN
cuesj-811	36	28	,	,	PUNCT
cuesj-811	36	29	specifically	specifically	ADV
cuesj-811	36	30	in	in	ADP
cuesj-811	36	31	the	the	DET
cuesj-811	36	32	central	central	ADJ
cuesj-811	36	33	and	and	CCONJ
cuesj-811	36	34	northwestern	northwestern	ADJ
cuesj-811	36	35	regions	region	NOUN
cuesj-811	36	36	.	.	PUNCT
cuesj-811	37	1	they	they	PRON
cuesj-811	37	2	suggested	suggest	VERB
cuesj-811	37	3	that	that	SCONJ
cuesj-811	37	4	this	this	DET
cuesj-811	37	5	increment	increment	NOUN
cuesj-811	37	6	is	be	AUX
cuesj-811	37	7	stemming	stem	VERB
cuesj-811	37	8	from	from	ADP
cuesj-811	37	9	changes	change	NOUN
cuesj-811	37	10	in	in	ADP
cuesj-811	37	11	the	the	DET
cuesj-811	37	12	patterns	pattern	NOUN
cuesj-811	37	13	of	of	ADP
cuesj-811	37	14	risk	risk	NOUN
cuesj-811	37	15	factors	factor	NOUN
cuesj-811	37	16	regarding	regard	VERB
cuesj-811	37	17	this	this	DET
cuesj-811	37	18	disease	disease	NOUN
cuesj-811	37	19	,	,	PUNCT
cuesj-811	37	20	that	that	ADV
cuesj-811	37	21	is	is	ADV
cuesj-811	37	22	,	,	PUNCT
cuesj-811	37	23	changes	change	NOUN
cuesj-811	37	24	in	in	ADP
cuesj-811	37	25	the	the	DET
cuesj-811	37	26	population	population	NOUN
cuesj-811	37	27	’s	’s	PART
cuesj-811	37	28	lifestyle	lifestyle	NOUN
cuesj-811	37	29	that	that	PRON
cuesj-811	37	30	caused	cause	VERB
cuesj-811	37	31	this	this	DET
cuesj-811	37	32	escalation.[20	escalation.[20	NOUN
cuesj-811	37	33	]	]	PUNCT
cuesj-811	37	34	meanwhile	meanwhile	ADV
cuesj-811	37	35	,	,	PUNCT
cuesj-811	37	36	it	it	PRON
cuesj-811	37	37	was	be	AUX
cuesj-811	37	38	illustrated	illustrate	VERB
cuesj-811	37	39	that	that	SCONJ
cuesj-811	37	40	,	,	PUNCT
cuesj-811	37	41	the	the	DET
cuesj-811	37	42	risk	risk	NOUN
cuesj-811	37	43	of	of	ADP
cuesj-811	37	44	confronting	confront	VERB
cuesj-811	37	45	severe	severe	ADJ
cuesj-811	37	46	and	and	CCONJ
cuesj-811	37	47	death	death	NOUN
cuesj-811	37	48	from	from	ADP
cuesj-811	37	49	this	this	DET
cuesj-811	37	50	disease	disease	NOUN
cuesj-811	37	51	in	in	ADP
cuesj-811	37	52	the	the	DET
cuesj-811	37	53	developed	develop	VERB
cuesj-811	37	54	countries	country	NOUN
cuesj-811	37	55	are	be	AUX
cuesj-811	37	56	higher	high	ADJ
cuesj-811	37	57	and	and	CCONJ
cuesj-811	37	58	nearly	nearly	ADV
cuesj-811	37	59	the	the	DET
cuesj-811	37	60	double	double	ADJ
cuesj-811	37	61	from	from	ADP
cuesj-811	37	62	those	those	PRON
cuesj-811	37	63	of	of	ADP
cuesj-811	37	64	less	less	ADJ
cuesj-811	37	65	developed	developed	ADJ
cuesj-811	37	66	countries	country	NOUN
cuesj-811	37	67	.	.	PUNCT
cuesj-811	38	1	yet	yet	ADV
cuesj-811	38	2	,	,	PUNCT
cuesj-811	38	3	the	the	DET
cuesj-811	38	4	latter	latter	ADJ
cuesj-811	38	5	countries	country	NOUN
cuesj-811	38	6	recorded	record	VERB
cuesj-811	38	7	higher	high	ADJ
cuesj-811	38	8	ovarian	ovarian	ADJ
cuesj-811	38	9	cancer	cancer	NOUN
cuesj-811	38	10	cases	case	NOUN
cuesj-811	38	11	because	because	SCONJ
cuesj-811	38	12	of	of	ADP
cuesj-811	38	13	the	the	DET
cuesj-811	38	14	large	large	ADJ
cuesj-811	38	15	populations	population	NOUN
cuesj-811	38	16	.	.	PUNCT
cuesj-811	39	1	comparing	compare	VERB
cuesj-811	39	2	the	the	DET
cuesj-811	39	3	diagnosed	diagnose	VERB
cuesj-811	39	4	cases	case	NOUN
cuesj-811	39	5	number	number	NOUN
cuesj-811	39	6	per	per	ADP
cuesj-811	39	7	year	year	NOUN
cuesj-811	39	8	china	china	PROPN
cuesj-811	39	9	recorded	record	VERB
cuesj-811	39	10	34,575	34,575	NUM
cuesj-811	39	11	,	,	PUNCT
cuesj-811	39	12	india	india	PROPN
cuesj-811	39	13	26,834	26,834	NUM
cuesj-811	39	14	and	and	CCONJ
cuesj-811	39	15	the	the	DET
cuesj-811	39	16	usa	usa	PROPN
cuesj-811	39	17	20,874.[21	20,874.[21	PROPN
cuesj-811	39	18	]	]	PUNCT
cuesj-811	39	19	after	after	ADP
cuesj-811	39	20	more	more	ADJ
cuesj-811	39	21	than	than	ADP
cuesj-811	39	22	two	two	NUM
cuesj-811	39	23	decades	decade	NOUN
cuesj-811	39	24	from	from	ADP
cuesj-811	39	25	the	the	DET
cuesj-811	39	26	discovering	discover	VERB
cuesj-811	39	27	ca125	ca125	NOUN
cuesj-811	39	28	,	,	PUNCT
cuesj-811	39	29	its	its	PRON
cuesj-811	39	30	antigen	antigen	NOUN
cuesj-811	39	31	was	be	AUX
cuesj-811	39	32	recommended	recommend	VERB
cuesj-811	39	33	for	for	ADP
cuesj-811	39	34	screening	screen	VERB
cuesj-811	39	35	women	woman	NOUN
cuesj-811	39	36	with	with	ADP
cuesj-811	39	37	high	high	ADJ
cuesj-811	39	38	risk	risk	NOUN
cuesj-811	39	39	with	with	ADP
cuesj-811	39	40	ovarian	ovarian	ADJ
cuesj-811	39	41	cancer	cancer	NOUN
cuesj-811	39	42	at	at	ADP
cuesj-811	39	43	clinical	clinical	ADJ
cuesj-811	39	44	level	level	NOUN
cuesj-811	39	45	regardless	regardless	ADV
cuesj-811	39	46	to	to	ADP
cuesj-811	39	47	its	its	PRON
cuesj-811	39	48	sensitivity	sensitivity	NOUN
cuesj-811	39	49	and	and	CCONJ
cuesj-811	39	50	specificity	specificity	NOUN
cuesj-811	39	51	limitation.[22	limitation.[22	PROPN
cuesj-811	39	52	]	]	PUNCT
cuesj-811	39	53	current	current	ADJ
cuesj-811	39	54	results	result	NOUN
cuesj-811	39	55	advise	advise	VERB
cuesj-811	39	56	that	that	SCONJ
cuesj-811	39	57	ca125	ca125	PRON
cuesj-811	39	58	possibly	possibly	ADV
cuesj-811	39	59	be	be	AUX
cuesj-811	39	60	a	a	DET
cuesj-811	39	61	foretelling	foretell	VERB
cuesj-811	39	62	indicator	indicator	NOUN
cuesj-811	39	63	of	of	ADP
cuesj-811	39	64	perinvasive	perinvasive	ADJ
cuesj-811	39	65	ovarian	ovarian	ADJ
cuesj-811	39	66	cancer	cancer	NOUN
cuesj-811	39	67	.	.	PUNCT
cuesj-811	40	1	the	the	DET
cuesj-811	40	2	ca125	ca125	NOUN
cuesj-811	40	3	measuring	measure	VERB
cuesj-811	40	4	approaches	approach	NOUN
cuesj-811	40	5	had	have	AUX
cuesj-811	40	6	progressed	progress	VERB
cuesj-811	40	7	toward	toward	ADP
cuesj-811	40	8	sensitive	sensitive	ADJ
cuesj-811	40	9	and	and	CCONJ
cuesj-811	40	10	reliable	reliable	ADJ
cuesj-811	40	11	double	double	ADJ
cuesj-811	40	12	-	-	PUNCT
cuesj-811	40	13	determinant	determinant	ADJ
cuesj-811	40	14	elisa	elisa	NOUN
cuesj-811	40	15	assays.[23	assays.[23	NOUN
cuesj-811	40	16	]	]	PUNCT
cuesj-811	40	17	while	while	SCONJ
cuesj-811	40	18	others	other	NOUN
cuesj-811	40	19	findings	finding	VERB
cuesj-811	40	20	that	that	SCONJ
cuesj-811	40	21	,	,	PUNCT
cuesj-811	40	22	the	the	DET
cuesj-811	40	23	escalated	escalate	VERB
cuesj-811	40	24	levels	level	NOUN
cuesj-811	40	25	of	of	ADP
cuesj-811	40	26	ca125	ca125	NOUN
cuesj-811	40	27	serum	serum	NOUN
cuesj-811	40	28	are	be	AUX
cuesj-811	40	29	not	not	PART
cuesj-811	40	30	correlated	correlate	VERB
cuesj-811	40	31	to	to	ADP
cuesj-811	40	32	the	the	DET
cuesj-811	40	33	size	size	NOUN
cuesj-811	40	34	of	of	ADP
cuesj-811	40	35	the	the	DET
cuesj-811	40	36	tumor	tumor	NOUN
cuesj-811	40	37	of	of	ADP
cuesj-811	40	38	both	both	DET
cuesj-811	40	39	age	age	NOUN
cuesj-811	40	40	groups.[24	groups.[24	PROPN
cuesj-811	40	41	]	]	PUNCT
cuesj-811	40	42	as	as	ADP
cuesj-811	40	43	a	a	DET
cuesj-811	40	44	glycosylated	glycosylated	ADJ
cuesj-811	40	45	membrane	membrane	NOUN
cuesj-811	40	46	protein	protein	NOUN
cuesj-811	40	47	and	and	CCONJ
cuesj-811	40	48	a	a	DET
cuesj-811	40	49	high	high	ADJ
cuesj-811	40	50	molecular	molecular	ADJ
cuesj-811	40	51	weight	weight	NOUN
cuesj-811	40	52	,	,	PUNCT
cuesj-811	40	53	the	the	DET
cuesj-811	40	54	ca125	ca125	NOUN
cuesj-811	40	55	can	can	AUX
cuesj-811	40	56	be	be	AUX
cuesj-811	40	57	identified	identify	VERB
cuesj-811	40	58	in	in	ADP
cuesj-811	40	59	the	the	DET
cuesj-811	40	60	serum	serum	NOUN
cuesj-811	40	61	which	which	PRON
cuesj-811	40	62	is	be	AUX
cuesj-811	40	63	levitated	levitate	VERB
cuesj-811	40	64	in	in	ADP
cuesj-811	40	65	over	over	ADP
cuesj-811	40	66	80	80	NUM
cuesj-811	40	67	%	%	NOUN
cuesj-811	40	68	of	of	ADP
cuesj-811	40	69	ovarian	ovarian	ADJ
cuesj-811	40	70	cancer	cancer	NOUN
cuesj-811	40	71	patients	patient	NOUN
cuesj-811	40	72	.	.	PUNCT
cuesj-811	41	1	developing	develop	VERB
cuesj-811	41	2	ca125	ca125	NOUN
cuesj-811	41	3	from	from	ADP
cuesj-811	41	4	the	the	DET
cuesj-811	41	5	coelomic	coelomic	ADJ
cuesj-811	41	6	epithelium	epithelium	NOUN
cuesj-811	41	7	facilitated	facilitate	VERB
cuesj-811	41	8	the	the	DET
cuesj-811	41	9	marking	marking	NOUN
cuesj-811	41	10	of	of	ADP
cuesj-811	41	11	the	the	DET
cuesj-811	41	12	epithelial	epithelial	NOUN
cuesj-811	41	13	.	.	PUNCT
cuesj-811	42	1	it	it	PRON
cuesj-811	42	2	had	have	AUX
cuesj-811	42	3	marked	mark	VERB
cuesj-811	42	4	90	90	NUM
cuesj-811	42	5	%	%	NOUN
cuesj-811	42	6	of	of	ADP
cuesj-811	42	7	advanced	advanced	ADJ
cuesj-811	42	8	and	and	CCONJ
cuesj-811	42	9	50	50	NUM
cuesj-811	42	10	%	%	NOUN
cuesj-811	42	11	of	of	ADP
cuesj-811	42	12	early	early	ADJ
cuesj-811	42	13	ovarian	ovarian	ADJ
cuesj-811	42	14	cancer	cancer	NOUN
cuesj-811	42	15	cases	case	NOUN
cuesj-811	42	16	but	but	CCONJ
cuesj-811	42	17	,	,	PUNCT
cuesj-811	42	18	20	20	NUM
cuesj-811	42	19	%	%	NOUN
cuesj-811	42	20	were	be	AUX
cuesj-811	42	21	marked	mark	VERB
cuesj-811	42	22	as	as	ADV
cuesj-811	42	23	low	low	ADJ
cuesj-811	42	24	or	or	CCONJ
cuesj-811	42	25	had	have	VERB
cuesj-811	42	26	no	no	DET
cuesj-811	42	27	expression	expression	NOUN
cuesj-811	42	28	.	.	PUNCT
cuesj-811	43	1	the	the	DET
cuesj-811	43	2	ca125	ca125	NOUN
cuesj-811	43	3	is	be	AUX
cuesj-811	43	4	likely	likely	ADJ
cuesj-811	43	5	to	to	PART
cuesj-811	43	6	arise	arise	VERB
cuesj-811	43	7	its	its	PRON
cuesj-811	43	8	level	level	NOUN
cuesj-811	43	9	if	if	SCONJ
cuesj-811	43	10	any	any	DET
cuesj-811	43	11	disruptions	disruption	NOUN
cuesj-811	43	12	occurred	occur	VERB
cuesj-811	43	13	to	to	ADP
cuesj-811	43	14	the	the	DET
cuesj-811	43	15	peritoneum	peritoneum	NOUN
cuesj-811	43	16	epithelial	epithelial	ADJ
cuesj-811	43	17	lining	lining	NOUN
cuesj-811	43	18	.	.	PUNCT
cuesj-811	44	1	similarly	similarly	ADV
cuesj-811	44	2	,	,	PUNCT
cuesj-811	44	3	pregnancy	pregnancy	NOUN
cuesj-811	44	4	,	,	PUNCT
cuesj-811	44	5	leiomyomata	leiomyomata	ADJ
cuesj-811	44	6	,	,	PUNCT
cuesj-811	44	7	ovarian	ovarian	ADJ
cuesj-811	44	8	cysts	cyst	NOUN
cuesj-811	44	9	,	,	PUNCT
cuesj-811	44	10	endometriosis	endometriosis	NOUN
cuesj-811	44	11	,	,	PUNCT
cuesj-811	44	12	appendicitis	appendicitis	NOUN
cuesj-811	44	13	,	,	PUNCT
cuesj-811	44	14	and	and	CCONJ
cuesj-811	44	15	diverticulitis	diverticulitis	NOUN
cuesj-811	44	16	which	which	PRON
cuesj-811	44	17	are	be	AUX
cuesj-811	44	18	all	all	ADV
cuesj-811	44	19	benign	benign	ADJ
cuesj-811	44	20	conditions	condition	NOUN
cuesj-811	44	21	the	the	DET
cuesj-811	44	22	ca125	ca125	NOUN
cuesj-811	44	23	level	level	NOUN
cuesj-811	44	24	were	be	AUX
cuesj-811	44	25	high	high	ADJ
cuesj-811	44	26	.	.	PUNCT
cuesj-811	45	1	equally	equally	ADV
cuesj-811	45	2	,	,	PUNCT
cuesj-811	45	3	lung	lung	NOUN
cuesj-811	45	4	,	,	PUNCT
cuesj-811	45	5	pancreas	pancrea	NOUN
cuesj-811	45	6	,	,	PUNCT
cuesj-811	45	7	colon	colon	NOUN
cuesj-811	45	8	and	and	CCONJ
cuesj-811	45	9	uterine	uterine	ADJ
cuesj-811	45	10	cancers	cancer	NOUN
cuesj-811	45	11	showed	show	VERB
cuesj-811	45	12	and	and	CCONJ
cuesj-811	45	13	escalation	escalation	NOUN
cuesj-811	45	14	in	in	ADP
cuesj-811	45	15	the	the	DET
cuesj-811	45	16	ca125	ca125	NOUN
cuesj-811	45	17	levels	level	NOUN
cuesj-811	45	18	.	.	PUNCT
cuesj-811	46	1	therefore	therefore	ADV
cuesj-811	46	2	,	,	PUNCT
cuesj-811	46	3	it	it	PRON
cuesj-811	46	4	is	be	AUX
cuesj-811	46	5	lacking	lack	VERB
cuesj-811	46	6	the	the	DET
cuesj-811	46	7	sensitivity	sensitivity	NOUN
cuesj-811	46	8	and	and	CCONJ
cuesj-811	46	9	specificity	specificity	NOUN
cuesj-811	46	10	and	and	CCONJ
cuesj-811	46	11	thus	thus	ADV
cuesj-811	46	12	,	,	PUNCT
cuesj-811	46	13	it	it	PRON
cuesj-811	46	14	will	will	AUX
cuesj-811	46	15	not	not	PART
cuesj-811	46	16	be	be	AUX
cuesj-811	46	17	adequate	adequate	ADJ
cuesj-811	46	18	to	to	PART
cuesj-811	46	19	identify	identify	VERB
cuesj-811	46	20	the	the	DET
cuesj-811	46	21	ovarian	ovarian	ADJ
cuesj-811	46	22	cancer	cancer	NOUN
cuesj-811	46	23	at	at	ADP
cuesj-811	46	24	early	early	ADJ
cuesj-811	46	25	stages.[25,26	stages.[25,26	NOUN
cuesj-811	46	26	]	]	X
cuesj-811	46	27	gyftaki	gyftaki	NOUN
cuesj-811	46	28	et	et	PROPN
cuesj-811	46	29	al	al	PROPN
cuesj-811	46	30	.	.	PROPN
cuesj-811	46	31	stated	state	VERB
cuesj-811	46	32	that	that	SCONJ
cuesj-811	46	33	,	,	PUNCT
cuesj-811	46	34	the	the	DET
cuesj-811	46	35	functionality	functionality	NOUN
cuesj-811	46	36	of	of	ADP
cuesj-811	46	37	a	a	DET
cuesj-811	46	38	normal	normal	ADJ
cuesj-811	46	39	thyroid	thyroid	NOUN
cuesj-811	46	40	is	be	AUX
cuesj-811	46	41	regulated	regulate	VERB
cuesj-811	46	42	by	by	ADP
cuesj-811	46	43	the	the	DET
cuesj-811	46	44	thyroid	thyroid	NOUN
cuesj-811	46	45	stimulating	stimulate	VERB
cuesj-811	46	46	hormone	hormone	NOUN
cuesj-811	46	47	(	(	PUNCT
cuesj-811	46	48	tsh	tsh	NOUN
cuesj-811	46	49	)	)	PUNCT
cuesj-811	46	50	by	by	ADP
cuesj-811	46	51	attaching	attach	VERB
cuesj-811	46	52	to	to	ADP
cuesj-811	46	53	the	the	DET
cuesj-811	46	54	thyroid	thyroid	NOUN
cuesj-811	46	55	receptor	receptor	NOUN
cuesj-811	46	56	tsh	tsh	NOUN
cuesj-811	46	57	receptor	receptor	NOUN
cuesj-811	46	58	that	that	PRON
cuesj-811	46	59	is	be	AUX
cuesj-811	46	60	located	locate	VERB
cuesj-811	46	61	at	at	ADP
cuesj-811	46	62	its	its	PRON
cuesj-811	46	63	cells	cell	NOUN
cuesj-811	46	64	surface	surface	NOUN
cuesj-811	46	65	.	.	PUNCT
cuesj-811	47	1	they	they	PRON
cuesj-811	47	2	further	far	ADV
cuesj-811	47	3	demonstrated	demonstrate	VERB
cuesj-811	47	4	that	that	SCONJ
cuesj-811	47	5	among	among	ADP
cuesj-811	47	6	other	other	ADJ
cuesj-811	47	7	tissues	tissue	NOUN
cuesj-811	47	8	,	,	PUNCT
cuesj-811	47	9	other	other	ADJ
cuesj-811	47	10	than	than	ADP
cuesj-811	47	11	the	the	DET
cuesj-811	47	12	thyroid	thyroid	NOUN
cuesj-811	47	13	,	,	PUNCT
cuesj-811	47	14	specifically	specifically	ADV
cuesj-811	47	15	the	the	DET
cuesj-811	47	16	surface	surface	NOUN
cuesj-811	47	17	of	of	ADP
cuesj-811	47	18	a	a	DET
cuesj-811	47	19	normal	normal	ADJ
cuesj-811	47	20	ovarian	ovarian	ADJ
cuesj-811	47	21	epithelium	epithelium	NOUN
cuesj-811	47	22	is	be	AUX
cuesj-811	47	23	amply	amply	ADV
cuesj-811	47	24	expressed	express	VERB
cuesj-811	47	25	on.[27	on.[27	PROPN
cuesj-811	47	26	]	]	PUNCT
cuesj-811	47	27	the	the	DET
cuesj-811	47	28	encoding	encoding	NOUN
cuesj-811	47	29	thyroid	thyroid	NOUN
cuesj-811	47	30	hormone	hormone	NOUN
cuesj-811	47	31	with	with	ADP
cuesj-811	47	32	estrogen	estrogen	NOUN
cuesj-811	47	33	receptors	receptor	NOUN
cuesj-811	47	34	(	(	PUNCT
cuesj-811	47	35	tr	tr	VERB
cuesj-811	47	36	)	)	PUNCT
cuesj-811	47	37	and	and	CCONJ
cuesj-811	47	38	(	(	PUNCT
cuesj-811	47	39	er	er	INTJ
cuesj-811	47	40	)	)	PUNCT
cuesj-811	47	41	were	be	AUX
cuesj-811	47	42	among	among	ADP
cuesj-811	47	43	various	various	ADJ
cuesj-811	47	44	nuclear	nuclear	ADJ
cuesj-811	47	45	hormone	hormone	NOUN
cuesj-811	47	46	receptor	receptor	NOUN
cuesj-811	47	47	genes	gene	NOUN
cuesj-811	47	48	that	that	PRON
cuesj-811	47	49	are	be	AUX
cuesj-811	47	50	distributed	distribute	VERB
cuesj-811	47	51	in	in	ADP
cuesj-811	47	52	ovarian	ovarian	ADJ
cuesj-811	47	53	surface	surface	NOUN
cuesj-811	47	54	epithelial	epithelial	ADJ
cuesj-811	47	55	cells	cell	NOUN
cuesj-811	47	56	(	(	PUNCT
cuesj-811	47	57	ose	ose	NOUN
cuesj-811	47	58	)	)	PUNCT
cuesj-811	47	59	.	.	PUNCT
cuesj-811	48	1	equally	equally	ADV
cuesj-811	48	2	important	important	ADJ
cuesj-811	48	3	,	,	PUNCT
cuesj-811	48	4	from	from	ADP
cuesj-811	48	5	the	the	DET
cuesj-811	48	6	epidemiology	epidemiology	NOUN
cuesj-811	48	7	perspective	perspective	NOUN
cuesj-811	48	8	,	,	PUNCT
cuesj-811	48	9	evidently	evidently	ADV
cuesj-811	48	10	correlate	correlate	VERB
cuesj-811	48	11	the	the	DET
cuesj-811	48	12	ovarian	ovarian	ADJ
cuesj-811	48	13	surface	surface	NOUN
cuesj-811	48	14	inflammation	inflammation	NOUN
cuesj-811	48	15	of	of	ADP
cuesj-811	48	16	the	the	DET
cuesj-811	48	17	ovary	ovary	NOUN
cuesj-811	48	18	and	and	CCONJ
cuesj-811	48	19	hyperthyroidism	hyperthyroidism	NOUN
cuesj-811	48	20	with	with	ADP
cuesj-811	48	21	the	the	DET
cuesj-811	48	22	ovarian	ovarian	ADJ
cuesj-811	48	23	cancer	cancer	NOUN
cuesj-811	48	24	(	(	PUNCT
cuesj-811	48	25	hormonedependent).[28	hormonedependent).[28	PROPN
cuesj-811	48	26	]	]	PUNCT
cuesj-811	48	27	hyperthyroidism	hyperthyroidism	NOUN
cuesj-811	48	28	is	be	AUX
cuesj-811	48	29	where	where	SCONJ
cuesj-811	48	30	hormones	hormone	NOUN
cuesj-811	48	31	of	of	ADP
cuesj-811	48	32	the	the	DET
cuesj-811	48	33	thyroid	thyroid	NOUN
cuesj-811	48	34	t3	t3	PROPN
cuesj-811	48	35	and	and	CCONJ
cuesj-811	48	36	t4	t4	PROPN
cuesj-811	48	37	excessive	excessive	ADJ
cuesj-811	48	38	concentrations	concentration	NOUN
cuesj-811	48	39	travel	travel	VERB
cuesj-811	48	40	through	through	ADP
cuesj-811	48	41	blood	blood	NOUN
cuesj-811	48	42	stream	stream	NOUN
cuesj-811	48	43	through	through	ADP
cuesj-811	48	44	the	the	DET
cuesj-811	48	45	human	human	ADJ
cuesj-811	48	46	body	body	NOUN
cuesj-811	48	47	reaching	reach	VERB
cuesj-811	48	48	the	the	DET
cuesj-811	48	49	ovarian	ovarian	ADJ
cuesj-811	48	50	tissue	tissue	NOUN
cuesj-811	48	51	and	and	CCONJ
cuesj-811	48	52	consequently	consequently	ADV
cuesj-811	48	53	causing	cause	VERB
cuesj-811	48	54	its	its	PRON
cuesj-811	48	55	inflammation	inflammation	NOUN
cuesj-811	48	56	.	.	PUNCT
cuesj-811	49	1	the	the	DET
cuesj-811	49	2	receptors	receptor	NOUN
cuesj-811	49	3	in	in	ADP
cuesj-811	49	4	the	the	DET
cuesj-811	49	5	ose	ose	NOUN
cuesj-811	49	6	cells	cell	NOUN
cuesj-811	49	7	are	be	AUX
cuesj-811	49	8	responsive	responsive	ADJ
cuesj-811	49	9	to	to	PART
cuesj-811	49	10	thyroid	thyroid	VERB
cuesj-811	49	11	and	and	CCONJ
cuesj-811	49	12	estrogen	estrogen	NOUN
cuesj-811	49	13	hormones	hormone	NOUN
cuesj-811	49	14	.	.	PUNCT
cuesj-811	50	1	however	however	ADV
cuesj-811	50	2	,	,	PUNCT
cuesj-811	50	3	direct	direct	ADJ
cuesj-811	50	4	effects	effect	NOUN
cuesj-811	50	5	of	of	ADP
cuesj-811	50	6	ovarian	ovarian	ADJ
cuesj-811	50	7	epithelial	epithelial	ADJ
cuesj-811	50	8	cells	cell	NOUN
cuesj-811	50	9	inflammation	inflammation	NOUN
cuesj-811	50	10	are	be	AUX
cuesj-811	50	11	compelled	compel	VERB
cuesj-811	50	12	by	by	ADP
cuesj-811	50	13	the	the	DET
cuesj-811	50	14	t3	t3	PROPN
cuesj-811	50	15	.	.	PUNCT
cuesj-811	51	1	once	once	SCONJ
cuesj-811	51	2	the	the	DET
cuesj-811	51	3	latter	latter	ADJ
cuesj-811	51	4	hormone	hormone	NOUN
cuesj-811	51	5	attaches	attach	VERB
cuesj-811	51	6	to	to	ADP
cuesj-811	51	7	its	its	PRON
cuesj-811	51	8	corresponding	corresponding	ADJ
cuesj-811	51	9	ose	ose	NOUN
cuesj-811	51	10	receptor	receptor	NOUN
cuesj-811	51	11	the	the	DET
cuesj-811	51	12	erα	erα	NOUN
cuesj-811	51	13	and	and	CCONJ
cuesj-811	51	14	mrna	mrna	PROPN
cuesj-811	51	15	expressions	expression	NOUN
cuesj-811	51	16	are	be	AUX
cuesj-811	51	17	increased	increase	VERB
cuesj-811	51	18	then	then	ADV
cuesj-811	51	19	the	the	DET
cuesj-811	51	20	estrogen	estrogen	NOUN
cuesj-811	51	21	receptor	receptor	NOUN
cuesj-811	51	22	action	action	NOUN
cuesj-811	51	23	is	be	AUX
cuesj-811	51	24	mirrored	mirror	VERB
cuesj-811	51	25	resulting	result	VERB
cuesj-811	51	26	in	in	ADP
cuesj-811	51	27	encoding	encode	VERB
cuesj-811	51	28	the	the	DET
cuesj-811	51	29	er	er	INTJ
cuesj-811	51	30	isoforms.[29	isoforms.[29	PROPN
cuesj-811	51	31	]	]	X
cuesj-811	51	32	they	they	PRON
cuesj-811	51	33	further	far	ADV
cuesj-811	51	34	suggested	suggest	VERB
cuesj-811	51	35	that	that	SCONJ
cuesj-811	51	36	,	,	PUNCT
cuesj-811	51	37	ovarian	ovarian	ADJ
cuesj-811	51	38	cancer	cancer	NOUN
cuesj-811	51	39	is	be	AUX
cuesj-811	51	40	highly	highly	ADV
cuesj-811	51	41	correlated	correlate	VERB
cuesj-811	51	42	with	with	ADP
cuesj-811	51	43	isoforms	isoform	NOUN
cuesj-811	51	44	and	and	CCONJ
cuesj-811	51	45	likely	likely	ADJ
cuesj-811	51	46	to	to	PART
cuesj-811	51	47	be	be	AUX
cuesj-811	51	48	linked	link	VERB
cuesj-811	51	49	with	with	ADP
cuesj-811	51	50	hyperthyroidism	hyperthyroidism	NOUN
cuesj-811	51	51	.	.	PUNCT
cuesj-811	52	1	another	another	DET
cuesj-811	52	2	research	research	NOUN
cuesj-811	52	3	expressed	express	VERB
cuesj-811	52	4	that	that	SCONJ
cuesj-811	52	5	in	in	ADP
cuesj-811	52	6	vitro	vitro	X
cuesj-811	52	7	the	the	DET
cuesj-811	52	8	thyroid	thyroid	NOUN
cuesj-811	52	9	hormones	hormone	NOUN
cuesj-811	52	10	existing	exist	VERB
cuesj-811	52	11	in	in	ADP
cuesj-811	52	12	ovaries	ovary	NOUN
cuesj-811	52	13	cells	cell	NOUN
cuesj-811	52	14	infected	infect	VERB
cuesj-811	52	15	with	with	ADP
cuesj-811	52	16	cancer	cancer	NOUN
cuesj-811	52	17	changed	change	VERB
cuesj-811	52	18	both	both	CCONJ
cuesj-811	52	19	the	the	DET
cuesj-811	52	20	genes	gene	NOUN
cuesj-811	52	21	expression	expression	NOUN
cuesj-811	52	22	that	that	PRON
cuesj-811	52	23	regulates	regulate	VERB
cuesj-811	52	24	cell	cell	NOUN
cuesj-811	52	25	cycle	cycle	NOUN
cuesj-811	52	26	and	and	CCONJ
cuesj-811	52	27	the	the	DET
cuesj-811	52	28	apoptosis	apoptosis	NOUN
cuesj-811	52	29	of	of	ADP
cuesj-811	52	30	cancer	cancer	NOUN
cuesj-811	52	31	cell	cell	NOUN
cuesj-811	52	32	.	.	PUNCT
cuesj-811	53	1	this	this	DET
cuesj-811	53	2	action	action	NOUN
cuesj-811	53	3	can	can	AUX
cuesj-811	53	4	be	be	AUX
cuesj-811	53	5	demonstrated	demonstrate	VERB
cuesj-811	53	6	by	by	ADP
cuesj-811	53	7	the	the	DET
cuesj-811	53	8	inclination	inclination	NOUN
cuesj-811	53	9	in	in	ADP
cuesj-811	53	10	the	the	DET
cuesj-811	53	11	genes	gene	NOUN
cuesj-811	53	12	expression	expression	NOUN
cuesj-811	53	13	of	of	ADP
cuesj-811	53	14	which	which	PRON
cuesj-811	53	15	are	be	AUX
cuesj-811	53	16	responsible	responsible	ADJ
cuesj-811	53	17	for	for	ADP
cuesj-811	53	18	the	the	DET
cuesj-811	53	19	tumor	tumor	NOUN
cuesj-811	53	20	’s	’s	PART
cuesj-811	53	21	protein	protein	NOUN
cuesj-811	53	22	suppression	suppression	NOUN
cuesj-811	53	23	p12	p12	NOUN
cuesj-811	53	24	and	and	CCONJ
cuesj-811	53	25	p16	p16	NOUN
cuesj-811	53	26	,	,	PUNCT
cuesj-811	53	27	besides	besides	ADV
cuesj-811	53	28	,	,	PUNCT
cuesj-811	53	29	its	its	PRON
cuesj-811	53	30	significant	significant	ADJ
cuesj-811	53	31	role	role	NOUN
cuesj-811	53	32	in	in	ADP
cuesj-811	53	33	regulating	regulate	VERB
cuesj-811	53	34	cell	cell	NOUN
cuesj-811	53	35	cycle.[30	cycle.[30	NOUN
cuesj-811	53	36	]	]	PUNCT
cuesj-811	53	37	anomalous	anomalous	ADJ
cuesj-811	53	38	hematological	hematological	ADJ
cuesj-811	53	39	incidences	incidence	NOUN
cuesj-811	53	40	recorded	record	VERB
cuesj-811	53	41	with	with	ADP
cuesj-811	53	42	ovarian	ovarian	ADJ
cuesj-811	53	43	cancer	cancer	NOUN
cuesj-811	53	44	patients	patient	NOUN
cuesj-811	53	45	when	when	SCONJ
cuesj-811	53	46	compared	compare	VERB
cuesj-811	53	47	with	with	ADP
cuesj-811	53	48	similar	similar	ADJ
cuesj-811	53	49	benign	benign	ADJ
cuesj-811	53	50	cases	case	NOUN
cuesj-811	53	51	such	such	ADJ
cuesj-811	53	52	as	as	ADP
cuesj-811	53	53	:	:	PUNCT
cuesj-811	53	54	first	first	ADV
cuesj-811	53	55	,	,	PUNCT
cuesj-811	53	56	hemoglobin	hemoglobin	NOUN
cuesj-811	53	57	hb	hb	PROPN
cuesj-811	53	58	and	and	CCONJ
cuesj-811	53	59	hematocrit	hematocrit	PROPN
cuesj-811	53	60	hct	hct	PROPN
cuesj-811	53	61	levels	level	NOUN
cuesj-811	53	62	were	be	AUX
cuesj-811	53	63	substantially	substantially	ADV
cuesj-811	53	64	low	low	ADJ
cuesj-811	53	65	,	,	PUNCT
cuesj-811	53	66	second	second	ADJ
cuesj-811	53	67	,	,	PUNCT
cuesj-811	53	68	high	high	ADJ
cuesj-811	53	69	platelet	platelet	NOUN
cuesj-811	53	70	count	count	NOUN
cuesj-811	53	71	,	,	PUNCT
cuesj-811	53	72	and	and	CCONJ
cuesj-811	53	73	thirdly	thirdly	ADV
cuesj-811	53	74	lymphocytes	lymphocyte	VERB
cuesj-811	53	75	values	value	NOUN
cuesj-811	53	76	were	be	AUX
cuesj-811	53	77	low.[31	low.[31	NOUN
cuesj-811	53	78	-	-	SYM
cuesj-811	53	79	33	33	NUM
cuesj-811	53	80	]	]	PUNCT
cuesj-811	53	81	ubeid	ubeid	NOUN
cuesj-811	53	82	,	,	PUNCT
cuesj-811	53	83	et	et	PROPN
cuesj-811	53	84	al	al	PROPN
cuesj-811	53	85	.	.	PUNCT
cuesj-811	53	86	:	:	PUNCT
cuesj-811	54	1	parameter	parameter	PROPN
cuesj-811	54	2	affecting	affect	VERB
cuesj-811	54	3	ca-125	ca-125	PROPN
cuesj-811	54	4	,	,	PUNCT
cuesj-811	54	5	tsh	tsh	NOUN
cuesj-811	54	6	,	,	PUNCT
cuesj-811	54	7	and	and	CCONJ
cuesj-811	54	8	cbc	cbc	NOUN
cuesj-811	54	9	3	3	NUM
cuesj-811	54	10	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-811	54	11	cuesj	cuesj	NOUN
cuesj-811	54	12	2023	2023	NUM
cuesj-811	54	13	,	,	PUNCT
cuesj-811	54	14	7	7	NUM
cuesj-811	54	15	(	(	PUNCT
cuesj-811	54	16	1	1	NUM
cuesj-811	54	17	):	):	PUNCT
cuesj-811	54	18	1	1	NUM
cuesj-811	54	19	-	-	SYM
cuesj-811	54	20	7	7	NUM
cuesj-811	54	21	van	van	PROPN
cuesj-811	54	22	der	der	NOUN
cuesj-811	54	23	zee	zee	PROPN
cuesj-811	54	24	et	et	PROPN
cuesj-811	54	25	al	al	PROPN
cuesj-811	54	26	.	.	PROPN
cuesj-811	54	27	illustrated	illustrate	VERB
cuesj-811	54	28	that	that	SCONJ
cuesj-811	54	29	within	within	ADP
cuesj-811	54	30	malignant	malignant	ADJ
cuesj-811	54	31	disease	disease	NOUN
cuesj-811	54	32	the	the	DET
cuesj-811	54	33	presence	presence	NOUN
cuesj-811	54	34	of	of	ADP
cuesj-811	54	35	a	a	DET
cuesj-811	54	36	conceivable	conceivable	ADJ
cuesj-811	54	37	relation	relation	NOUN
cuesj-811	54	38	between	between	ADP
cuesj-811	54	39	hemoglobin	hemoglobin	NOUN
cuesj-811	54	40	il-6	il-6	NOUN
cuesj-811	54	41	levels	level	NOUN
cuesj-811	54	42	and	and	CCONJ
cuesj-811	54	43	platelets	platelet	NOUN
cuesj-811	54	44	.	.	PUNCT
cuesj-811	55	1	they	they	PRON
cuesj-811	55	2	also	also	ADV
cuesj-811	55	3	stated	state	VERB
cuesj-811	55	4	that	that	SCONJ
cuesj-811	55	5	,	,	PUNCT
cuesj-811	55	6	as	as	SCONJ
cuesj-811	55	7	such	such	ADJ
cuesj-811	55	8	patients	patient	NOUN
cuesj-811	55	9	show	show	VERB
cuesj-811	55	10	negative	negative	ADJ
cuesj-811	55	11	predicting	predict	VERB
cuesj-811	55	12	factors	factor	NOUN
cuesj-811	55	13	when	when	SCONJ
cuesj-811	55	14	there	there	PRON
cuesj-811	55	15	is	be	VERB
cuesj-811	55	16	an	an	DET
cuesj-811	55	17	elevated	elevated	ADJ
cuesj-811	55	18	pre	pre	ADJ
cuesj-811	55	19	-	-	ADJ
cuesj-811	55	20	treatment	treatment	ADJ
cuesj-811	55	21	platelet	platelet	NOUN
cuesj-811	55	22	counts	count	NOUN
cuesj-811	55	23	in	in	ADP
cuesj-811	55	24	addition	addition	NOUN
cuesj-811	55	25	to	to	ADP
cuesj-811	55	26	,	,	PUNCT
cuesj-811	55	27	low	low	ADJ
cuesj-811	55	28	levels	level	NOUN
cuesj-811	55	29	of	of	ADP
cuesj-811	55	30	pretreatment	pretreatment	NOUN
cuesj-811	55	31	hemoglobin	hemoglobin	NOUN
cuesj-811	55	32	.	.	PUNCT
cuesj-811	56	1	they	they	PRON
cuesj-811	56	2	additionally	additionally	ADV
cuesj-811	56	3	spotted	spot	VERB
cuesj-811	56	4	an	an	DET
cuesj-811	56	5	association	association	NOUN
cuesj-811	56	6	between	between	ADP
cuesj-811	56	7	il-6	il-6	NOUN
cuesj-811	56	8	cystic	cystic	ADJ
cuesj-811	56	9	fluid	fluid	NOUN
cuesj-811	56	10	levels	level	NOUN
cuesj-811	56	11	with	with	ADP
cuesj-811	56	12	the	the	DET
cuesj-811	56	13	level	level	NOUN
cuesj-811	56	14	of	of	ADP
cuesj-811	56	15	hemoglobin	hemoglobin	NOUN
cuesj-811	56	16	and	and	CCONJ
cuesj-811	56	17	platelet	platelet	NOUN
cuesj-811	56	18	counts.[9	counts.[9	NOUN
cuesj-811	56	19	]	]	X
cuesj-811	56	20	other	other	ADJ
cuesj-811	56	21	scholars	scholar	NOUN
cuesj-811	56	22	suggested	suggest	VERB
cuesj-811	56	23	similar	similar	ADJ
cuesj-811	56	24	association	association	NOUN
cuesj-811	56	25	in	in	ADP
cuesj-811	56	26	those	those	DET
cuesj-811	56	27	patients	patient	NOUN
cuesj-811	56	28	with	with	ADP
cuesj-811	56	29	progressive	progressive	ADJ
cuesj-811	56	30	illness	illness	NOUN
cuesj-811	56	31	where	where	SCONJ
cuesj-811	56	32	anemia	anemia	NOUN
cuesj-811	56	33	is	be	AUX
cuesj-811	56	34	probably	probably	ADV
cuesj-811	56	35	related	relate	VERB
cuesj-811	56	36	to	to	ADP
cuesj-811	56	37	il-6	il-6	NOUN
cuesj-811	56	38	levels.[10	levels.[10	PROPN
cuesj-811	56	39	]	]	PUNCT
cuesj-811	56	40	which	which	PRON
cuesj-811	56	41	agrees	agree	VERB
cuesj-811	56	42	with	with	ADP
cuesj-811	56	43	nomelini	nomelini	PROPN
cuesj-811	56	44	et	et	NOUN
cuesj-811	56	45	al.[34	al.[34	PROPN
cuesj-811	56	46	]	]	PUNCT
cuesj-811	56	47	identification	identification	NOUN
cuesj-811	56	48	of	of	ADP
cuesj-811	56	49	the	the	DET
cuesj-811	56	50	prognostic	prognostic	ADJ
cuesj-811	56	51	factors	factor	NOUN
cuesj-811	56	52	,	,	PUNCT
cuesj-811	56	53	which	which	PRON
cuesj-811	56	54	are	be	AUX
cuesj-811	56	55	resulting	result	VERB
cuesj-811	56	56	from	from	ADP
cuesj-811	56	57	a	a	DET
cuesj-811	56	58	probable	probable	ADJ
cuesj-811	56	59	role	role	NOUN
cuesj-811	56	60	of	of	ADP
cuesj-811	56	61	il-6	il-6	NOUN
cuesj-811	56	62	tumor	tumor	NOUN
cuesj-811	56	63	derived	derive	VERB
cuesj-811	56	64	alongside	alongside	ADV
cuesj-811	56	65	with	with	ADP
cuesj-811	56	66	irregular	irregular	ADJ
cuesj-811	56	67	rates	rate	NOUN
cuesj-811	56	68	of	of	ADP
cuesj-811	56	69	hemoglobin	hemoglobin	NOUN
cuesj-811	56	70	and	and	CCONJ
cuesj-811	56	71	platelet	platelet	NOUN
cuesj-811	56	72	levels	level	NOUN
cuesj-811	56	73	.	.	PUNCT
cuesj-811	57	1	a	a	DET
cuesj-811	57	2	late	late	ADJ
cuesj-811	57	3	research	research	NOUN
cuesj-811	57	4	weighed	weigh	VERB
cuesj-811	57	5	other	other	ADJ
cuesj-811	57	6	ovarian	ovarian	ADJ
cuesj-811	57	7	cancer	cancer	NOUN
cuesj-811	57	8	predictive	predictive	ADJ
cuesj-811	57	9	factors	factor	NOUN
cuesj-811	57	10	for	for	ADP
cuesj-811	57	11	survival	survival	NOUN
cuesj-811	57	12	.	.	PUNCT
cuesj-811	58	1	it	it	PRON
cuesj-811	58	2	comprises	comprise	VERB
cuesj-811	58	3	the	the	DET
cuesj-811	58	4	ratios	ratio	NOUN
cuesj-811	58	5	of	of	ADP
cuesj-811	58	6	nlr	nlr	PROPN
cuesj-811	58	7	along	along	ADP
cuesj-811	58	8	with	with	ADP
cuesj-811	58	9	plr	plr	NOUN
cuesj-811	58	10	.	.	PUNCT
cuesj-811	59	1	it	it	PRON
cuesj-811	59	2	also	also	ADV
cuesj-811	59	3	added	add	VERB
cuesj-811	59	4	that	that	SCONJ
cuesj-811	59	5	these	these	DET
cuesj-811	59	6	ratios	ratio	NOUN
cuesj-811	59	7	highlight	highlight	VERB
cuesj-811	59	8	the	the	DET
cuesj-811	59	9	possibility	possibility	NOUN
cuesj-811	59	10	to	to	PART
cuesj-811	59	11	differentiate	differentiate	VERB
cuesj-811	59	12	whether	whether	SCONJ
cuesj-811	59	13	the	the	DET
cuesj-811	59	14	ovarian	ovarian	ADJ
cuesj-811	59	15	masses	masse	NOUN
cuesj-811	59	16	are	be	AUX
cuesj-811	59	17	malignant	malignant	ADJ
cuesj-811	59	18	or	or	CCONJ
cuesj-811	59	19	benign	benign	ADJ
cuesj-811	59	20	.	.	PUNCT
cuesj-811	60	1	yet	yet	ADV
cuesj-811	60	2	,	,	PUNCT
cuesj-811	60	3	because	because	SCONJ
cuesj-811	60	4	of	of	ADP
cuesj-811	60	5	their	their	PRON
cuesj-811	60	6	values	value	NOUN
cuesj-811	60	7	it	it	PRON
cuesj-811	60	8	does	do	AUX
cuesj-811	60	9	not	not	PART
cuesj-811	60	10	have	have	VERB
cuesj-811	60	11	a	a	DET
cuesj-811	60	12	total	total	ADJ
cuesj-811	60	13	consensus	consensus	NOUN
cuesj-811	60	14	as	as	ADP
cuesj-811	60	15	an	an	DET
cuesj-811	60	16	ovarian	ovarian	ADJ
cuesj-811	60	17	cancer	cancer	NOUN
cuesj-811	60	18	screening	screen	VERB
cuesj-811	60	19	tool	tool	NOUN
cuesj-811	60	20	.	.	PUNCT
cuesj-811	61	1	moreover	moreover	ADV
cuesj-811	61	2	,	,	PUNCT
cuesj-811	61	3	the	the	DET
cuesj-811	61	4	research	research	NOUN
cuesj-811	61	5	illustrated	illustrate	VERB
cuesj-811	61	6	another	another	DET
cuesj-811	61	7	survival	survival	NOUN
cuesj-811	61	8	predictive	predictive	ADJ
cuesj-811	61	9	factor	factor	NOUN
cuesj-811	61	10	concerning	concern	VERB
cuesj-811	61	11	eoc	eoc	NOUN
cuesj-811	61	12	patients	patient	NOUN
cuesj-811	61	13	whose	whose	DET
cuesj-811	61	14	illness	illness	NOUN
cuesj-811	61	15	is	be	AUX
cuesj-811	61	16	in	in	ADP
cuesj-811	61	17	early	early	ADJ
cuesj-811	61	18	and	and	CCONJ
cuesj-811	61	19	advanced	advanced	ADJ
cuesj-811	61	20	stages	stage	NOUN
cuesj-811	61	21	.	.	PUNCT
cuesj-811	62	1	this	this	DET
cuesj-811	62	2	factor	factor	NOUN
cuesj-811	62	3	signifies	signify	VERB
cuesj-811	62	4	the	the	DET
cuesj-811	62	5	absolute	absolute	ADJ
cuesj-811	62	6	neutrophil	neutrophil	ADJ
cuesj-811	62	7	count	count	NOUN
cuesj-811	62	8	to	to	ADP
cuesj-811	62	9	absolute	absolute	ADJ
cuesj-811	62	10	monocyte	monocyte	NOUN
cuesj-811	62	11	count	count	NOUN
cuesj-811	62	12	ratio	ratio	NOUN
cuesj-811	62	13	(	(	PUNCT
cuesj-811	62	14	anc	anc	PROPN
cuesj-811	62	15	)	)	PUNCT
cuesj-811	62	16	and	and	CCONJ
cuesj-811	62	17	(	(	PUNCT
cuesj-811	62	18	amc	amc	PROPN
cuesj-811	62	19	)	)	PUNCT
cuesj-811	62	20	,	,	PUNCT
cuesj-811	62	21	respectively.[15	respectively.[15	PROPN
cuesj-811	62	22	]	]	PUNCT
cuesj-811	62	23	aim	aim	NOUN
cuesj-811	62	24	of	of	ADP
cuesj-811	62	25	the	the	DET
cuesj-811	62	26	study	study	NOUN
cuesj-811	62	27	many	many	ADJ
cuesj-811	62	28	women	woman	NOUN
cuesj-811	62	29	can	can	AUX
cuesj-811	62	30	survive	survive	VERB
cuesj-811	62	31	from	from	ADP
cuesj-811	62	32	ovarian	ovarian	ADJ
cuesj-811	62	33	cancer	cancer	NOUN
cuesj-811	62	34	if	if	SCONJ
cuesj-811	62	35	early	early	ADJ
cuesj-811	62	36	diagnosis	diagnosis	NOUN
cuesj-811	62	37	of	of	ADP
cuesj-811	62	38	the	the	DET
cuesj-811	62	39	disease	disease	NOUN
cuesj-811	62	40	occurs	occur	VERB
cuesj-811	62	41	.	.	PUNCT
cuesj-811	63	1	ca125	ca125	X
cuesj-811	63	2	protein	protein	NOUN
cuesj-811	63	3	test	test	NOUN
cuesj-811	63	4	may	may	AUX
cuesj-811	63	5	help	help	VERB
cuesj-811	63	6	to	to	ADP
cuesj-811	63	7	early	early	ADJ
cuesj-811	63	8	diagnosis	diagnosis	NOUN
cuesj-811	63	9	and	and	CCONJ
cuesj-811	63	10	help	help	VERB
cuesj-811	63	11	others	other	NOUN
cuesj-811	63	12	whose	whose	DET
cuesj-811	63	13	life	life	NOUN
cuesj-811	63	14	are	be	AUX
cuesj-811	63	15	at	at	ADP
cuesj-811	63	16	risk	risk	NOUN
cuesj-811	63	17	because	because	SCONJ
cuesj-811	63	18	of	of	ADP
cuesj-811	63	19	the	the	DET
cuesj-811	63	20	disease	disease	NOUN
cuesj-811	63	21	,	,	PUNCT
cuesj-811	63	22	alongside	alongside	ADP
cuesj-811	63	23	with	with	ADP
cuesj-811	63	24	high	high	ADJ
cuesj-811	63	25	tests	test	NOUN
cuesj-811	63	26	’	'	PUNCT
cuesj-811	63	27	accuracy	accuracy	NOUN
cuesj-811	63	28	.	.	PUNCT
cuesj-811	64	1	many	many	ADJ
cuesj-811	64	2	noncancerous	noncancerous	ADJ
cuesj-811	64	3	factors	factor	NOUN
cuesj-811	64	4	can	can	AUX
cuesj-811	64	5	elevate	elevate	VERB
cuesj-811	64	6	ca125	ca125	PRON
cuesj-811	64	7	levels	level	NOUN
cuesj-811	64	8	.	.	PUNCT
cuesj-811	65	1	in	in	ADP
cuesj-811	65	2	this	this	DET
cuesj-811	65	3	study	study	NOUN
cuesj-811	65	4	,	,	PUNCT
cuesj-811	65	5	we	we	PRON
cuesj-811	65	6	attempted	attempt	VERB
cuesj-811	65	7	to	to	PART
cuesj-811	65	8	evaluate	evaluate	VERB
cuesj-811	65	9	how	how	SCONJ
cuesj-811	65	10	tsh	tsh	ADJ
cuesj-811	65	11	levels	level	NOUN
cuesj-811	65	12	affect	affect	VERB
cuesj-811	65	13	the	the	DET
cuesj-811	65	14	ca125	ca125	NOUN
cuesj-811	65	15	levels	level	NOUN
cuesj-811	65	16	among	among	ADP
cuesj-811	65	17	women	woman	NOUN
cuesj-811	65	18	of	of	ADP
cuesj-811	65	19	different	different	ADJ
cuesj-811	65	20	ages	age	NOUN
cuesj-811	65	21	,	,	PUNCT
cuesj-811	65	22	and	and	CCONJ
cuesj-811	65	23	how	how	SCONJ
cuesj-811	65	24	does	do	AUX
cuesj-811	65	25	ca125	ca125	ADV
cuesj-811	65	26	affect	affect	VERB
cuesj-811	65	27	the	the	DET
cuesj-811	65	28	levels	level	NOUN
cuesj-811	65	29	of	of	ADP
cuesj-811	65	30	some	some	DET
cuesj-811	65	31	hematological	hematological	ADJ
cuesj-811	65	32	parameters	parameter	NOUN
cuesj-811	65	33	.	.	PUNCT
cuesj-811	66	1	materials	material	NOUN
cuesj-811	66	2	and	and	CCONJ
cuesj-811	66	3	methods	method	NOUN
cuesj-811	66	4	all	all	PRON
cuesj-811	66	5	samples	sample	NOUN
cuesj-811	66	6	64	64	NUM
cuesj-811	66	7	,	,	PUNCT
cuesj-811	66	8	20	20	NUM
cuesj-811	66	9	control	control	NOUN
cuesj-811	66	10	group	group	NOUN
cuesj-811	66	11	and	and	CCONJ
cuesj-811	66	12	44	44	NUM
cuesj-811	66	13	non	non	ADJ
cuesj-811	66	14	-	-	ADJ
cuesj-811	66	15	cancerous	cancerous	ADJ
cuesj-811	66	16	patients	patient	NOUN
cuesj-811	66	17	were	be	AUX
cuesj-811	66	18	collected	collect	VERB
cuesj-811	66	19	at	at	ADP
cuesj-811	66	20	“	"	PUNCT
cuesj-811	66	21	alfa	alfa	NOUN
cuesj-811	66	22	lab	lab	NOUN
cuesj-811	66	23	for	for	ADP
cuesj-811	66	24	medical	medical	ADJ
cuesj-811	66	25	analysis	analysis	NOUN
cuesj-811	66	26	”	"	PUNCT
cuesj-811	66	27	in	in	ADP
cuesj-811	66	28	erbil	erbil	PROPN
cuesj-811	66	29	city	city	PROPN
cuesj-811	66	30	.	.	PUNCT
cuesj-811	67	1	about	about	ADV
cuesj-811	67	2	6	6	NUM
cuesj-811	67	3	ml	ml	NOUN
cuesj-811	67	4	of	of	ADP
cuesj-811	67	5	blood	blood	NOUN
cuesj-811	67	6	were	be	AUX
cuesj-811	67	7	collected	collect	VERB
cuesj-811	67	8	from	from	ADP
cuesj-811	67	9	each	each	PRON
cuesj-811	67	10	,	,	PUNCT
cuesj-811	67	11	2	2	NUM
cuesj-811	67	12	ml	ml	NOUN
cuesj-811	67	13	were	be	AUX
cuesj-811	67	14	used	use	VERB
cuesj-811	67	15	for	for	ADP
cuesj-811	67	16	hematological	hematological	ADJ
cuesj-811	67	17	performance	performance	NOUN
cuesj-811	67	18	routine	routine	ADJ
cuesj-811	67	19	tests	test	NOUN
cuesj-811	67	20	including	include	VERB
cuesj-811	67	21	blood	blood	NOUN
cuesj-811	67	22	film	film	NOUN
cuesj-811	67	23	,	,	PUNCT
cuesj-811	67	24	wbc	wbc	PROPN
cuesj-811	67	25	,	,	PUNCT
cuesj-811	67	26	hb	hb	PROPN
cuesj-811	67	27	.	.	PROPN
cuesj-811	67	28	,	,	PUNCT
cuesj-811	67	29	plt	plt	PROPN
cuesj-811	67	30	.	.	PROPN
cuesj-811	67	31	,	,	PUNCT
cuesj-811	67	32	and	and	CCONJ
cuesj-811	67	33	dlc	dlc	NOUN
cuesj-811	67	34	.	.	PUNCT
cuesj-811	68	1	the	the	DET
cuesj-811	68	2	remaining	remain	VERB
cuesj-811	68	3	4	4	NUM
cuesj-811	68	4	ml	ml	NOUN
cuesj-811	68	5	samples	sample	NOUN
cuesj-811	68	6	were	be	AUX
cuesj-811	68	7	put	put	VERB
cuesj-811	68	8	aside	aside	ADV
cuesj-811	68	9	for	for	ADP
cuesj-811	68	10	clotting	clotting	NOUN
cuesj-811	68	11	in	in	ADP
cuesj-811	68	12	gel	gel	NOUN
cuesj-811	68	13	tubes	tube	NOUN
cuesj-811	68	14	and	and	CCONJ
cuesj-811	68	15	centrifuged	centrifuge	VERB
cuesj-811	68	16	for	for	ADP
cuesj-811	68	17	15	15	NUM
cuesj-811	68	18	min	min	NOUN
cuesj-811	68	19	at	at	ADP
cuesj-811	68	20	2500	2500	NUM
cuesj-811	68	21	rpm	rpm	NOUN
cuesj-811	68	22	.	.	PUNCT
cuesj-811	69	1	then	then	ADV
cuesj-811	69	2	,	,	PUNCT
cuesj-811	69	3	the	the	DET
cuesj-811	69	4	serum	serum	NOUN
cuesj-811	69	5	was	be	AUX
cuesj-811	69	6	used	use	VERB
cuesj-811	69	7	for	for	ADP
cuesj-811	69	8	conducting	conduct	VERB
cuesj-811	69	9	the	the	DET
cuesj-811	69	10	test	test	NOUN
cuesj-811	69	11	of	of	ADP
cuesj-811	69	12	electrochemiluminescence	electrochemiluminescence	NOUN
cuesj-811	69	13	immunoassay	immunoassay	PROPN
cuesj-811	69	14	by	by	ADP
cuesj-811	69	15	adding	add	VERB
cuesj-811	69	16	0.5	0.5	NUM
cuesj-811	69	17	ml	ml	NOUN
cuesj-811	69	18	of	of	ADP
cuesj-811	69	19	serum	serum	NOUN
cuesj-811	69	20	in	in	ADP
cuesj-811	69	21	a	a	DET
cuesj-811	69	22	special	special	ADJ
cuesj-811	69	23	tube	tube	NOUN
cuesj-811	69	24	for	for	ADP
cuesj-811	69	25	measuring	measure	VERB
cuesj-811	69	26	serum	serum	NOUN
cuesj-811	69	27	ca-125	ca-125	PROPN
cuesj-811	69	28	and	and	CCONJ
cuesj-811	69	29	an	an	DET
cuesj-811	69	30	automated	automate	VERB
cuesj-811	69	31	medonic	medonic	ADJ
cuesj-811	69	32	coulter	coulter	PROPN
cuesj-811	69	33	was	be	AUX
cuesj-811	69	34	used	use	VERB
cuesj-811	69	35	to	to	PART
cuesj-811	69	36	determine	determine	VERB
cuesj-811	69	37	the	the	DET
cuesj-811	69	38	complete	complete	ADJ
cuesj-811	69	39	blood	blood	NOUN
cuesj-811	69	40	count	count	NOUN
cuesj-811	69	41	(	(	PUNCT
cuesj-811	69	42	cbc	cbc	PROPN
cuesj-811	69	43	)	)	PUNCT
cuesj-811	69	44	to	to	ADP
cuesj-811	69	45	all	all	DET
cuesj-811	69	46	collected	collect	VERB
cuesj-811	69	47	samples	sample	NOUN
cuesj-811	69	48	.	.	PUNCT
cuesj-811	70	1	statistical	statistical	ADJ
cuesj-811	70	2	analysis	analysis	NOUN
cuesj-811	70	3	since	since	SCONJ
cuesj-811	70	4	the	the	DET
cuesj-811	70	5	study	study	NOUN
cuesj-811	70	6	in	in	ADP
cuesj-811	70	7	hand	hand	NOUN
cuesj-811	70	8	is	be	AUX
cuesj-811	70	9	quantitative	quantitative	ADJ
cuesj-811	70	10	the	the	DET
cuesj-811	70	11	augmented	augment	VERB
cuesj-811	70	12	data	datum	NOUN
cuesj-811	70	13	were	be	AUX
cuesj-811	70	14	evaluated	evaluate	VERB
cuesj-811	70	15	,	,	PUNCT
cuesj-811	70	16	and	and	CCONJ
cuesj-811	70	17	analyzed	analyze	VERB
cuesj-811	70	18	statistically	statistically	ADV
cuesj-811	70	19	,	,	PUNCT
cuesj-811	70	20	which	which	PRON
cuesj-811	70	21	was	be	AUX
cuesj-811	70	22	organized	organize	VERB
cuesj-811	70	23	in	in	ADP
cuesj-811	70	24	tables	table	NOUN
cuesj-811	70	25	.	.	PUNCT
cuesj-811	71	1	afterward	afterward	ADV
cuesj-811	71	2	data	datum	NOUN
cuesj-811	71	3	were	be	AUX
cuesj-811	71	4	analyzed	analyze	VERB
cuesj-811	71	5	with	with	ADP
cuesj-811	71	6	the	the	DET
cuesj-811	71	7	version	version	NOUN
cuesj-811	71	8	18	18	NUM
cuesj-811	71	9	of	of	ADP
cuesj-811	71	10	the	the	DET
cuesj-811	71	11	statistical	statistical	ADJ
cuesj-811	71	12	package	package	NOUN
cuesj-811	71	13	for	for	ADP
cuesj-811	71	14	the	the	DET
cuesj-811	71	15	social	social	ADJ
cuesj-811	71	16	sciences	sciences	PROPN
cuesj-811	71	17	software	software	NOUN
cuesj-811	71	18	.	.	PUNCT
cuesj-811	72	1	then	then	ADV
cuesj-811	72	2	the	the	DET
cuesj-811	72	3	appointed	appoint	VERB
cuesj-811	72	4	variables	variable	NOUN
cuesj-811	72	5	were	be	AUX
cuesj-811	72	6	compared	compare	VERB
cuesj-811	72	7	following	follow	VERB
cuesj-811	72	8	students	student	NOUN
cuesj-811	72	9	f	f	NOUN
cuesj-811	72	10	-	-	PUNCT
cuesj-811	72	11	test	test	NOUN
cuesj-811	72	12	and	and	CCONJ
cuesj-811	72	13	t	t	NOUN
cuesj-811	72	14	-	-	PUNCT
cuesj-811	72	15	test	test	NOUN
cuesj-811	72	16	.	.	PUNCT
cuesj-811	73	1	later	later	ADV
cuesj-811	73	2	,	,	PUNCT
cuesj-811	73	3	the	the	DET
cuesj-811	73	4	p	p	NOUN
cuesj-811	73	5	value	value	NOUN
cuesj-811	73	6	indicates	indicate	VERB
cuesj-811	73	7	whether	whether	SCONJ
cuesj-811	73	8	a	a	DET
cuesj-811	73	9	certain	certain	ADJ
cuesj-811	73	10	variable	variable	NOUN
cuesj-811	73	11	is	be	AUX
cuesj-811	73	12	significant	significant	ADJ
cuesj-811	73	13	,	,	PUNCT
cuesj-811	73	14	if	if	SCONJ
cuesj-811	73	15	it	it	PRON
cuesj-811	73	16	was	be	AUX
cuesj-811	73	17	either	either	CCONJ
cuesj-811	73	18	<	<	X
cuesj-811	73	19	0.01	0.01	NUM
cuesj-811	73	20	or	or	CCONJ
cuesj-811	73	21	0.05	0.05	NUM
cuesj-811	73	22	.	.	PUNCT
cuesj-811	74	1	results	result	VERB
cuesj-811	74	2	this	this	DET
cuesj-811	74	3	study	study	NOUN
cuesj-811	74	4	included	include	VERB
cuesj-811	74	5	44	44	NUM
cuesj-811	74	6	non	non	ADJ
cuesj-811	74	7	-	-	ADJ
cuesj-811	74	8	cancerous	cancerous	ADJ
cuesj-811	74	9	female	female	ADJ
cuesj-811	74	10	patients	patient	NOUN
cuesj-811	74	11	.	.	PUNCT
cuesj-811	75	1	their	their	PRON
cuesj-811	75	2	ages	age	NOUN
cuesj-811	75	3	ranged	range	VERB
cuesj-811	75	4	from	from	ADP
cuesj-811	75	5	(	(	PUNCT
cuesj-811	75	6	15	15	NUM
cuesj-811	75	7	to	to	PART
cuesj-811	75	8	59	59	NUM
cuesj-811	75	9	)	)	PUNCT
cuesj-811	75	10	years	year	NOUN
cuesj-811	75	11	,	,	PUNCT
cuesj-811	75	12	with	with	ADP
cuesj-811	75	13	a	a	DET
cuesj-811	75	14	mean	mean	ADJ
cuesj-811	75	15	age	age	NOUN
cuesj-811	75	16	of	of	ADP
cuesj-811	75	17	(	(	PUNCT
cuesj-811	75	18	37.8	37.8	NUM
cuesj-811	75	19	)	)	PUNCT
cuesj-811	75	20	year	year	NOUN
cuesj-811	75	21	.	.	PUNCT
cuesj-811	76	1	in	in	ADP
cuesj-811	76	2	addition	addition	NOUN
cuesj-811	76	3	to	to	ADP
cuesj-811	76	4	,	,	PUNCT
cuesj-811	76	5	20	20	NUM
cuesj-811	76	6	healthy	healthy	ADJ
cuesj-811	76	7	individuals	individual	NOUN
cuesj-811	76	8	were	be	AUX
cuesj-811	76	9	included	include	VERB
cuesj-811	76	10	as	as	ADP
cuesj-811	76	11	control	control	NOUN
cuesj-811	76	12	group	group	NOUN
cuesj-811	76	13	.	.	PUNCT
cuesj-811	77	1	table	table	NOUN
cuesj-811	77	2	1	1	NUM
cuesj-811	77	3	shows	show	NOUN
cuesj-811	77	4	and	and	CCONJ
cuesj-811	77	5	compare	compare	VERB
cuesj-811	77	6	the	the	DET
cuesj-811	77	7	ratio	ratio	NOUN
cuesj-811	77	8	of	of	ADP
cuesj-811	77	9	tsh	tsh	NOUN
cuesj-811	77	10	and	and	CCONJ
cuesj-811	77	11	ca125	ca125	NOUN
cuesj-811	77	12	in	in	ADP
cuesj-811	77	13	both	both	CCONJ
cuesj-811	77	14	control	control	NOUN
cuesj-811	77	15	groups	group	NOUN
cuesj-811	77	16	and	and	CCONJ
cuesj-811	77	17	patient	patient	ADJ
cuesj-811	77	18	group	group	NOUN
cuesj-811	77	19	while	while	SCONJ
cuesj-811	77	20	[	[	X
cuesj-811	77	21	table	table	NOUN
cuesj-811	77	22	2	2	NUM
cuesj-811	77	23	]	]	PUNCT
cuesj-811	77	24	demonstrates	demonstrate	VERB
cuesj-811	77	25	the	the	DET
cuesj-811	77	26	results	result	NOUN
cuesj-811	77	27	of	of	ADP
cuesj-811	77	28	cbc	cbc	NOUN
cuesj-811	77	29	parameters	parameter	NOUN
cuesj-811	77	30	,	,	PUNCT
cuesj-811	77	31	alongside	alongside	SCONJ
cuesj-811	77	32	with	with	ADP
cuesj-811	77	33	(	(	PUNCT
cuesj-811	77	34	7	7	X
cuesj-811	77	35	)	)	PUNCT
cuesj-811	77	36	figures	figure	NOUN
cuesj-811	77	37	were	be	AUX
cuesj-811	77	38	created	create	VERB
cuesj-811	77	39	accordingly	accordingly	ADV
cuesj-811	77	40	,	,	PUNCT
cuesj-811	77	41	to	to	PART
cuesj-811	77	42	compare	compare	VERB
cuesj-811	77	43	between	between	ADP
cuesj-811	77	44	mean	mean	NOUN
cuesj-811	77	45	of	of	ADP
cuesj-811	77	46	ca125	ca125	NOUN
cuesj-811	77	47	with	with	ADP
cuesj-811	77	48	mean	mean	NOUN
cuesj-811	77	49	of	of	ADP
cuesj-811	77	50	each	each	DET
cuesj-811	77	51	(	(	PUNCT
cuesj-811	77	52	cbc	cbc	PROPN
cuesj-811	77	53	)	)	PUNCT
cuesj-811	77	54	parameter	parameter	NOUN
cuesj-811	77	55	separately	separately	ADV
cuesj-811	77	56	.	.	PUNCT
cuesj-811	78	1	in	in	ADP
cuesj-811	78	2	addition	addition	NOUN
cuesj-811	78	3	to	to	ADP
cuesj-811	78	4	,	,	PUNCT
cuesj-811	78	5	a	a	DET
cuesj-811	78	6	figure	figure	NOUN
cuesj-811	78	7	illustrating	illustrate	VERB
cuesj-811	78	8	the	the	DET
cuesj-811	78	9	ratio	ratio	NOUN
cuesj-811	78	10	of	of	ADP
cuesj-811	78	11	ca125	ca125	NOUN
cuesj-811	78	12	level	level	NOUN
cuesj-811	78	13	as	as	SCONJ
cuesj-811	78	14	the	the	DET
cuesj-811	78	15	age	age	NOUN
cuesj-811	78	16	rises	rise	VERB
cuesj-811	78	17	.	.	PUNCT
cuesj-811	79	1	table	table	NOUN
cuesj-811	79	2	1	1	NUM
cuesj-811	79	3	shows	show	VERB
cuesj-811	79	4	no	no	DET
cuesj-811	79	5	significant	significant	ADJ
cuesj-811	79	6	variance	variance	NOUN
cuesj-811	79	7	in	in	ADP
cuesj-811	79	8	tsh	tsh	NOUN
cuesj-811	79	9	levels	level	NOUN
cuesj-811	79	10	between	between	ADP
cuesj-811	79	11	members	member	NOUN
cuesj-811	79	12	of	of	ADP
cuesj-811	79	13	both	both	DET
cuesj-811	79	14	study	study	NOUN
cuesj-811	79	15	groups	group	NOUN
cuesj-811	79	16	;	;	PUNCT
cuesj-811	79	17	however	however	ADV
cuesj-811	79	18	,	,	PUNCT
cuesj-811	79	19	it	it	PRON
cuesj-811	79	20	identified	identify	VERB
cuesj-811	79	21	a	a	DET
cuesj-811	79	22	high	high	ADJ
cuesj-811	79	23	substantial	substantial	ADJ
cuesj-811	79	24	variation	variation	NOUN
cuesj-811	79	25	between	between	ADP
cuesj-811	79	26	ca125	ca125	NOUN
cuesj-811	79	27	of	of	ADP
cuesj-811	79	28	both	both	DET
cuesj-811	79	29	groups	group	NOUN
cuesj-811	79	30	.	.	PUNCT
cuesj-811	80	1	while	while	SCONJ
cuesj-811	80	2	[	[	X
cuesj-811	80	3	figure	figure	NOUN
cuesj-811	80	4	1	1	NUM
cuesj-811	80	5	]	]	PUNCT
cuesj-811	80	6	highlights	highlight	VERB
cuesj-811	80	7	the	the	DET
cuesj-811	80	8	correlation	correlation	NOUN
cuesj-811	80	9	between	between	ADP
cuesj-811	80	10	ca125	ca125	NOUN
cuesj-811	80	11	and	and	CCONJ
cuesj-811	80	12	tsh	tsh	NOUN
cuesj-811	80	13	ratio	ratio	NOUN
cuesj-811	80	14	in	in	ADP
cuesj-811	80	15	patient	patient	ADJ
cuesj-811	80	16	and	and	CCONJ
cuesj-811	80	17	control	control	NOUN
cuesj-811	80	18	groups	group	NOUN
cuesj-811	80	19	.	.	PUNCT
cuesj-811	81	1	[	[	X
cuesj-811	81	2	table	table	NOUN
cuesj-811	81	3	2	2	NUM
cuesj-811	81	4	]	]	PUNCT
cuesj-811	81	5	shows	show	VERB
cuesj-811	81	6	different	different	ADJ
cuesj-811	81	7	cbc	cbc	NOUN
cuesj-811	81	8	parameters	parameter	NOUN
cuesj-811	81	9	,	,	PUNCT
cuesj-811	81	10	the	the	DET
cuesj-811	81	11	wbc	wbc	NOUN
cuesj-811	81	12	shown	show	VERB
cuesj-811	81	13	significant	significant	ADJ
cuesj-811	81	14	variance	variance	NOUN
cuesj-811	81	15	in	in	ADP
cuesj-811	81	16	patient	patient	NOUN
cuesj-811	81	17	and	and	CCONJ
cuesj-811	81	18	control	control	NOUN
cuesj-811	81	19	groups	group	NOUN
cuesj-811	81	20	.	.	PUNCT
cuesj-811	82	1	meanwhile	meanwhile	ADV
cuesj-811	82	2	,	,	PUNCT
cuesj-811	82	3	there	there	PRON
cuesj-811	82	4	was	be	VERB
cuesj-811	82	5	no	no	DET
cuesj-811	82	6	substantial	substantial	ADJ
cuesj-811	82	7	variation	variation	NOUN
cuesj-811	82	8	in	in	ADP
cuesj-811	82	9	lymphocyte	lymphocyte	ADJ
cuesj-811	82	10	,	,	PUNCT
cuesj-811	82	11	monocyte	monocyte	ADJ
cuesj-811	82	12	,	,	PUNCT
cuesj-811	82	13	granulocyte	granulocyte	ADJ
cuesj-811	82	14	,	,	PUNCT
cuesj-811	82	15	and	and	CCONJ
cuesj-811	82	16	hemoglobin	hemoglobin	NOUN
cuesj-811	82	17	,	,	PUNCT
cuesj-811	82	18	but	but	CCONJ
cuesj-811	82	19	it	it	PRON
cuesj-811	82	20	identified	identify	VERB
cuesj-811	82	21	a	a	DET
cuesj-811	82	22	high	high	ADJ
cuesj-811	82	23	significant	significant	ADJ
cuesj-811	82	24	difference	difference	NOUN
cuesj-811	82	25	between	between	ADP
cuesj-811	82	26	rbcs	rbc	NOUN
cuesj-811	82	27	of	of	ADP
cuesj-811	82	28	patient	patient	ADJ
cuesj-811	82	29	group	group	NOUN
cuesj-811	82	30	and	and	CCONJ
cuesj-811	82	31	control	control	NOUN
cuesj-811	82	32	group	group	NOUN
cuesj-811	82	33	.	.	PUNCT
cuesj-811	83	1	in	in	ADP
cuesj-811	83	2	[	[	X
cuesj-811	83	3	figure	figure	NOUN
cuesj-811	83	4	2	2	NUM
cuesj-811	83	5	]	]	PUNCT
cuesj-811	83	6	,	,	PUNCT
cuesj-811	83	7	there	there	PRON
cuesj-811	83	8	is	be	VERB
cuesj-811	83	9	a	a	DET
cuesj-811	83	10	difference	difference	NOUN
cuesj-811	83	11	between	between	ADP
cuesj-811	83	12	wbc	wbc	PROPN
cuesj-811	83	13	ratio	ratio	NOUN
cuesj-811	83	14	in	in	ADP
cuesj-811	83	15	patient	patient	ADJ
cuesj-811	83	16	group	group	NOUN
cuesj-811	83	17	and	and	CCONJ
cuesj-811	83	18	control	control	NOUN
cuesj-811	83	19	group	group	NOUN
cuesj-811	83	20	as	as	ADP
cuesj-811	83	21	the	the	DET
cuesj-811	83	22	ca125	ca125	NOUN
cuesj-811	83	23	ratio	ratio	NOUN
cuesj-811	83	24	rises	rise	VERB
cuesj-811	83	25	.	.	PUNCT
cuesj-811	84	1	in	in	ADP
cuesj-811	84	2	[	[	X
cuesj-811	84	3	figure	figure	NOUN
cuesj-811	84	4	3	3	NUM
cuesj-811	84	5	]	]	PUNCT
cuesj-811	84	6	,	,	PUNCT
cuesj-811	84	7	lymphocyte	lymphocyte	ADJ
cuesj-811	84	8	ratio	ratio	NOUN
cuesj-811	84	9	results	result	NOUN
cuesj-811	84	10	show	show	VERB
cuesj-811	84	11	no	no	DET
cuesj-811	84	12	variance	variance	NOUN
cuesj-811	84	13	in	in	ADP
cuesj-811	84	14	patient	patient	ADJ
cuesj-811	84	15	group	group	NOUN
cuesj-811	84	16	and	and	CCONJ
cuesj-811	84	17	control	control	NOUN
cuesj-811	84	18	group	group	NOUN
cuesj-811	84	19	as	as	SCONJ
cuesj-811	84	20	the	the	DET
cuesj-811	84	21	ca125	ca125	NOUN
cuesj-811	84	22	rises	rise	VERB
cuesj-811	84	23	.	.	PUNCT
cuesj-811	85	1	figure	figure	VERB
cuesj-811	85	2	4	4	NUM
cuesj-811	85	3	shows	show	VERB
cuesj-811	85	4	the	the	DET
cuesj-811	85	5	similarly	similarly	ADV
cuesj-811	85	6	,	,	PUNCT
cuesj-811	85	7	monocyte	monocyte	ADJ
cuesj-811	85	8	ratio	ratio	NOUN
cuesj-811	85	9	shows	show	VERB
cuesj-811	85	10	no	no	DET
cuesj-811	85	11	difference	difference	NOUN
cuesj-811	85	12	in	in	ADP
cuesj-811	85	13	patient	patient	ADJ
cuesj-811	85	14	group	group	NOUN
cuesj-811	85	15	and	and	CCONJ
cuesj-811	85	16	control	control	NOUN
cuesj-811	85	17	group	group	NOUN
cuesj-811	85	18	as	as	ADP
cuesj-811	85	19	the	the	DET
cuesj-811	85	20	ca125	ca125	NOUN
cuesj-811	85	21	ratio	ratio	NOUN
cuesj-811	85	22	rises	rise	VERB
cuesj-811	85	23	.	.	PUNCT
cuesj-811	86	1	in	in	ADP
cuesj-811	86	2	[	[	PUNCT
cuesj-811	86	3	figure	figure	NOUN
cuesj-811	86	4	5	5	NUM
cuesj-811	86	5	]	]	PUNCT
cuesj-811	86	6	,	,	PUNCT
cuesj-811	86	7	there	there	PRON
cuesj-811	86	8	is	be	VERB
cuesj-811	86	9	difference	difference	NOUN
cuesj-811	86	10	between	between	ADP
cuesj-811	86	11	granulocyte	granulocyte	ADJ
cuesj-811	86	12	ratio	ratio	NOUN
cuesj-811	86	13	in	in	ADP
cuesj-811	86	14	patient	patient	ADJ
cuesj-811	86	15	group	group	NOUN
cuesj-811	86	16	and	and	CCONJ
cuesj-811	86	17	control	control	NOUN
cuesj-811	86	18	group	group	NOUN
cuesj-811	86	19	as	as	ADP
cuesj-811	86	20	the	the	DET
cuesj-811	86	21	ca125	ca125	NOUN
cuesj-811	86	22	ratio	ratio	NOUN
cuesj-811	86	23	rises	rise	VERB
cuesj-811	86	24	.	.	PUNCT
cuesj-811	87	1	in	in	ADP
cuesj-811	87	2	[	[	X
cuesj-811	87	3	figure	figure	NOUN
cuesj-811	87	4	6	6	NUM
cuesj-811	87	5	]	]	PUNCT
cuesj-811	87	6	,	,	PUNCT
cuesj-811	87	7	there	there	PRON
cuesj-811	87	8	is	be	VERB
cuesj-811	87	9	difference	difference	NOUN
cuesj-811	87	10	between	between	ADP
cuesj-811	87	11	rbc	rbc	PROPN
cuesj-811	87	12	ratio	ratio	NOUN
cuesj-811	87	13	in	in	ADP
cuesj-811	87	14	patient	patient	ADJ
cuesj-811	87	15	group	group	NOUN
cuesj-811	87	16	and	and	CCONJ
cuesj-811	87	17	control	control	NOUN
cuesj-811	87	18	group	group	NOUN
cuesj-811	87	19	as	as	SCONJ
cuesj-811	87	20	ca125	ca125	ADJ
cuesj-811	87	21	ratio	ratio	NOUN
cuesj-811	87	22	rises	rise	VERB
cuesj-811	87	23	.	.	PUNCT
cuesj-811	88	1	[	[	X
cuesj-811	88	2	figure	figure	NOUN
cuesj-811	88	3	7	7	NUM
cuesj-811	88	4	]	]	PUNCT
cuesj-811	88	5	shows	show	VERB
cuesj-811	88	6	that	that	SCONJ
cuesj-811	88	7	there	there	PRON
cuesj-811	88	8	is	be	VERB
cuesj-811	88	9	non	non	ADJ
cuesj-811	88	10	-	-	ADJ
cuesj-811	88	11	significant	significant	ADJ
cuesj-811	88	12	difference	difference	NOUN
cuesj-811	88	13	between	between	ADP
cuesj-811	88	14	hb	hb	PROPN
cuesj-811	88	15	ratio	ratio	NOUN
cuesj-811	88	16	in	in	ADP
cuesj-811	88	17	patient	patient	ADJ
cuesj-811	88	18	group	group	NOUN
cuesj-811	88	19	and	and	CCONJ
cuesj-811	88	20	control	control	NOUN
cuesj-811	88	21	group	group	NOUN
cuesj-811	88	22	as	as	SCONJ
cuesj-811	88	23	ca125	ca125	ADJ
cuesj-811	88	24	ratio	ratio	NOUN
cuesj-811	88	25	rises	rise	VERB
cuesj-811	88	26	.	.	PUNCT
cuesj-811	89	1	figure	figure	VERB
cuesj-811	89	2	8	8	NUM
cuesj-811	89	3	shows	show	NOUN
cuesj-811	89	4	,	,	PUNCT
cuesj-811	89	5	ca125	ca125	CCONJ
cuesj-811	89	6	ratio	ratio	NOUN
cuesj-811	89	7	as	as	SCONJ
cuesj-811	89	8	the	the	DET
cuesj-811	89	9	age	age	NOUN
cuesj-811	89	10	rises	rise	VERB
cuesj-811	89	11	,	,	PUNCT
cuesj-811	89	12	where	where	SCONJ
cuesj-811	89	13	there	there	PRON
cuesj-811	89	14	is	be	VERB
cuesj-811	89	15	no	no	DET
cuesj-811	89	16	difference	difference	NOUN
cuesj-811	89	17	to	to	PART
cuesj-811	89	18	be	be	AUX
cuesj-811	89	19	considered	consider	VERB
cuesj-811	89	20	as	as	ADP
cuesj-811	89	21	indication	indication	NOUN
cuesj-811	89	22	related	relate	VERB
cuesj-811	89	23	to	to	ADP
cuesj-811	89	24	the	the	DET
cuesj-811	89	25	difference	difference	NOUN
cuesj-811	89	26	in	in	ADP
cuesj-811	89	27	the	the	DET
cuesj-811	89	28	age	age	NOUN
cuesj-811	89	29	of	of	ADP
cuesj-811	89	30	women	woman	NOUN
cuesj-811	89	31	,	,	PUNCT
cuesj-811	89	32	despite	despite	SCONJ
cuesj-811	89	33	the	the	DET
cuesj-811	89	34	high	high	ADJ
cuesj-811	89	35	peaks	peak	NOUN
cuesj-811	89	36	in	in	ADP
cuesj-811	89	37	age	age	NOUN
cuesj-811	89	38	(	(	PUNCT
cuesj-811	89	39	34–37	34–37	NUM
cuesj-811	89	40	)	)	PUNCT
cuesj-811	89	41	years	year	NOUN
cuesj-811	89	42	and	and	CCONJ
cuesj-811	89	43	(	(	PUNCT
cuesj-811	89	44	50	50	NUM
cuesj-811	89	45	)	)	PUNCT
cuesj-811	89	46	years	year	NOUN
cuesj-811	89	47	.	.	PUNCT
cuesj-811	90	1	thus	thus	ADV
cuesj-811	90	2	,	,	PUNCT
cuesj-811	90	3	the	the	DET
cuesj-811	90	4	age	age	NOUN
cuesj-811	90	5	of	of	ADP
cuesj-811	90	6	women	woman	NOUN
cuesj-811	90	7	does	do	AUX
cuesj-811	90	8	not	not	PART
cuesj-811	90	9	give	give	VERB
cuesj-811	90	10	any	any	DET
cuesj-811	90	11	sign	sign	NOUN
cuesj-811	90	12	to	to	PART
cuesj-811	90	13	be	be	AUX
cuesj-811	90	14	mentioned	mention	VERB
cuesj-811	90	15	.	.	PUNCT
cuesj-811	91	1	discussion	discussion	NOUN
cuesj-811	91	2	this	this	DET
cuesj-811	91	3	study	study	NOUN
cuesj-811	91	4	is	be	AUX
cuesj-811	91	5	aiming	aim	VERB
cuesj-811	91	6	to	to	PART
cuesj-811	91	7	discover	discover	VERB
cuesj-811	91	8	possible	possible	ADJ
cuesj-811	91	9	correlations	correlation	NOUN
cuesj-811	91	10	linking	link	VERB
cuesj-811	91	11	tsh	tsh	ADJ
cuesj-811	91	12	level	level	NOUN
cuesj-811	91	13	and	and	CCONJ
cuesj-811	91	14	ca125	ca125	ADP
cuesj-811	91	15	with	with	ADP
cuesj-811	91	16	hematological	hematological	ADJ
cuesj-811	91	17	parameters	parameter	NOUN
cuesj-811	91	18	among	among	ADP
cuesj-811	91	19	women	woman	NOUN
cuesj-811	91	20	of	of	ADP
cuesj-811	91	21	different	different	ADJ
cuesj-811	91	22	ages	age	NOUN
cuesj-811	91	23	.	.	PUNCT
cuesj-811	92	1	in	in	ADP
cuesj-811	92	2	the	the	DET
cuesj-811	92	3	present	present	ADJ
cuesj-811	92	4	study	study	NOUN
cuesj-811	92	5	,	,	PUNCT
cuesj-811	92	6	no	no	DET
cuesj-811	92	7	association	association	NOUN
cuesj-811	92	8	was	be	AUX
cuesj-811	92	9	found	find	VERB
cuesj-811	92	10	between	between	ADP
cuesj-811	92	11	tsh	tsh	NOUN
cuesj-811	92	12	and	and	CCONJ
cuesj-811	92	13	ca125	ca125	NOUN
cuesj-811	92	14	levels	level	NOUN
cuesj-811	92	15	.	.	PUNCT
cuesj-811	93	1	as	as	SCONJ
cuesj-811	93	2	the	the	DET
cuesj-811	93	3	ca125	ca125	PROPN
cuesj-811	93	4	levels	level	NOUN
cuesj-811	93	5	elevated	elevate	VERB
cuesj-811	93	6	no	no	DET
cuesj-811	93	7	significant	significant	ADJ
cuesj-811	93	8	change	change	NOUN
cuesj-811	93	9	were	be	AUX
cuesj-811	93	10	recognized	recognize	VERB
cuesj-811	93	11	in	in	ADP
cuesj-811	93	12	tsh	tsh	ADJ
cuesj-811	93	13	levels	level	NOUN
cuesj-811	93	14	.	.	PUNCT
cuesj-811	94	1	nine	nine	NUM
cuesj-811	94	2	patients	patient	NOUN
cuesj-811	94	3	with	with	ADP
cuesj-811	94	4	high	high	ADJ
cuesj-811	94	5	ca125	ca125	NOUN
cuesj-811	94	6	levels	level	NOUN
cuesj-811	94	7	above	above	ADP
cuesj-811	94	8	ubeid	ubeid	NOUN
cuesj-811	94	9	,	,	PUNCT
cuesj-811	94	10	et	et	PROPN
cuesj-811	94	11	al	al	PROPN
cuesj-811	94	12	.	.	PUNCT
cuesj-811	94	13	:	:	PUNCT
cuesj-811	94	14	parameter	parameter	PROPN
cuesj-811	94	15	affecting	affect	VERB
cuesj-811	94	16	ca-125	ca-125	PROPN
cuesj-811	94	17	,	,	PUNCT
cuesj-811	94	18	tsh	tsh	NOUN
cuesj-811	94	19	,	,	PUNCT
cuesj-811	94	20	and	and	CCONJ
cuesj-811	94	21	cbc	cbc	NOUN
cuesj-811	94	22	4	4	NUM
cuesj-811	94	23	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-811	94	24	cuesj	cuesj	NOUN
cuesj-811	94	25	2023	2023	NUM
cuesj-811	94	26	,	,	PUNCT
cuesj-811	94	27	7	7	NUM
cuesj-811	94	28	(	(	PUNCT
cuesj-811	94	29	1	1	NUM
cuesj-811	94	30	):	):	PUNCT
cuesj-811	94	31	1	1	NUM
cuesj-811	94	32	-	-	SYM
cuesj-811	94	33	7	7	NUM
cuesj-811	94	34	the	the	DET
cuesj-811	94	35	normal	normal	ADJ
cuesj-811	94	36	were	be	AUX
cuesj-811	94	37	found	find	VERB
cuesj-811	94	38	,	,	PUNCT
cuesj-811	94	39	but	but	CCONJ
cuesj-811	94	40	their	their	PRON
cuesj-811	94	41	tsh	tsh	NOUN
cuesj-811	94	42	levels	level	NOUN
cuesj-811	94	43	were	be	AUX
cuesj-811	94	44	still	still	ADV
cuesj-811	94	45	at	at	ADP
cuesj-811	94	46	normal	normal	ADJ
cuesj-811	94	47	range	range	NOUN
cuesj-811	94	48	as	as	ADP
cuesj-811	94	49	other	other	ADJ
cuesj-811	94	50	(	(	PUNCT
cuesj-811	94	51	35	35	NUM
cuesj-811	94	52	)	)	PUNCT
cuesj-811	94	53	patients	patient	NOUN
cuesj-811	94	54	.	.	PUNCT
cuesj-811	95	1	meanwhile	meanwhile	ADV
cuesj-811	95	2	,	,	PUNCT
cuesj-811	95	3	the	the	DET
cuesj-811	95	4	failure	failure	NOUN
cuesj-811	95	5	of	of	ADP
cuesj-811	95	6	ovulation	ovulation	NOUN
cuesj-811	95	7	is	be	AUX
cuesj-811	95	8	considered	consider	VERB
cuesj-811	95	9	owing	owe	VERB
cuesj-811	95	10	to	to	ADP
cuesj-811	95	11	severe	severe	ADJ
cuesj-811	95	12	hypothyroidism	hypothyroidism	NOUN
cuesj-811	95	13	,	,	PUNCT
cuesj-811	95	14	whereas	whereas	SCONJ
cuesj-811	95	15	,	,	PUNCT
cuesj-811	95	16	menstrual	menstrual	ADJ
cuesj-811	95	17	anomalies	anomaly	NOUN
cuesj-811	95	18	stem	stem	VERB
cuesj-811	95	19	from	from	ADP
cuesj-811	95	20	hypothyroidism	hypothyroidism	NOUN
cuesj-811	95	21	and	and	CCONJ
cuesj-811	95	22	hyperthyroidism.[35	hyperthyroidism.[35	PROPN
cuesj-811	95	23	]	]	X
cuesj-811	96	1	rae	rae	PROPN
cuesj-811	96	2	et	et	PROPN
cuesj-811	96	3	al	al	PROPN
cuesj-811	96	4	.	.	PROPN
cuesj-811	96	5	suggested	suggest	VERB
cuesj-811	96	6	,	,	PUNCT
cuesj-811	96	7	ovaries	ovary	NOUN
cuesj-811	96	8	sensitivity	sensitivity	NOUN
cuesj-811	96	9	to	to	ADP
cuesj-811	96	10	estrogen	estrogen	NOUN
cuesj-811	96	11	and	and	CCONJ
cuesj-811	96	12	its	its	PRON
cuesj-811	96	13	inflammatory	inflammatory	ADJ
cuesj-811	96	14	state	state	NOUN
cuesj-811	96	15	be	be	AUX
cuesj-811	96	16	affected	affect	VERB
cuesj-811	96	17	due	due	ADP
cuesj-811	96	18	to	to	ADP
cuesj-811	96	19	the	the	DET
cuesj-811	96	20	status	status	NOUN
cuesj-811	96	21	of	of	ADP
cuesj-811	96	22	the	the	DET
cuesj-811	96	23	thyroid	thyroid	NOUN
cuesj-811	96	24	hormone	hormone	NOUN
cuesj-811	96	25	,	,	PUNCT
cuesj-811	96	26	which	which	PRON
cuesj-811	96	27	consequently	consequently	ADV
cuesj-811	96	28	raise	raise	VERB
cuesj-811	96	29	a	a	DET
cuesj-811	96	30	gynecological	gynecological	ADJ
cuesj-811	96	31	health	health	NOUN
cuesj-811	96	32	and	and	CCONJ
cuesj-811	96	33	disease	disease	NOUN
cuesj-811	96	34	impact.[28	impact.[28	PROPN
cuesj-811	96	35	]	]	PUNCT
cuesj-811	96	36	according	accord	VERB
cuesj-811	96	37	to	to	ADP
cuesj-811	96	38	kang	kang	PROPN
cuesj-811	96	39	et	et	PROPN
cuesj-811	96	40	al	al	PROPN
cuesj-811	96	41	.	.	PROPN
cuesj-811	96	42	advocated	advocate	VERB
cuesj-811	96	43	the	the	DET
cuesj-811	96	44	absence	absence	NOUN
cuesj-811	96	45	of	of	ADP
cuesj-811	96	46	possible	possible	ADJ
cuesj-811	96	47	relationship	relationship	NOUN
cuesj-811	96	48	in	in	ADP
cuesj-811	96	49	the	the	DET
cuesj-811	96	50	history	history	NOUN
cuesj-811	96	51	of	of	ADP
cuesj-811	96	52	hyperthyroidism	hyperthyroidism	NOUN
cuesj-811	96	53	and	and	CCONJ
cuesj-811	96	54	hypothyroidism	hypothyroidism	NOUN
cuesj-811	96	55	with	with	ADP
cuesj-811	96	56	ovarian	ovarian	ADJ
cuesj-811	96	57	cancer.[36	cancer.[36	PROPN
cuesj-811	96	58	]	]	PUNCT
cuesj-811	96	59	however	however	ADV
cuesj-811	96	60	,	,	PUNCT
cuesj-811	96	61	current	current	ADJ
cuesj-811	96	62	hyperthyroidism	hyperthyroidism	NOUN
cuesj-811	96	63	history	history	NOUN
cuesj-811	96	64	was	be	AUX
cuesj-811	96	65	linked	link	VERB
cuesj-811	96	66	with	with	ADP
cuesj-811	96	67	the	the	DET
cuesj-811	96	68	increment	increment	NOUN
cuesj-811	96	69	of	of	ADP
cuesj-811	96	70	5	5	NUM
cuesj-811	96	71	-	-	PUNCT
cuesj-811	96	72	year	year	NOUN
cuesj-811	96	73	mortality	mortality	NOUN
cuesj-811	96	74	among	among	ADP
cuesj-811	96	75	ovarian	ovarian	ADJ
cuesj-811	96	76	cancer	cancer	NOUN
cuesj-811	96	77	patients	patient	NOUN
cuesj-811	96	78	.	.	PUNCT
cuesj-811	97	1	yet	yet	ADV
cuesj-811	97	2	,	,	PUNCT
cuesj-811	97	3	a	a	DET
cuesj-811	97	4	mildly	mildly	ADV
cuesj-811	97	5	decreased	decrease	VERB
cuesj-811	97	6	mortality	mortality	NOUN
cuesj-811	97	7	risk	risk	NOUN
cuesj-811	97	8	was	be	AUX
cuesj-811	97	9	associated	associate	VERB
cuesj-811	97	10	with	with	ADP
cuesj-811	97	11	hypothyroidism.[4	hypothyroidism.[4	NOUN
cuesj-811	97	12	]	]	PUNCT
cuesj-811	97	13	while	while	SCONJ
cuesj-811	97	14	other	other	ADJ
cuesj-811	97	15	scholars	scholar	NOUN
cuesj-811	97	16	stated	state	VERB
cuesj-811	97	17	that	that	SCONJ
cuesj-811	97	18	,	,	PUNCT
cuesj-811	97	19	although	although	SCONJ
cuesj-811	97	20	,	,	PUNCT
cuesj-811	97	21	hyperthyroidism	hyperthyroidism	NOUN
cuesj-811	97	22	,	,	PUNCT
cuesj-811	97	23	and	and	CCONJ
cuesj-811	97	24	oc	oc	ADP
cuesj-811	97	25	association	association	NOUN
cuesj-811	97	26	apparently	apparently	ADV
cuesj-811	97	27	persist	persist	VERB
cuesj-811	97	28	only	only	ADV
cuesj-811	97	29	at	at	ADP
cuesj-811	97	30	an	an	DET
cuesj-811	97	31	epidemiological	epidemiological	ADJ
cuesj-811	97	32	level	level	NOUN
cuesj-811	97	33	.	.	PUNCT
cuesj-811	98	1	yet	yet	ADV
cuesj-811	98	2	,	,	PUNCT
cuesj-811	98	3	the	the	DET
cuesj-811	98	4	demonstration	demonstration	NOUN
cuesj-811	98	5	of	of	ADP
cuesj-811	98	6	the	the	DET
cuesj-811	98	7	association	association	NOUN
cuesj-811	98	8	mechanism	mechanism	NOUN
cuesj-811	98	9	has	have	AUX
cuesj-811	98	10	not	not	PART
cuesj-811	98	11	been	be	AUX
cuesj-811	98	12	prevailed.[37	prevailed.[37	NOUN
cuesj-811	98	13	]	]	X
cuesj-811	98	14	table	table	NOUN
cuesj-811	98	15	1	1	NUM
cuesj-811	98	16	:	:	PUNCT
cuesj-811	98	17	tsh	tsh	NOUN
cuesj-811	98	18	and	and	CCONJ
cuesj-811	98	19	ca125	ca125	ADP
cuesj-811	98	20	ratio	ratio	NOUN
cuesj-811	98	21	of	of	ADP
cuesj-811	98	22	patient	patient	ADJ
cuesj-811	98	23	group	group	NOUN
cuesj-811	98	24	and	and	CCONJ
cuesj-811	98	25	control	control	NOUN
cuesj-811	98	26	group	group	NOUN
cuesj-811	98	27	parameters	parameter	NOUN
cuesj-811	98	28	no	no	INTJ
cuesj-811	98	29	.	.	PUNCT
cuesj-811	99	1	all	all	DET
cuesj-811	99	2	patients	patient	NOUN
cuesj-811	99	3	no	no	INTJ
cuesj-811	99	4	.	.	PUNCT
cuesj-811	100	1	c.g	c.g	PROPN
cuesj-811	100	2	t	t	NOUN
cuesj-811	100	3	-	-	PUNCT
cuesj-811	100	4	test	test	NOUN
cuesj-811	100	5	p	p	NOUN
cuesj-811	100	6	value	value	NOUN
cuesj-811	100	7	p	p	PROPN
cuesj-811	100	8	mean±se	mean±se	PROPN
cuesj-811	100	9	mean±se	mean±se	PROPN
cuesj-811	100	10	tsh	tsh	PROPN
cuesj-811	100	11	(	(	PUNCT
cuesj-811	100	12	miu	miu	PROPN
cuesj-811	100	13	/	/	SYM
cuesj-811	100	14	ml	ml	NOUN
cuesj-811	100	15	)	)	PUNCT
cuesj-811	100	16	44	44	NUM
cuesj-811	100	17	2.20±0.17	2.20±0.17	NUM
cuesj-811	100	18	20	20	NUM
cuesj-811	101	1	2.00±0.25	2.00±0.25	NUM
cuesj-811	101	2	0.526	0.526	NUM
cuesj-811	102	1	n.s	n.s	PROPN
cuesj-811	102	2	ca-125	ca-125	PROPN
cuesj-811	102	3	(	(	PUNCT
cuesj-811	102	4	u	u	NOUN
cuesj-811	102	5	/	/	SYM
cuesj-811	102	6	ml	ml	NOUN
cuesj-811	102	7	)	)	PUNCT
cuesj-811	102	8	44	44	NUM
cuesj-811	102	9	27.68±4.79	27.68±4.79	NUM
cuesj-811	102	10	20	20	NUM
cuesj-811	102	11	14.43±0.84	14.43±0.84	NUM
cuesj-811	102	12	0.009	0.009	NUM
cuesj-811	102	13	h.s	h.s	PROPN
cuesj-811	102	14	*	*	PROPN
cuesj-811	102	15	*	*	PROPN
cuesj-811	103	1	p	p	X
cuesj-811	103	2	:	:	PUNCT
cuesj-811	103	3	probability	probability	NOUN
cuesj-811	103	4	,	,	PUNCT
cuesj-811	103	5	*	*	PUNCT
cuesj-811	103	6	p<0.05	p<0.05	NOUN
cuesj-811	103	7	:	:	PUNCT
cuesj-811	103	8	significant	significant	ADJ
cuesj-811	103	9	,	,	PUNCT
cuesj-811	103	10	p≥0.05	p≥0.05	NOUN
cuesj-811	103	11	:	:	PUNCT
cuesj-811	103	12	non	non	ADJ
cuesj-811	103	13	-	-	ADJ
cuesj-811	103	14	significant	significant	ADJ
cuesj-811	103	15	,	,	PUNCT
cuesj-811	103	16	*	*	PUNCT
cuesj-811	103	17	*	*	PUNCT
cuesj-811	103	18	p<0.01	p<0.01	ADJ
cuesj-811	103	19	:	:	PUNCT
cuesj-811	103	20	highly	highly	ADV
cuesj-811	103	21	significant	significant	ADJ
cuesj-811	103	22	table	table	NOUN
cuesj-811	103	23	2	2	NUM
cuesj-811	103	24	:	:	PUNCT
cuesj-811	103	25	cbc	cbc	NOUN
cuesj-811	103	26	parameters	parameter	NOUN
cuesj-811	103	27	of	of	ADP
cuesj-811	103	28	patient	patient	ADJ
cuesj-811	103	29	group	group	NOUN
cuesj-811	103	30	and	and	CCONJ
cuesj-811	103	31	control	control	NOUN
cuesj-811	103	32	group	group	NOUN
cuesj-811	103	33	hematological	hematological	ADJ
cuesj-811	103	34	parameters	parameter	NOUN
cuesj-811	103	35	no	no	INTJ
cuesj-811	103	36	.	.	PUNCT
cuesj-811	104	1	all	all	DET
cuesj-811	104	2	patients	patient	NOUN
cuesj-811	104	3	no	no	INTJ
cuesj-811	104	4	.	.	PUNCT
cuesj-811	105	1	c.g	c.g	PROPN
cuesj-811	105	2	t	t	NOUN
cuesj-811	105	3	-	-	PUNCT
cuesj-811	105	4	test	test	NOUN
cuesj-811	105	5	p	p	NOUN
cuesj-811	105	6	value	value	NOUN
cuesj-811	105	7	p	p	PROPN
cuesj-811	105	8	mean±se	mean±se	PROPN
cuesj-811	105	9	mean±se	mean±se	PROPN
cuesj-811	105	10	wbc	wbc	PROPN
cuesj-811	105	11	(	(	PUNCT
cuesj-811	105	12	×109	×109	PROPN
cuesj-811	105	13	/	/	SYM
cuesj-811	105	14	l	l	NOUN
cuesj-811	105	15	)	)	PUNCT
cuesj-811	105	16	44	44	NUM
cuesj-811	106	1	8.19±0.33	8.19±0.33	NUM
cuesj-811	106	2	20	20	NUM
cuesj-811	106	3	6.79±0.39	6.79±0.39	NUM
cuesj-811	106	4	0.010	0.010	NUM
cuesj-811	106	5	s	s	NOUN
cuesj-811	106	6	*	*	NOUN
cuesj-811	106	7	lymphocyte	lymphocyte	ADJ
cuesj-811	106	8	(	(	PUNCT
cuesj-811	106	9	×109	×109	PROPN
cuesj-811	106	10	/	/	SYM
cuesj-811	106	11	l	l	NOUN
cuesj-811	106	12	)	)	PUNCT
cuesj-811	106	13	44	44	NUM
cuesj-811	106	14	2.55±0.13	2.55±0.13	NUM
cuesj-811	106	15	20	20	NUM
cuesj-811	106	16	2.95±0.23	2.95±0.23	NUM
cuesj-811	106	17	0.158	0.158	NUM
cuesj-811	106	18	n.s	n.s	PROPN
cuesj-811	106	19	monocyte	monocyte	NOUN
cuesj-811	106	20	(	(	PUNCT
cuesj-811	106	21	×109	×109	PROPN
cuesj-811	106	22	/	/	SYM
cuesj-811	106	23	l	l	NOUN
cuesj-811	106	24	)	)	PUNCT
cuesj-811	106	25	44	44	NUM
cuesj-811	106	26	0.46±0.02	0.46±0.02	NUM
cuesj-811	106	27	20	20	NUM
cuesj-811	106	28	0.45±0.05	0.45±0.05	NOUN
cuesj-811	106	29	0.884	0.884	NUM
cuesj-811	106	30	n.s	n.s	PROPN
cuesj-811	106	31	granulocyte	granulocyte	NOUN
cuesj-811	106	32	(	(	PUNCT
cuesj-811	106	33	×109	×109	PROPN
cuesj-811	106	34	/	/	SYM
cuesj-811	106	35	l	l	NOUN
cuesj-811	106	36	)	)	PUNCT
cuesj-811	106	37	44	44	NUM
cuesj-811	106	38	5.16±0.22	5.16±0.22	NOUN
cuesj-811	106	39	20	20	NUM
cuesj-811	106	40	4.63±0.34	4.63±0.34	NOUN
cuesj-811	106	41	0.213	0.213	NUM
cuesj-811	106	42	n.s	n.s	PROPN
cuesj-811	106	43	hb	hb	X
cuesj-811	106	44	(	(	PUNCT
cuesj-811	106	45	×109	×109	PROPN
cuesj-811	106	46	/	/	SYM
cuesj-811	106	47	l	l	NOUN
cuesj-811	106	48	)	)	PUNCT
cuesj-811	106	49	44	44	NUM
cuesj-811	106	50	12.06±0.26	12.06±0.26	NUM
cuesj-811	106	51	20	20	NUM
cuesj-811	106	52	12.59±0.30	12.59±0.30	NUM
cuesj-811	106	53	0.203	0.203	NUM
cuesj-811	106	54	n.s	n.s	PROPN
cuesj-811	106	55	rbc	rbc	PROPN
cuesj-811	106	56	(	(	PUNCT
cuesj-811	106	57	×109	×109	PROPN
cuesj-811	106	58	/	/	SYM
cuesj-811	106	59	l	l	NOUN
cuesj-811	106	60	)	)	PUNCT
cuesj-811	106	61	44	44	NUM
cuesj-811	106	62	4.48±0.06	4.48±0.06	NUM
cuesj-811	106	63	20	20	NUM
cuesj-811	106	64	5.03±0.14	5.03±0.14	NUM
cuesj-811	106	65	0.002	0.002	NUM
cuesj-811	106	66	h.s	h.s	PROPN
cuesj-811	106	67	*	*	PROPN
cuesj-811	106	68	*	*	PROPN
cuesj-811	107	1	p	p	X
cuesj-811	107	2	:	:	PUNCT
cuesj-811	107	3	probability	probability	NOUN
cuesj-811	107	4	,	,	PUNCT
cuesj-811	107	5	*	*	PUNCT
cuesj-811	107	6	p<0.05	p<0.05	NOUN
cuesj-811	107	7	:	:	PUNCT
cuesj-811	107	8	significant	significant	ADJ
cuesj-811	107	9	,	,	PUNCT
cuesj-811	107	10	p≥0.05	p≥0.05	NOUN
cuesj-811	107	11	:	:	PUNCT
cuesj-811	107	12	non	non	ADJ
cuesj-811	107	13	-	-	ADJ
cuesj-811	107	14	significant	significant	ADJ
cuesj-811	107	15	,	,	PUNCT
cuesj-811	107	16	*	*	PUNCT
cuesj-811	107	17	*	*	PUNCT
cuesj-811	107	18	p<0.01	p<0.01	ADJ
cuesj-811	107	19	:	:	PUNCT
cuesj-811	107	20	highly	highly	ADV
cuesj-811	107	21	significant	significant	ADJ
cuesj-811	107	22	figure	figure	NOUN
cuesj-811	107	23	1	1	NUM
cuesj-811	107	24	:	:	PUNCT
cuesj-811	107	25	correlation	correlation	NOUN
cuesj-811	107	26	between	between	ADP
cuesj-811	107	27	ca125	ca125	NOUN
cuesj-811	107	28	and	and	CCONJ
cuesj-811	107	29	tsh	tsh	NOUN
cuesj-811	107	30	ratio	ratio	NOUN
cuesj-811	107	31	in	in	ADP
cuesj-811	107	32	patient	patient	ADJ
cuesj-811	107	33	group	group	NOUN
cuesj-811	107	34	and	and	CCONJ
cuesj-811	107	35	control	control	PROPN
cuesj-811	107	36	group	group	NOUN
cuesj-811	107	37	figure	figure	NOUN
cuesj-811	107	38	2	2	NUM
cuesj-811	107	39	:	:	PUNCT
cuesj-811	107	40	correlation	correlation	NOUN
cuesj-811	107	41	between	between	ADP
cuesj-811	107	42	ca125	ca125	NOUN
cuesj-811	107	43	and	and	CCONJ
cuesj-811	107	44	wbc	wbc	PROPN
cuesj-811	107	45	ratio	ratio	NOUN
cuesj-811	107	46	in	in	ADP
cuesj-811	107	47	patient	patient	ADJ
cuesj-811	107	48	group	group	NOUN
cuesj-811	107	49	and	and	CCONJ
cuesj-811	107	50	control	control	PROPN
cuesj-811	107	51	group	group	NOUN
cuesj-811	107	52	figure	figure	NOUN
cuesj-811	107	53	3	3	NUM
cuesj-811	107	54	:	:	PUNCT
cuesj-811	107	55	correlation	correlation	NOUN
cuesj-811	107	56	between	between	ADP
cuesj-811	107	57	ca125	ca125	NOUN
cuesj-811	107	58	and	and	CCONJ
cuesj-811	107	59	lymphocyte	lymphocyte	ADJ
cuesj-811	107	60	ratio	ratio	NOUN
cuesj-811	107	61	in	in	ADP
cuesj-811	107	62	patient	patient	ADJ
cuesj-811	107	63	group	group	NOUN
cuesj-811	107	64	and	and	CCONJ
cuesj-811	107	65	control	control	PROPN
cuesj-811	107	66	group	group	NOUN
cuesj-811	107	67	figure	figure	NOUN
cuesj-811	107	68	4	4	NUM
cuesj-811	107	69	:	:	PUNCT
cuesj-811	107	70	correlation	correlation	NOUN
cuesj-811	107	71	between	between	ADP
cuesj-811	107	72	ca125	ca125	NOUN
cuesj-811	107	73	and	and	CCONJ
cuesj-811	107	74	monocyte	monocyte	ADJ
cuesj-811	107	75	ratio	ratio	NOUN
cuesj-811	107	76	in	in	ADP
cuesj-811	107	77	patient	patient	ADJ
cuesj-811	107	78	group	group	NOUN
cuesj-811	107	79	and	and	CCONJ
cuesj-811	107	80	control	control	PROPN
cuesj-811	107	81	group	group	NOUN
cuesj-811	107	82	ubeid	ubeid	NOUN
cuesj-811	107	83	,	,	PUNCT
cuesj-811	107	84	et	et	PROPN
cuesj-811	107	85	al	al	PROPN
cuesj-811	107	86	.	.	PUNCT
cuesj-811	107	87	:	:	PUNCT
cuesj-811	108	1	parameter	parameter	PROPN
cuesj-811	108	2	affecting	affect	VERB
cuesj-811	108	3	ca-125	ca-125	PROPN
cuesj-811	108	4	,	,	PUNCT
cuesj-811	108	5	tsh	tsh	NOUN
cuesj-811	108	6	,	,	PUNCT
cuesj-811	108	7	and	and	CCONJ
cuesj-811	108	8	cbc	cbc	PROPN
cuesj-811	108	9	5	5	NUM
cuesj-811	108	10	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-811	108	11	cuesj	cuesj	NOUN
cuesj-811	108	12	2023	2023	NUM
cuesj-811	108	13	,	,	PUNCT
cuesj-811	108	14	7	7	NUM
cuesj-811	108	15	(	(	PUNCT
cuesj-811	108	16	1	1	NUM
cuesj-811	108	17	):	):	PUNCT
cuesj-811	108	18	1	1	NUM
cuesj-811	108	19	-	-	SYM
cuesj-811	108	20	7	7	NUM
cuesj-811	108	21	bishara	bishara	NOUN
cuesj-811	108	22	et	et	PROPN
cuesj-811	108	23	al	al	PROPN
cuesj-811	108	24	.	.	PROPN
cuesj-811	108	25	reported	report	VERB
cuesj-811	108	26	that	that	SCONJ
cuesj-811	108	27	even	even	ADV
cuesj-811	108	28	when	when	SCONJ
cuesj-811	108	29	a	a	DET
cuesj-811	108	30	fractional	fractional	ADJ
cuesj-811	108	31	count	count	NOUN
cuesj-811	108	32	of	of	ADP
cuesj-811	108	33	lymphocyte	lymphocyte	NOUN
cuesj-811	108	34	to	to	PART
cuesj-811	108	35	wbcs	wbcs	VERB
cuesj-811	108	36	total	total	NOUN
cuesj-811	108	37	is	be	AUX
cuesj-811	108	38	significantly	significantly	ADV
cuesj-811	108	39	associated	associate	VERB
cuesj-811	108	40	with	with	ADP
cuesj-811	108	41	mortality	mortality	NOUN
cuesj-811	108	42	.	.	PUNCT
cuesj-811	109	1	while	while	SCONJ
cuesj-811	109	2	an	an	DET
cuesj-811	109	3	elevated	elevated	ADJ
cuesj-811	109	4	count	count	NOUN
cuesj-811	109	5	of	of	ADP
cuesj-811	109	6	monocyte	monocyte	NOUN
cuesj-811	109	7	showed	show	VERB
cuesj-811	109	8	a	a	DET
cuesj-811	109	9	substantial	substantial	ADJ
cuesj-811	109	10	recurrence	recurrence	NOUN
cuesj-811	109	11	association	association	NOUN
cuesj-811	109	12	.	.	PUNCT
cuesj-811	110	1	however	however	ADV
cuesj-811	110	2	,	,	PUNCT
cuesj-811	110	3	a	a	DET
cuesj-811	110	4	raised	raise	VERB
cuesj-811	110	5	count	count	NOUN
cuesj-811	110	6	of	of	ADP
cuesj-811	110	7	eosinophil	eosinophil	ADJ
cuesj-811	110	8	was	be	AUX
cuesj-811	110	9	a	a	DET
cuesj-811	110	10	mortality	mortality	NOUN
cuesj-811	110	11	and	and	CCONJ
cuesj-811	110	12	recurrence	recurrence	NOUN
cuesj-811	110	13	predictor	predictor	NOUN
cuesj-811	110	14	among	among	ADP
cuesj-811	110	15	the	the	DET
cuesj-811	110	16	ovarian	ovarian	ADJ
cuesj-811	110	17	cancer	cancer	NOUN
cuesj-811	110	18	women	woman	NOUN
cuesj-811	110	19	.	.	PUNCT
cuesj-811	111	1	equally	equally	ADV
cuesj-811	111	2	,	,	PUNCT
cuesj-811	111	3	bekmezci	bekmezci	NOUN
cuesj-811	111	4	and	and	CCONJ
cuesj-811	111	5	gunenc[38	gunenc[38	PROPN
cuesj-811	111	6	]	]	PUNCT
cuesj-811	111	7	reported	report	VERB
cuesj-811	111	8	that	that	SCONJ
cuesj-811	111	9	,	,	PUNCT
cuesj-811	111	10	in	in	ADP
cuesj-811	111	11	older	old	ADJ
cuesj-811	111	12	women	woman	NOUN
cuesj-811	111	13	both	both	PRON
cuesj-811	111	14	preoperative	preoperative	VERB
cuesj-811	111	15	nlr	nlr	PROPN
cuesj-811	111	16	alongside	alongside	ADP
cuesj-811	111	17	to	to	ADP
cuesj-811	111	18	ca125	ca125	ADV
cuesj-811	111	19	are	be	AUX
cuesj-811	111	20	to	to	PART
cuesj-811	111	21	be	be	AUX
cuesj-811	111	22	a	a	DET
cuesj-811	111	23	conceivable	conceivable	ADJ
cuesj-811	111	24	prognostic	prognostic	ADJ
cuesj-811	111	25	malignant	malignant	NOUN
cuesj-811	111	26	adnexal	adnexal	VERB
cuesj-811	111	27	mass	mass	PROPN
cuesj-811	111	28	indicator.[39	indicator.[39	PROPN
cuesj-811	111	29	]	]	PUNCT
cuesj-811	111	30	yildirim	yildirim	NOUN
cuesj-811	111	31	et	et	PROPN
cuesj-811	111	32	al	al	PROPN
cuesj-811	111	33	.	.	PROPN
cuesj-811	111	34	demonstrated	demonstrate	VERB
cuesj-811	111	35	that	that	SCONJ
cuesj-811	111	36	in	in	ADP
cuesj-811	111	37	patients	patient	NOUN
cuesj-811	111	38	of	of	ADP
cuesj-811	111	39	ovarian	ovarian	ADJ
cuesj-811	111	40	cancer	cancer	NOUN
cuesj-811	111	41	,	,	PUNCT
cuesj-811	111	42	nlr	nlr	PROPN
cuesj-811	111	43	,	,	PUNCT
cuesj-811	111	44	and	and	CCONJ
cuesj-811	111	45	plr	plr	NOUN
cuesj-811	111	46	values	value	NOUN
cuesj-811	111	47	are	be	AUX
cuesj-811	111	48	significantly	significantly	ADV
cuesj-811	111	49	high	high	ADJ
cuesj-811	111	50	when	when	SCONJ
cuesj-811	111	51	compared	compare	VERB
cuesj-811	111	52	to	to	ADP
cuesj-811	111	53	patients	patient	NOUN
cuesj-811	111	54	of	of	ADP
cuesj-811	111	55	benign	benign	ADJ
cuesj-811	111	56	ovarian	ovarian	ADJ
cuesj-811	111	57	tumor.[40	tumor.[40	NOUN
cuesj-811	111	58	]	]	PUNCT
cuesj-811	111	59	furthermore	furthermore	ADV
cuesj-811	111	60	,	,	PUNCT
cuesj-811	111	61	no	no	DET
cuesj-811	111	62	change	change	NOUN
cuesj-811	111	63	was	be	AUX
cuesj-811	111	64	observed	observe	VERB
cuesj-811	111	65	in	in	ADP
cuesj-811	111	66	granulocyte	granulocyte	ADJ
cuesj-811	111	67	,	,	PUNCT
cuesj-811	111	68	monocyte	monocyte	NOUN
cuesj-811	111	69	,	,	PUNCT
cuesj-811	111	70	and	and	CCONJ
cuesj-811	111	71	lymphocyte	lymphocyte	ADJ
cuesj-811	111	72	values	value	NOUN
cuesj-811	111	73	as	as	SCONJ
cuesj-811	111	74	the	the	DET
cuesj-811	111	75	ca125	ca125	NOUN
cuesj-811	111	76	was	be	AUX
cuesj-811	111	77	elevated.[41	elevated.[41	PROPN
cuesj-811	111	78	]	]	PUNCT
cuesj-811	111	79	obermair	obermair	NOUN
cuesj-811	111	80	et	et	PROPN
cuesj-811	111	81	al	al	PROPN
cuesj-811	111	82	.	.	PROPN
cuesj-811	111	83	illustrated	illustrate	VERB
cuesj-811	111	84	that	that	SCONJ
cuesj-811	111	85	the	the	DET
cuesj-811	111	86	inversed	inversed	ADJ
cuesj-811	111	87	hb	hb	X
cuesj-811	111	88	concentrations	concentration	NOUN
cuesj-811	111	89	were	be	AUX
cuesj-811	111	90	associated	associate	VERB
cuesj-811	111	91	to	to	ADP
cuesj-811	111	92	the	the	DET
cuesj-811	111	93	disease	disease	NOUN
cuesj-811	111	94	stage	stage	NOUN
cuesj-811	111	95	along	along	ADP
cuesj-811	111	96	with	with	ADP
cuesj-811	111	97	the	the	DET
cuesj-811	111	98	chronic	chronic	ADJ
cuesj-811	111	99	inflammatory	inflammatory	ADJ
cuesj-811	111	100	status	status	NOUN
cuesj-811	111	101	severity	severity	NOUN
cuesj-811	111	102	.	.	PUNCT
cuesj-811	112	1	while	while	SCONJ
cuesj-811	112	2	,	,	PUNCT
cuesj-811	112	3	förhécz	förhécz	VERB
cuesj-811	112	4	et	et	PROPN
cuesj-811	112	5	al.[42	al.[42	PROPN
cuesj-811	112	6	]	]	PUNCT
cuesj-811	112	7	suggested	suggest	VERB
cuesj-811	112	8	that	that	SCONJ
cuesj-811	112	9	red	red	ADJ
cuesj-811	112	10	cell	cell	NOUN
cuesj-811	112	11	distribution	distribution	NOUN
cuesj-811	112	12	width	width	NOUN
cuesj-811	112	13	(	(	PUNCT
cuesj-811	112	14	rdw	rdw	X
cuesj-811	112	15	)	)	PUNCT
cuesj-811	112	16	was	be	AUX
cuesj-811	112	17	linked	link	VERB
cuesj-811	112	18	with	with	ADP
cuesj-811	112	19	the	the	DET
cuesj-811	112	20	stage	stage	NOUN
cuesj-811	112	21	of	of	ADP
cuesj-811	112	22	the	the	DET
cuesj-811	112	23	ovarian	ovarian	ADJ
cuesj-811	112	24	cancer	cancer	NOUN
cuesj-811	112	25	,	,	PUNCT
cuesj-811	112	26	if	if	SCONJ
cuesj-811	112	27	the	the	DET
cuesj-811	112	28	stage	stage	NOUN
cuesj-811	112	29	is	be	AUX
cuesj-811	112	30	advanced	advanced	ADJ
cuesj-811	112	31	or	or	CCONJ
cuesj-811	112	32	high	high	ADJ
cuesj-811	112	33	,	,	PUNCT
cuesj-811	112	34	equally	equally	ADV
cuesj-811	112	35	the	the	DET
cuesj-811	112	36	rdw	rdw	NOUN
cuesj-811	112	37	is	be	AUX
cuesj-811	112	38	high.[43	high.[43	ADJ
cuesj-811	112	39	]	]	X
cuesj-811	112	40	similarly	similarly	ADV
cuesj-811	112	41	,	,	PUNCT
cuesj-811	112	42	it	it	PRON
cuesj-811	112	43	was	be	AUX
cuesj-811	112	44	positively	positively	ADV
cuesj-811	112	45	correlated	correlate	VERB
cuesj-811	112	46	with	with	ADP
cuesj-811	112	47	ca125	ca125	NOUN
cuesj-811	112	48	levels	level	NOUN
cuesj-811	112	49	.	.	PUNCT
cuesj-811	113	1	where	where	SCONJ
cuesj-811	113	2	,	,	PUNCT
cuesj-811	113	3	an	an	DET
cuesj-811	113	4	elevated	elevated	ADJ
cuesj-811	113	5	rdw	rdw	NOUN
cuesj-811	113	6	in	in	ADP
cuesj-811	113	7	peripheral	peripheral	ADJ
cuesj-811	113	8	blood	blood	NOUN
cuesj-811	113	9	smears	smear	NOUN
cuesj-811	113	10	probably	probably	ADV
cuesj-811	113	11	to	to	PART
cuesj-811	113	12	correlate	correlate	VERB
cuesj-811	113	13	with	with	ADP
cuesj-811	113	14	iron	iron	NOUN
cuesj-811	113	15	,	,	PUNCT
cuesj-811	113	16	vitamin	vitamin	NOUN
cuesj-811	113	17	b12	b12	NOUN
cuesj-811	113	18	,	,	PUNCT
cuesj-811	113	19	or	or	CCONJ
cuesj-811	113	20	folic	folic	ADJ
cuesj-811	113	21	acid	acid	NOUN
cuesj-811	113	22	,	,	PUNCT
cuesj-811	113	23	and	and	CCONJ
cuesj-811	113	24	hb	hb	NOUN
cuesj-811	113	25	deficiencies	deficiency	NOUN
cuesj-811	113	26	;	;	PUNCT
cuesj-811	113	27	hemolysis	hemolysis	NOUN
cuesj-811	113	28	or	or	CCONJ
cuesj-811	113	29	the	the	DET
cuesj-811	113	30	transfusion	transfusion	NOUN
cuesj-811	113	31	of	of	ADP
cuesj-811	113	32	the	the	DET
cuesj-811	113	33	blood	blood	NOUN
cuesj-811	113	34	is	be	AUX
cuesj-811	113	35	a	a	DET
cuesj-811	113	36	reason	reason	NOUN
cuesj-811	113	37	of	of	ADP
cuesj-811	113	38	elevating	elevate	VERB
cuesj-811	113	39	the	the	DET
cuesj-811	113	40	rdw.[44	rdw.[44	NOUN
cuesj-811	113	41	]	]	PUNCT
cuesj-811	113	42	in	in	ADP
cuesj-811	113	43	the	the	DET
cuesj-811	113	44	present	present	ADJ
cuesj-811	113	45	work	work	NOUN
cuesj-811	113	46	,	,	PUNCT
cuesj-811	113	47	there	there	PRON
cuesj-811	113	48	was	be	VERB
cuesj-811	113	49	no	no	DET
cuesj-811	113	50	significant	significant	ADJ
cuesj-811	113	51	change	change	NOUN
cuesj-811	113	52	of	of	ADP
cuesj-811	113	53	hb	hb	PROPN
cuesj-811	113	54	levels	level	NOUN
cuesj-811	113	55	,	,	PUNCT
cuesj-811	113	56	as	as	SCONJ
cuesj-811	113	57	the	the	DET
cuesj-811	113	58	ca25	ca25	PROPN
cuesj-811	113	59	levels	level	NOUN
cuesj-811	113	60	elevated	elevate	VERB
cuesj-811	113	61	among	among	ADP
cuesj-811	113	62	non	non	ADJ
cuesj-811	113	63	-	-	ADJ
cuesj-811	113	64	cancerous	cancerous	ADJ
cuesj-811	113	65	women	woman	NOUN
cuesj-811	113	66	.	.	PUNCT
cuesj-811	114	1	but	but	CCONJ
cuesj-811	114	2	a	a	DET
cuesj-811	114	3	lower	low	ADJ
cuesj-811	114	4	rbc	rbc	PROPN
cuesj-811	114	5	count	count	NOUN
cuesj-811	114	6	of	of	ADP
cuesj-811	114	7	patients	patient	NOUN
cuesj-811	114	8	was	be	AUX
cuesj-811	114	9	recognized	recognize	VERB
cuesj-811	114	10	.	.	PUNCT
cuesj-811	115	1	lehtovirta	lehtovirta	PROPN
cuesj-811	115	2	et	et	PROPN
cuesj-811	115	3	al	al	PROPN
cuesj-811	115	4	.	.	PROPN
cuesj-811	115	5	and	and	CCONJ
cuesj-811	115	6	juma	juma	PROPN
cuesj-811	115	7	and	and	CCONJ
cuesj-811	115	8	ubeid	ubeid	PROPN
cuesj-811	115	9	demonstrated	demonstrate	VERB
cuesj-811	115	10	that	that	SCONJ
cuesj-811	115	11	,	,	PUNCT
cuesj-811	115	12	the	the	DET
cuesj-811	115	13	ca125	ca125	NOUN
cuesj-811	115	14	test	test	NOUN
cuesj-811	115	15	should	should	AUX
cuesj-811	115	16	not	not	PART
cuesj-811	115	17	be	be	AUX
cuesj-811	115	18	conducted	conduct	VERB
cuesj-811	115	19	directly	directly	ADV
cuesj-811	115	20	,	,	PUNCT
cuesj-811	115	21	before	before	ADV
cuesj-811	115	22	,	,	PUNCT
cuesj-811	115	23	or	or	CCONJ
cuesj-811	115	24	during	during	ADP
cuesj-811	115	25	menstrual	menstrual	ADJ
cuesj-811	115	26	cycle	cycle	NOUN
cuesj-811	115	27	,	,	PUNCT
cuesj-811	115	28	as	as	SCONJ
cuesj-811	115	29	the	the	DET
cuesj-811	115	30	ca125	ca125	PROPN
cuesj-811	115	31	physiological	physiological	ADJ
cuesj-811	115	32	elevation	elevation	NOUN
cuesj-811	115	33	levels	level	NOUN
cuesj-811	115	34	possibly	possibly	ADV
cuesj-811	115	35	to	to	PART
cuesj-811	115	36	provide	provide	VERB
cuesj-811	115	37	false	false	ADJ
cuesj-811	115	38	and	and	CCONJ
cuesj-811	115	39	positive	positive	ADJ
cuesj-811	115	40	results	result	NOUN
cuesj-811	115	41	.	.	PUNCT
cuesj-811	116	1	in	in	ADP
cuesj-811	116	2	the	the	DET
cuesj-811	116	3	present	present	ADJ
cuesj-811	116	4	study	study	NOUN
cuesj-811	116	5	,	,	PUNCT
cuesj-811	116	6	patients	patient	NOUN
cuesj-811	116	7	with	with	ADP
cuesj-811	116	8	high	high	ADJ
cuesj-811	116	9	ca125	ca125	NOUN
cuesj-811	116	10	were	be	AUX
cuesj-811	116	11	found	find	VERB
cuesj-811	116	12	,	,	PUNCT
cuesj-811	116	13	with	with	ADP
cuesj-811	116	14	normal	normal	ADJ
cuesj-811	116	15	levels	level	NOUN
cuesj-811	116	16	of	of	ADP
cuesj-811	116	17	each	each	DET
cuesj-811	116	18	parameter	parameter	NOUN
cuesj-811	116	19	wbc	wbc	PROPN
cuesj-811	116	20	,	,	PUNCT
cuesj-811	116	21	hb	hb	PROPN
cuesj-811	116	22	,	,	PUNCT
cuesj-811	116	23	and	and	CCONJ
cuesj-811	116	24	tsh	tsh	NOUN
cuesj-811	116	25	,	,	PUNCT
cuesj-811	116	26	but	but	CCONJ
cuesj-811	116	27	without	without	ADP
cuesj-811	116	28	respect	respect	NOUN
cuesj-811	116	29	to	to	ADP
cuesj-811	116	30	their	their	PRON
cuesj-811	116	31	menstrual	menstrual	ADJ
cuesj-811	116	32	cycle	cycle	NOUN
cuesj-811	116	33	.	.	PUNCT
cuesj-811	117	1	as	as	SCONJ
cuesj-811	117	2	it	it	PRON
cuesj-811	117	3	was	be	AUX
cuesj-811	117	4	revealed	reveal	VERB
cuesj-811	117	5	by	by	ADP
cuesj-811	117	6	the	the	DET
cuesj-811	117	7	previous	previous	ADJ
cuesj-811	117	8	studies	study	NOUN
cuesj-811	117	9	,	,	PUNCT
cuesj-811	117	10	that	that	SCONJ
cuesj-811	117	11	hyperthyroidism	hyperthyroidism	NOUN
cuesj-811	117	12	and	and	CCONJ
cuesj-811	117	13	mortality	mortality	NOUN
cuesj-811	117	14	rate	rate	NOUN
cuesj-811	117	15	are	be	AUX
cuesj-811	117	16	correlated	correlate	VERB
cuesj-811	117	17	to	to	ADP
cuesj-811	117	18	patients	patient	NOUN
cuesj-811	117	19	of	of	ADP
cuesj-811	117	20	ovarian	ovarian	ADJ
cuesj-811	117	21	cancer	cancer	NOUN
cuesj-811	117	22	.	.	PUNCT
cuesj-811	118	1	in	in	ADP
cuesj-811	118	2	addition	addition	NOUN
cuesj-811	118	3	,	,	PUNCT
cuesj-811	118	4	high	high	ADJ
cuesj-811	118	5	rdw	rdw	X
cuesj-811	118	6	signifies	signify	VERB
cuesj-811	118	7	the	the	DET
cuesj-811	118	8	disease	disease	NOUN
cuesj-811	118	9	advanced	advanced	ADJ
cuesj-811	118	10	stage	stage	NOUN
cuesj-811	118	11	.	.	PUNCT
cuesj-811	119	1	whereas	whereas	SCONJ
cuesj-811	119	2	,	,	PUNCT
cuesj-811	119	3	ca125	ca125	PRON
cuesj-811	119	4	was	be	AUX
cuesj-811	119	5	inadequate	inadequate	ADJ
cuesj-811	119	6	biomarker	biomarker	NOUN
cuesj-811	119	7	for	for	ADP
cuesj-811	119	8	diagnosing	diagnose	VERB
cuesj-811	119	9	early	early	ADJ
cuesj-811	119	10	ovarian	ovarian	ADJ
cuesj-811	119	11	cancer.[45,46	cancer.[45,46	NOUN
cuesj-811	119	12	]	]	PUNCT
cuesj-811	119	13	as	as	SCONJ
cuesj-811	119	14	the	the	DET
cuesj-811	119	15	age	age	NOUN
cuesj-811	119	16	rises	rise	VERB
cuesj-811	119	17	,	,	PUNCT
cuesj-811	119	18	many	many	ADJ
cuesj-811	119	19	factors	factor	NOUN
cuesj-811	119	20	will	will	AUX
cuesj-811	119	21	have	have	VERB
cuesj-811	119	22	effect	effect	NOUN
cuesj-811	119	23	on	on	ADP
cuesj-811	119	24	human	human	ADJ
cuesj-811	119	25	health	health	NOUN
cuesj-811	119	26	.	.	PUNCT
cuesj-811	120	1	in	in	ADP
cuesj-811	120	2	this	this	DET
cuesj-811	120	3	regard	regard	NOUN
cuesj-811	120	4	many	many	ADJ
cuesj-811	120	5	determinants	determinant	NOUN
cuesj-811	120	6	impact	impact	VERB
cuesj-811	120	7	the	the	DET
cuesj-811	120	8	ca125	ca125	NOUN
cuesj-811	120	9	level	level	NOUN
cuesj-811	120	10	especially	especially	ADV
cuesj-811	120	11	in	in	ADP
cuesj-811	120	12	females	female	NOUN
cuesj-811	120	13	who	who	PRON
cuesj-811	120	14	passed	pass	VERB
cuesj-811	120	15	menopause	menopause	NOUN
cuesj-811	120	16	and	and	CCONJ
cuesj-811	120	17	ovarian	ovarian	ADJ
cuesj-811	120	18	cancer	cancer	NOUN
cuesj-811	120	19	disease	disease	NOUN
cuesj-811	120	20	free	free	ADJ
cuesj-811	120	21	.	.	PUNCT
cuesj-811	121	1	these	these	DET
cuesj-811	121	2	factors	factor	NOUN
cuesj-811	121	3	are	be	AUX
cuesj-811	121	4	:	:	PUNCT
cuesj-811	121	5	age	age	NOUN
cuesj-811	121	6	,	,	PUNCT
cuesj-811	121	7	hysterectomy	hysterectomy	NOUN
cuesj-811	121	8	,	,	PUNCT
cuesj-811	121	9	obesity	obesity	NOUN
cuesj-811	121	10	,	,	PUNCT
cuesj-811	121	11	race	race	NOUN
cuesj-811	121	12	/	/	SYM
cuesj-811	121	13	ethnicity	ethnicity	NOUN
cuesj-811	121	14	,	,	PUNCT
cuesj-811	121	15	and	and	CCONJ
cuesj-811	121	16	the	the	DET
cuesj-811	121	17	smoking	smoking	NOUN
cuesj-811	121	18	background.[47	background.[47	VERB
cuesj-811	121	19	]	]	PUNCT
cuesj-811	121	20	the	the	DET
cuesj-811	121	21	serum	serum	NOUN
cuesj-811	121	22	of	of	ADP
cuesj-811	121	23	carbohydrate	carbohydrate	NOUN
cuesj-811	121	24	antigen	antigen	NOUN
cuesj-811	122	1	ca125	ca125	PUNCT
cuesj-811	122	2	serves	serve	VERB
cuesj-811	122	3	an	an	DET
cuesj-811	122	4	indicator	indicator	NOUN
cuesj-811	122	5	to	to	ADP
cuesj-811	122	6	the	the	DET
cuesj-811	122	7	inclination	inclination	NOUN
cuesj-811	122	8	risk	risk	NOUN
cuesj-811	122	9	of	of	ADP
cuesj-811	122	10	ovarian	ovarian	ADJ
cuesj-811	122	11	cancer	cancer	NOUN
cuesj-811	122	12	.	.	PUNCT
cuesj-811	123	1	it	it	PRON
cuesj-811	123	2	is	be	AUX
cuesj-811	123	3	also	also	ADV
cuesj-811	123	4	obesity	obesity	NOUN
cuesj-811	123	5	indicator	indicator	NOUN
cuesj-811	123	6	which	which	PRON
cuesj-811	123	7	is	be	AUX
cuesj-811	123	8	considered	consider	VERB
cuesj-811	123	9	a	a	DET
cuesj-811	123	10	significant	significant	ADJ
cuesj-811	123	11	element	element	NOUN
cuesj-811	123	12	to	to	ADP
cuesj-811	123	13	the	the	DET
cuesj-811	123	14	metabolic	metabolic	NOUN
cuesj-811	123	15	syndrome.[48	syndrome.[48	NOUN
cuesj-811	123	16	]	]	PUNCT
cuesj-811	123	17	it	it	PRON
cuesj-811	123	18	is	be	AUX
cuesj-811	123	19	worthy	worthy	ADJ
cuesj-811	123	20	to	to	PART
cuesj-811	123	21	mention	mention	VERB
cuesj-811	123	22	that	that	SCONJ
cuesj-811	123	23	,	,	PUNCT
cuesj-811	123	24	the	the	DET
cuesj-811	123	25	level	level	NOUN
cuesj-811	123	26	of	of	ADP
cuesj-811	123	27	serum	serum	NOUN
cuesj-811	124	1	ca125	ca125	ADV
cuesj-811	124	2	showed	show	VERB
cuesj-811	124	3	a	a	DET
cuesj-811	124	4	significant	significant	ADJ
cuesj-811	124	5	inclination	inclination	NOUN
cuesj-811	124	6	in	in	ADP
cuesj-811	124	7	patients	patient	NOUN
cuesj-811	124	8	of	of	ADP
cuesj-811	124	9	chronic	chronic	ADJ
cuesj-811	124	10	heart	heart	NOUN
cuesj-811	124	11	failure.[49,50	failure.[49,50	PROPN
cuesj-811	124	12	]	]	PUNCT
cuesj-811	124	13	conclusion	conclusion	NOUN
cuesj-811	124	14	the	the	DET
cuesj-811	124	15	study	study	NOUN
cuesj-811	124	16	revealed	reveal	VERB
cuesj-811	124	17	that	that	SCONJ
cuesj-811	124	18	there	there	PRON
cuesj-811	124	19	was	be	VERB
cuesj-811	124	20	no	no	DET
cuesj-811	124	21	association	association	NOUN
cuesj-811	124	22	regarding	regard	VERB
cuesj-811	124	23	ca125	ca125	NOUN
cuesj-811	124	24	serum	serum	NOUN
cuesj-811	124	25	and	and	CCONJ
cuesj-811	124	26	the	the	DET
cuesj-811	124	27	levels	level	NOUN
cuesj-811	124	28	of	of	ADP
cuesj-811	124	29	tsh	tsh	NOUN
cuesj-811	124	30	.	.	PUNCT
cuesj-811	125	1	however	however	ADV
cuesj-811	125	2	,	,	PUNCT
cuesj-811	125	3	the	the	DET
cuesj-811	125	4	elevated	elevated	ADJ
cuesj-811	125	5	ca125	ca125	NOUN
cuesj-811	125	6	levels	level	NOUN
cuesj-811	125	7	in	in	ADP
cuesj-811	125	8	healthy	healthy	ADJ
cuesj-811	125	9	females	female	NOUN
cuesj-811	125	10	could	could	AUX
cuesj-811	125	11	be	be	AUX
cuesj-811	125	12	related	relate	VERB
cuesj-811	125	13	to	to	ADP
cuesj-811	125	14	other	other	ADJ
cuesj-811	125	15	noncancerous	noncancerous	ADJ
cuesj-811	125	16	factors	factor	NOUN
cuesj-811	125	17	such	such	ADJ
cuesj-811	125	18	as	as	ADP
cuesj-811	125	19	menstrual	menstrual	ADJ
cuesj-811	125	20	cycle	cycle	NOUN
cuesj-811	125	21	,	,	PUNCT
cuesj-811	125	22	or	or	CCONJ
cuesj-811	125	23	postmenopausal	postmenopausal	NOUN
cuesj-811	125	24	.	.	PUNCT
cuesj-811	126	1	figure	figure	VERB
cuesj-811	126	2	5	5	NUM
cuesj-811	126	3	:	:	PUNCT
cuesj-811	126	4	correlation	correlation	NOUN
cuesj-811	126	5	between	between	ADP
cuesj-811	126	6	ca125	ca125	NOUN
cuesj-811	126	7	and	and	CCONJ
cuesj-811	126	8	granulocyte	granulocyte	ADJ
cuesj-811	126	9	ratio	ratio	NOUN
cuesj-811	126	10	in	in	ADP
cuesj-811	126	11	patient	patient	ADJ
cuesj-811	126	12	group	group	NOUN
cuesj-811	126	13	and	and	CCONJ
cuesj-811	126	14	control	control	PROPN
cuesj-811	126	15	group	group	NOUN
cuesj-811	126	16	figure	figure	NOUN
cuesj-811	126	17	6	6	NUM
cuesj-811	126	18	:	:	PUNCT
cuesj-811	126	19	correlation	correlation	NOUN
cuesj-811	126	20	between	between	ADP
cuesj-811	126	21	ca125	ca125	NOUN
cuesj-811	126	22	and	and	CCONJ
cuesj-811	126	23	rbc	rbc	PROPN
cuesj-811	126	24	ratio	ratio	NOUN
cuesj-811	126	25	in	in	ADP
cuesj-811	126	26	patient	patient	ADJ
cuesj-811	126	27	group	group	NOUN
cuesj-811	126	28	and	and	CCONJ
cuesj-811	126	29	control	control	PROPN
cuesj-811	126	30	group	group	NOUN
cuesj-811	126	31	figure	figure	NOUN
cuesj-811	126	32	7	7	NUM
cuesj-811	126	33	:	:	PUNCT
cuesj-811	126	34	correlation	correlation	NOUN
cuesj-811	126	35	between	between	ADP
cuesj-811	126	36	ca125	ca125	NOUN
cuesj-811	126	37	and	and	CCONJ
cuesj-811	126	38	hb	hb	PROPN
cuesj-811	126	39	ratio	ratio	NOUN
cuesj-811	126	40	in	in	ADP
cuesj-811	126	41	patient	patient	ADJ
cuesj-811	126	42	group	group	NOUN
cuesj-811	126	43	and	and	CCONJ
cuesj-811	126	44	control	control	PROPN
cuesj-811	126	45	group	group	NOUN
cuesj-811	126	46	figure	figure	NOUN
cuesj-811	126	47	8	8	NUM
cuesj-811	126	48	:	:	PUNCT
cuesj-811	126	49	correlation	correlation	NOUN
cuesj-811	126	50	between	between	ADP
cuesj-811	126	51	ca125	ca125	NOUN
cuesj-811	126	52	and	and	CCONJ
cuesj-811	126	53	age	age	NOUN
cuesj-811	126	54	ubeid	ubeid	NOUN
cuesj-811	126	55	,	,	PUNCT
cuesj-811	126	56	et	et	PROPN
cuesj-811	126	57	al	al	PROPN
cuesj-811	126	58	.	.	PUNCT
cuesj-811	126	59	:	:	PUNCT
cuesj-811	127	1	parameter	parameter	PROPN
cuesj-811	127	2	affecting	affect	VERB
cuesj-811	127	3	ca-125	ca-125	PROPN
cuesj-811	127	4	,	,	PUNCT
cuesj-811	127	5	tsh	tsh	NOUN
cuesj-811	127	6	,	,	PUNCT
cuesj-811	127	7	and	and	CCONJ
cuesj-811	127	8	cbc	cbc	PROPN
cuesj-811	127	9	6	6	NUM
cuesj-811	127	10	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-811	127	11	cuesj	cuesj	NOUN
cuesj-811	127	12	2023	2023	NUM
cuesj-811	127	13	,	,	PUNCT
cuesj-811	127	14	7	7	NUM
cuesj-811	127	15	(	(	PUNCT
cuesj-811	127	16	1	1	NUM
cuesj-811	127	17	):	):	PUNCT
cuesj-811	127	18	1	1	NUM
cuesj-811	127	19	-	-	SYM
cuesj-811	127	20	7	7	NUM
cuesj-811	127	21	furthermore	furthermore	ADV
cuesj-811	127	22	,	,	PUNCT
cuesj-811	127	23	wbc	wbc	ADJ
cuesj-811	127	24	parameters	parameter	NOUN
cuesj-811	127	25	and	and	CCONJ
cuesj-811	127	26	hb	hb	PROPN
cuesj-811	127	27	levels	level	NOUN
cuesj-811	127	28	were	be	AUX
cuesj-811	127	29	not	not	PART
cuesj-811	127	30	affected	affect	VERB
cuesj-811	127	31	by	by	ADP
cuesj-811	127	32	ca125	ca125	PROPN
cuesj-811	127	33	.	.	PUNCT
cuesj-811	128	1	the	the	DET
cuesj-811	128	2	only	only	ADJ
cuesj-811	128	3	parameters	parameter	NOUN
cuesj-811	128	4	that	that	PRON
cuesj-811	128	5	were	be	AUX
cuesj-811	128	6	affected	affect	VERB
cuesj-811	128	7	with	with	ADP
cuesj-811	128	8	ca125	ca125	NOUN
cuesj-811	128	9	elevation	elevation	NOUN
cuesj-811	128	10	were	be	AUX
cuesj-811	128	11	rbc	rbc	PROPN
cuesj-811	128	12	.	.	PUNCT
cuesj-811	129	1	the	the	DET
cuesj-811	129	2	study	study	NOUN
cuesj-811	129	3	results	result	NOUN
cuesj-811	129	4	show	show	VERB
cuesj-811	129	5	that	that	SCONJ
cuesj-811	129	6	there	there	PRON
cuesj-811	129	7	was	be	VERB
cuesj-811	129	8	no	no	DET
cuesj-811	129	9	association	association	NOUN
cuesj-811	129	10	between	between	ADP
cuesj-811	129	11	ca125	ca125	PROPN
cuesj-811	129	12	and	and	CCONJ
cuesj-811	129	13	women	woman	NOUN
cuesj-811	129	14	age	age	NOUN
cuesj-811	129	15	.	.	PUNCT
cuesj-811	130	1	references	reference	NOUN
cuesj-811	130	2	1	1	NUM
cuesj-811	130	3	.	.	PUNCT
cuesj-811	130	4	z.	z.	PROPN
cuesj-811	130	5	r.	r.	PROPN
cuesj-811	130	6	yurkovetsky	yurkovetsky	PROPN
cuesj-811	130	7	,	,	PUNCT
cuesj-811	130	8	f.	f.	PROPN
cuesj-811	130	9	y.	y.	PROPN
cuesj-811	130	10	linkov	linkov	PROPN
cuesj-811	130	11	,	,	PUNCT
cuesj-811	130	12	d.	d.	PROPN
cuesj-811	130	13	e	e	PROPN
cuesj-811	130	14	malehorn	malehorn	ADJ
cuesj-811	130	15	and	and	CCONJ
cuesj-811	130	16	a.	a.	PROPN
cuesj-811	130	17	e.	e.	PROPN
cuesj-811	130	18	lokshin	lokshin	PROPN
cuesj-811	130	19	.	.	PUNCT
cuesj-811	131	1	multiple	multiple	ADJ
cuesj-811	131	2	biomarker	biomarker	NOUN
cuesj-811	131	3	panels	panel	NOUN
cuesj-811	131	4	for	for	ADP
cuesj-811	131	5	early	early	ADJ
cuesj-811	131	6	detection	detection	NOUN
cuesj-811	131	7	of	of	ADP
cuesj-811	131	8	ovarian	ovarian	ADJ
cuesj-811	131	9	cancer	cancer	NOUN
cuesj-811	131	10	.	.	PUNCT
cuesj-811	132	1	future	future	ADJ
cuesj-811	132	2	oncology	oncology	NOUN
cuesj-811	132	3	,	,	PUNCT
cuesj-811	132	4	vol	vol	NOUN
cuesj-811	132	5	.	.	PROPN
cuesj-811	132	6	2	2	NUM
cuesj-811	132	7	,	,	PUNCT
cuesj-811	132	8	no	no	INTJ
cuesj-811	132	9	.	.	NOUN
cuesj-811	132	10	6	6	NUM
cuesj-811	132	11	,	,	PUNCT
cuesj-811	132	12	pp	pp	ADJ
cuesj-811	132	13	.	.	PUNCT
cuesj-811	133	1	733	733	NUM
cuesj-811	133	2	-	-	SYM
cuesj-811	133	3	741	741	NUM
cuesj-811	133	4	,	,	PUNCT
cuesj-811	133	5	2006	2006	NUM
cuesj-811	133	6	.	.	PUNCT
cuesj-811	134	1	2	2	NUM
cuesj-811	134	2	.	.	PUNCT
cuesj-811	134	3	k.	k.	PROPN
cuesj-811	134	4	a.	a.	PROPN
cuesj-811	134	5	sikaris	sikaris	PROPN
cuesj-811	134	6	.	.	PUNCT
cuesj-811	135	1	ca125	ca125	NOUN
cuesj-811	135	2	-	-	PUNCT
cuesj-811	135	3	a	a	DET
cuesj-811	135	4	test	test	NOUN
cuesj-811	135	5	with	with	ADP
cuesj-811	135	6	a	a	DET
cuesj-811	135	7	change	change	NOUN
cuesj-811	135	8	of	of	ADP
cuesj-811	135	9	heart	heart	NOUN
cuesj-811	135	10	.	.	PUNCT
cuesj-811	136	1	heart	heart	NOUN
cuesj-811	136	2	,	,	PUNCT
cuesj-811	136	3	lung	lung	NOUN
cuesj-811	136	4	and	and	CCONJ
cuesj-811	136	5	circulation	circulation	NOUN
cuesj-811	136	6	,	,	PUNCT
cuesj-811	136	7	vol	vol	NOUN
cuesj-811	136	8	.	.	PROPN
cuesj-811	136	9	20	20	NUM
cuesj-811	136	10	,	,	PUNCT
cuesj-811	136	11	no	no	INTJ
cuesj-811	136	12	.	.	NOUN
cuesj-811	136	13	10	10	NUM
cuesj-811	136	14	,	,	PUNCT
cuesj-811	136	15	pp	pp	ADJ
cuesj-811	136	16	.	.	PUNCT
cuesj-811	137	1	634	634	NUM
cuesj-811	137	2	-	-	SYM
cuesj-811	137	3	640	640	NUM
cuesj-811	137	4	,	,	PUNCT
cuesj-811	137	5	2011	2011	NUM
cuesj-811	137	6	.	.	PUNCT
cuesj-811	138	1	3	3	X
cuesj-811	138	2	.	.	X
cuesj-811	138	3	r.	r.	PROPN
cuesj-811	138	4	c.	c.	PROPN
cuesj-811	138	5	bast	bast	PROPN
cuesj-811	138	6	,	,	PUNCT
cuesj-811	138	7	d.	d.	PROPN
cuesj-811	138	8	badgwell	badgwell	PROPN
cuesj-811	138	9	,	,	PUNCT
cuesj-811	138	10	z.	z.	PROPN
cuesj-811	138	11	lu	lu	PROPN
cuesj-811	138	12	,	,	PUNCT
cuesj-811	138	13	r.	r.	PROPN
cuesj-811	138	14	marquez	marquez	PROPN
cuesj-811	138	15	,	,	PUNCT
cuesj-811	138	16	d.	d.	PROPN
cuesj-811	138	17	rosen	rosen	PROPN
cuesj-811	138	18	,	,	PUNCT
cuesj-811	138	19	j.	j.	PROPN
cuesj-811	138	20	liu	liu	PROPN
cuesj-811	138	21	,	,	PUNCT
cuesj-811	138	22	k.	k.	PROPN
cuesj-811	138	23	a.	a.	PROPN
cuesj-811	139	1	baggerly	baggerly	ADV
cuesj-811	139	2	,	,	PUNCT
cuesj-811	139	3	e.	e.	PROPN
cuesj-811	139	4	n.	n.	PROPN
cuesj-811	139	5	atkinson	atkinson	PROPN
cuesj-811	139	6	,	,	PUNCT
cuesj-811	139	7	s.	s.	PROPN
cuesj-811	139	8	skates	skates	PROPN
cuesj-811	139	9	,	,	PUNCT
cuesj-811	139	10	z.	z.	PROPN
cuesj-811	139	11	zhang	zhang	PROPN
cuesj-811	139	12	,	,	PUNCT
cuesj-811	139	13	a.	a.	PROPN
cuesj-811	139	14	lokshin	lokshin	PROPN
cuesj-811	139	15	,	,	PUNCT
cuesj-811	139	16	u.	u.	PROPN
cuesj-811	139	17	menon	menon	PROPN
cuesj-811	139	18	,	,	PUNCT
cuesj-811	139	19	i.	i.	PROPN
cuesj-811	139	20	jacobs	jacobs	PROPN
cuesj-811	139	21	and	and	CCONJ
cuesj-811	139	22	k.	k.	PROPN
cuesj-811	139	23	lu	lu	PROPN
cuesj-811	139	24	.	.	PUNCT
cuesj-811	140	1	new	new	ADJ
cuesj-811	140	2	tumor	tumor	NOUN
cuesj-811	140	3	markers	marker	NOUN
cuesj-811	140	4	:	:	PUNCT
cuesj-811	140	5	ca125	ca125	NOUN
cuesj-811	140	6	and	and	CCONJ
cuesj-811	140	7	beyond	beyond	ADP
cuesj-811	140	8	.	.	PUNCT
cuesj-811	141	1	international	international	ADJ
cuesj-811	141	2	journal	journal	NOUN
cuesj-811	141	3	of	of	ADP
cuesj-811	141	4	gynecologic	gynecologic	ADJ
cuesj-811	141	5	cancer	cancer	NOUN
cuesj-811	141	6	,	,	PUNCT
cuesj-811	141	7	vol	vol	NOUN
cuesj-811	141	8	.	.	PROPN
cuesj-811	141	9	15	15	NUM
cuesj-811	141	10	,	,	PUNCT
cuesj-811	141	11	pp	pp	ADJ
cuesj-811	141	12	.	.	PUNCT
cuesj-811	142	1	274	274	NUM
cuesj-811	142	2	-	-	SYM
cuesj-811	142	3	281	281	NUM
cuesj-811	142	4	,	,	PUNCT
cuesj-811	142	5	2005	2005	NUM
cuesj-811	142	6	.	.	PUNCT
cuesj-811	143	1	4	4	X
cuesj-811	143	2	.	.	X
cuesj-811	143	3	a.	a.	PROPN
cuesj-811	143	4	n.	n.	PROPN
cuesj-811	143	5	minlikeeva	minlikeeva	PROPN
cuesj-811	143	6	,	,	PUNCT
cuesj-811	143	7	j.	j.	PROPN
cuesj-811	143	8	l.	l.	PROPN
cuesj-811	143	9	freudenheim	freudenheim	PROPN
cuesj-811	143	10	,	,	PUNCT
cuesj-811	143	11	r.	r.	PROPN
cuesj-811	143	12	a.	a.	NOUN
cuesj-811	143	13	cannioto	cannioto	PROPN
cuesj-811	143	14	,	,	PUNCT
cuesj-811	143	15	k.	k.	PROPN
cuesj-811	143	16	h.	h.	PROPN
cuesj-811	143	17	eng	eng	PROPN
cuesj-811	143	18	,	,	PUNCT
cuesj-811	143	19	j.	j.	PROPN
cuesj-811	143	20	b.	b.	PROPN
cuesj-811	143	21	szender	szender	PROPN
cuesj-811	143	22	,	,	PUNCT
cuesj-811	143	23	p.	p.	PROPN
cuesj-811	143	24	mayor	mayor	NOUN
cuesj-811	143	25	,	,	PUNCT
cuesj-811	143	26	j.	j.	PROPN
cuesj-811	143	27	l	l	PROPN
cuesj-811	143	28	etter	etter	PROPN
cuesj-811	143	29	,	,	PUNCT
cuesj-811	143	30	d.	d.	PROPN
cuesj-811	143	31	w.	w.	PROPN
cuesj-811	143	32	cramer	cramer	PROPN
cuesj-811	143	33	,	,	PUNCT
cuesj-811	143	34	b.	b.	PROPN
cuesj-811	143	35	diergaarde	diergaarde	PROPN
cuesj-811	143	36	,	,	PUNCT
cuesj-811	143	37	j.	j.	PROPN
cuesj-811	143	38	a.	a.	PROPN
cuesj-811	143	39	doherty	doherty	PROPN
cuesj-811	143	40	,	,	PUNCT
cuesj-811	143	41	t.	t.	PROPN
cuesj-811	143	42	dörk	dörk	PROPN
cuesj-811	143	43	,	,	PUNCT
cuesj-811	143	44	r.	r.	PROPN
cuesj-811	143	45	edwards	edwards	PROPN
cuesj-811	143	46	,	,	PUNCT
cuesj-811	143	47	a.	a.	PROPN
cuesj-811	143	48	defazio	defazio	PROPN
cuesj-811	143	49	,	,	PUNCT
cuesj-811	143	50	g.	g.	PROPN
cuesj-811	143	51	friel	friel	PROPN
cuesj-811	143	52	,	,	PUNCT
cuesj-811	143	53	m.	m.	PROPN
cuesj-811	143	54	t	t	PROPN
cuesj-811	143	55	goodman	goodman	PROPN
cuesj-811	143	56	,	,	PUNCT
cuesj-811	143	57	p.	p.	NOUN
cuesj-811	143	58	hillemanns	hillemanns	PROPN
cuesj-811	143	59	,	,	PUNCT
cuesj-811	143	60	e.	e.	PROPN
cuesj-811	143	61	høgdall	høgdall	PROPN
cuesj-811	143	62	,	,	PUNCT
cuesj-811	143	63	a.	a.	PROPN
cuesj-811	143	64	jensen	jensen	PROPN
cuesj-811	143	65	,	,	PUNCT
cuesj-811	143	66	s.	s.	PROPN
cuesj-811	143	67	j.	j.	PROPN
cuesj-811	143	68	jordan	jordan	PROPN
cuesj-811	143	69	,	,	PUNCT
cuesj-811	143	70	b.	b.	PROPN
cuesj-811	143	71	y.	y.	PROPN
cuesj-811	143	72	karlan	karlan	PROPN
cuesj-811	143	73	,	,	PUNCT
cuesj-811	143	74	s.	s.	PROPN
cuesj-811	143	75	k.	k.	PROPN
cuesj-811	143	76	kjær	kjær	PROPN
cuesj-811	143	77	,	,	PUNCT
cuesj-811	143	78	r.	r.	PROPN
cuesj-811	143	79	klapdor	klapdor	PROPN
cuesj-811	143	80	,	,	PUNCT
cuesj-811	143	81	k.	k.	PROPN
cuesj-811	143	82	matsuo	matsuo	PROPN
cuesj-811	143	83	,	,	PUNCT
cuesj-811	143	84	m.	m.	PROPN
cuesj-811	143	85	mizuno	mizuno	PROPN
cuesj-811	143	86	,	,	PUNCT
cuesj-811	143	87	c.	c.	PROPN
cuesj-811	143	88	m.	m.	PROPN
cuesj-811	143	89	nagle	nagle	PROPN
cuesj-811	143	90	,	,	PUNCT
cuesj-811	143	91	k.	k.	PROPN
cuesj-811	143	92	odunsi	odunsi	PROPN
cuesj-811	143	93	,	,	PUNCT
cuesj-811	143	94	l.	l.	PROPN
cuesj-811	143	95	paddock	paddock	PROPN
cuesj-811	143	96	,	,	PUNCT
cuesj-811	143	97	m.	m.	NOUN
cuesj-811	143	98	a.	a.	NOUN
cuesj-811	143	99	rossing	rossing	NOUN
cuesj-811	143	100	,	,	PUNCT
cuesj-811	143	101	j.	j.	PROPN
cuesj-811	143	102	m.	m.	PROPN
cuesj-811	143	103	schildkraut	schildkraut	PROPN
cuesj-811	143	104	,	,	PUNCT
cuesj-811	143	105	b.	b.	PROPN
cuesj-811	143	106	schmalfeldt	schmalfeldt	PROPN
cuesj-811	143	107	,	,	PUNCT
cuesj-811	143	108	b.	b.	PROPN
cuesj-811	143	109	h.	h.	PROPN
cuesj-811	143	110	segal	segal	PROPN
cuesj-811	143	111	,	,	PUNCT
cuesj-811	143	112	k.	k.	PROPN
cuesj-811	143	113	starbuck	starbuck	PROPN
cuesj-811	143	114	,	,	PUNCT
cuesj-811	143	115	k.	k.	PROPN
cuesj-811	143	116	l.	l.	PROPN
cuesj-811	143	117	terry	terry	PROPN
cuesj-811	143	118	,	,	PUNCT
cuesj-811	143	119	p.	p.	PROPN
cuesj-811	143	120	m.	m.	PROPN
cuesj-811	143	121	webb	webb	PROPN
cuesj-811	143	122	,	,	PUNCT
cuesj-811	143	123	e.	e.	PROPN
cuesj-811	143	124	zsiros	zsiros	PROPN
cuesj-811	143	125	,	,	PUNCT
cuesj-811	144	1	r.	r.	PROPN
cuesj-811	144	2	b.	b.	PROPN
cuesj-811	144	3	ness	ness	PROPN
cuesj-811	144	4	,	,	PUNCT
cuesj-811	144	5	f.	f.	PROPN
cuesj-811	144	6	modugno	modugno	PROPN
cuesj-811	144	7	,	,	PUNCT
cuesj-811	144	8	e.	e.	PROPN
cuesj-811	144	9	v.	v.	PROPN
cuesj-811	144	10	bandera	bandera	PROPN
cuesj-811	144	11	,	,	PUNCT
cuesj-811	144	12	j.	j.	PROPN
cuesj-811	144	13	chang	chang	PROPN
cuesj-811	144	14	-	-	PUNCT
cuesj-811	144	15	claude	claude	PROPN
cuesj-811	144	16	and	and	CCONJ
cuesj-811	144	17	k.	k.	PROPN
cuesj-811	144	18	b.	b.	PROPN
cuesj-811	144	19	moysich	moysich	PROPN
cuesj-811	144	20	.	.	PUNCT
cuesj-811	145	1	history	history	NOUN
cuesj-811	145	2	of	of	ADP
cuesj-811	145	3	thyroid	thyroid	NOUN
cuesj-811	145	4	disease	disease	NOUN
cuesj-811	145	5	and	and	CCONJ
cuesj-811	145	6	survival	survival	NOUN
cuesj-811	145	7	of	of	ADP
cuesj-811	145	8	ovarian	ovarian	ADJ
cuesj-811	145	9	cancer	cancer	NOUN
cuesj-811	145	10	patients	patient	NOUN
cuesj-811	145	11	:	:	PUNCT
cuesj-811	145	12	results	result	VERB
cuesj-811	145	13	from	from	ADP
cuesj-811	145	14	the	the	DET
cuesj-811	145	15	ovarian	ovarian	ADJ
cuesj-811	145	16	cancer	cancer	NOUN
cuesj-811	145	17	association	association	PROPN
cuesj-811	145	18	consortium	consortium	PROPN
cuesj-811	145	19	,	,	PUNCT
cuesj-811	145	20	a	a	DET
cuesj-811	145	21	brief	brief	ADJ
cuesj-811	145	22	report	report	NOUN
cuesj-811	145	23	.	.	PUNCT
cuesj-811	146	1	british	british	ADJ
cuesj-811	146	2	journal	journal	PROPN
cuesj-811	146	3	of	of	ADP
cuesj-811	146	4	cancer	cancer	NOUN
cuesj-811	146	5	,	,	PUNCT
cuesj-811	146	6	vol	vol	NOUN
cuesj-811	146	7	.	.	PROPN
cuesj-811	146	8	117	117	NUM
cuesj-811	146	9	,	,	PUNCT
cuesj-811	146	10	no	no	INTJ
cuesj-811	146	11	.	.	NOUN
cuesj-811	146	12	7	7	NUM
cuesj-811	146	13	,	,	PUNCT
cuesj-811	146	14	pp	pp	ADJ
cuesj-811	146	15	.	.	PUNCT
cuesj-811	146	16	1063	1063	NUM
cuesj-811	146	17	-	-	SYM
cuesj-811	146	18	1069	1069	NUM
cuesj-811	146	19	,	,	PUNCT
cuesj-811	146	20	2017	2017	NUM
cuesj-811	146	21	.	.	PUNCT
cuesj-811	147	1	5	5	X
cuesj-811	147	2	.	.	X
cuesj-811	147	3	e.	e.	PROPN
cuesj-811	147	4	shinderman	shinderman	PROPN
cuesj-811	147	5	-	-	PUNCT
cuesj-811	147	6	maman	maman	NOUN
cuesj-811	147	7	,	,	PUNCT
cuesj-811	147	8	k.	k.	PROPN
cuesj-811	147	9	cohen	cohen	PROPN
cuesj-811	147	10	,	,	PUNCT
cuesj-811	147	11	c.	c.	PROPN
cuesj-811	147	12	weingarten	weingarten	PROPN
cuesj-811	147	13	,	,	PUNCT
cuesj-811	147	14	d.	d.	PROPN
cuesj-811	147	15	nabriski	nabriski	PROPN
cuesj-811	147	16	,	,	PUNCT
cuesj-811	147	17	o.	o.	PROPN
cuesj-811	147	18	twito	twito	PROPN
cuesj-811	147	19	,	,	PUNCT
cuesj-811	147	20	l.	l.	PROPN
cuesj-811	147	21	baraf	baraf	PROPN
cuesj-811	147	22	,	,	PUNCT
cuesj-811	147	23	a.	a.	NOUN
cuesj-811	147	24	hercbergs	hercbergs	PROPN
cuesj-811	147	25	,	,	PUNCT
cuesj-811	147	26	p.	p.	PROPN
cuesj-811	147	27	j.	j.	PROPN
cuesj-811	147	28	davis	davis	PROPN
cuesj-811	147	29	,	,	PUNCT
cuesj-811	147	30	h.	h.	PROPN
cuesj-811	147	31	werner	werner	PROPN
cuesj-811	147	32	,	,	PUNCT
cuesj-811	147	33	m.	m.	NOUN
cuesj-811	147	34	ellis	ellis	PROPN
cuesj-811	147	35	and	and	CCONJ
cuesj-811	147	36	o.	o.	PROPN
cuesj-811	147	37	ashur	ashur	PROPN
cuesj-811	147	38	-	-	PUNCT
cuesj-811	147	39	fabian	fabian	NOUN
cuesj-811	147	40	.	.	PUNCT
cuesj-811	148	1	the	the	DET
cuesj-811	148	2	thyroid	thyroid	NOUN
cuesj-811	148	3	hormone	hormone	NOUN
cuesj-811	148	4	-	-	PUNCT
cuesj-811	148	5	αvβ3	αvβ3	NOUN
cuesj-811	148	6	integrin	integrin	NOUN
cuesj-811	148	7	axis	axis	NOUN
cuesj-811	148	8	in	in	ADP
cuesj-811	148	9	ovarian	ovarian	ADJ
cuesj-811	148	10	cancer	cancer	NOUN
cuesj-811	148	11	:	:	PUNCT
cuesj-811	148	12	regulation	regulation	NOUN
cuesj-811	148	13	of	of	ADP
cuesj-811	148	14	gene	gene	NOUN
cuesj-811	148	15	transcription	transcription	NOUN
cuesj-811	148	16	and	and	CCONJ
cuesj-811	148	17	mapkdependent	mapkdependent	NOUN
cuesj-811	148	18	proliferation	proliferation	NOUN
cuesj-811	148	19	.	.	PUNCT
cuesj-811	149	1	oncogene	oncogene	NOUN
cuesj-811	149	2	,	,	PUNCT
cuesj-811	149	3	vol	vol	NOUN
cuesj-811	149	4	.	.	PROPN
cuesj-811	149	5	35	35	NUM
cuesj-811	149	6	,	,	PUNCT
cuesj-811	149	7	no	no	INTJ
cuesj-811	149	8	.	.	NOUN
cuesj-811	149	9	15	15	NUM
cuesj-811	149	10	,	,	PUNCT
cuesj-811	149	11	pp	pp	ADJ
cuesj-811	149	12	.	.	PUNCT
cuesj-811	149	13	19771987	19771987	NUM
cuesj-811	149	14	,	,	PUNCT
cuesj-811	149	15	2016	2016	NUM
cuesj-811	149	16	.	.	PUNCT
cuesj-811	150	1	6	6	NUM
cuesj-811	150	2	.	.	X
cuesj-811	150	3	r.	r.	PROPN
cuesj-811	150	4	kimura	kimura	PROPN
cuesj-811	150	5	,	,	PUNCT
cuesj-811	150	6	k.	k.	PROPN
cuesj-811	150	7	imaeda	imaeda	PROPN
cuesj-811	150	8	,	,	PUNCT
cuesj-811	150	9	t.	t.	PROPN
cuesj-811	150	10	mizuno	mizuno	PROPN
cuesj-811	150	11	,	,	PUNCT
cuesj-811	150	12	k.	k.	PROPN
cuesj-811	150	13	wakami	wakami	PROPN
cuesj-811	150	14	,	,	PUNCT
cuesj-811	150	15	k.	k.	PROPN
cuesj-811	150	16	yamada	yamada	PROPN
cuesj-811	150	17	,	,	PUNCT
cuesj-811	150	18	n.	n.	PROPN
cuesj-811	150	19	okayama	okayama	PROPN
cuesj-811	150	20	,	,	PUNCT
cuesj-811	150	21	y.	y.	PROPN
cuesj-811	150	22	kamiya	kamiya	PROPN
cuesj-811	150	23	and	and	CCONJ
cuesj-811	150	24	t.	t.	PROPN
cuesj-811	150	25	joh	joh	PROPN
cuesj-811	150	26	.	.	PROPN
cuesj-811	150	27	severe	severe	ADJ
cuesj-811	150	28	ascites	ascite	NOUN
cuesj-811	150	29	with	with	ADP
cuesj-811	150	30	hypothyroidism	hypothyroidism	NOUN
cuesj-811	150	31	and	and	CCONJ
cuesj-811	150	32	elevated	elevated	ADJ
cuesj-811	150	33	ca125	ca125	NOUN
cuesj-811	150	34	concentration	concentration	NOUN
cuesj-811	150	35	:	:	PUNCT
cuesj-811	150	36	a	a	DET
cuesj-811	150	37	case	case	NOUN
cuesj-811	150	38	report	report	NOUN
cuesj-811	150	39	.	.	PUNCT
cuesj-811	151	1	endocrine	endocrine	PROPN
cuesj-811	151	2	journal	journal	NOUN
cuesj-811	151	3	,	,	PUNCT
cuesj-811	151	4	vol	vol	NOUN
cuesj-811	151	5	.	.	PROPN
cuesj-811	151	6	54	54	NUM
cuesj-811	151	7	,	,	PUNCT
cuesj-811	151	8	no	no	INTJ
cuesj-811	151	9	.	.	NOUN
cuesj-811	151	10	5	5	NUM
cuesj-811	151	11	,	,	PUNCT
cuesj-811	151	12	pp	pp	ADJ
cuesj-811	151	13	.	.	PUNCT
cuesj-811	152	1	751	751	NUM
cuesj-811	152	2	-	-	SYM
cuesj-811	152	3	755	755	NUM
cuesj-811	152	4	,	,	PUNCT
cuesj-811	152	5	2007	2007	NUM
cuesj-811	152	6	.	.	PUNCT
cuesj-811	153	1	7	7	X
cuesj-811	153	2	.	.	PUNCT
cuesj-811	153	3	k.	k.	PROPN
cuesj-811	153	4	a.	a.	PROPN
cuesj-811	153	5	williams	williams	PROPN
cuesj-811	153	6	,	,	PUNCT
cuesj-811	153	7	s.	s.	PROPN
cuesj-811	153	8	i.	i.	PROPN
cuesj-811	153	9	labidi	labidi	PROPN
cuesj-811	153	10	-	-	PUNCT
cuesj-811	153	11	galy	galy	PROPN
cuesj-811	153	12	,	,	PUNCT
cuesj-811	153	13	k.	k.	PROPN
cuesj-811	153	14	l.	l.	PROPN
cuesj-811	153	15	terry	terry	PROPN
cuesj-811	153	16	,	,	PUNCT
cuesj-811	153	17	a.	a.	PROPN
cuesj-811	153	18	f.	f.	PROPN
cuesj-811	153	19	vitonis	vitonis	PROPN
cuesj-811	153	20	,	,	PUNCT
cuesj-811	153	21	w.	w.	PROPN
cuesj-811	153	22	r.	r.	PROPN
cuesj-811	153	23	welch	welch	PROPN
cuesj-811	153	24	,	,	PUNCT
cuesj-811	153	25	a.	a.	PROPN
cuesj-811	153	26	goodman	goodman	PROPN
cuesj-811	153	27	and	and	CCONJ
cuesj-811	153	28	d.	d.	PROPN
cuesj-811	153	29	w.	w.	PROPN
cuesj-811	153	30	cramer	cramer	PROPN
cuesj-811	153	31	.	.	PUNCT
cuesj-811	154	1	prognostic	prognostic	ADJ
cuesj-811	154	2	significance	significance	NOUN
cuesj-811	154	3	and	and	CCONJ
cuesj-811	154	4	predictors	predictor	NOUN
cuesj-811	154	5	of	of	ADP
cuesj-811	154	6	the	the	DET
cuesj-811	154	7	neutrophil	neutrophil	NOUN
cuesj-811	154	8	-	-	PUNCT
cuesj-811	154	9	to	to	ADP
cuesj-811	154	10	-	-	PUNCT
cuesj-811	154	11	lymphocyte	lymphocyte	ADJ
cuesj-811	154	12	ratio	ratio	NOUN
cuesj-811	154	13	in	in	ADP
cuesj-811	154	14	ovarian	ovarian	ADJ
cuesj-811	154	15	cancer	cancer	NOUN
cuesj-811	154	16	.	.	PUNCT
cuesj-811	155	1	gynecologic	gynecologic	ADJ
cuesj-811	155	2	oncology	oncology	NOUN
cuesj-811	155	3	,	,	PUNCT
cuesj-811	155	4	vol	vol	NOUN
cuesj-811	155	5	.	.	PROPN
cuesj-811	155	6	132	132	NUM
cuesj-811	155	7	,	,	PUNCT
cuesj-811	155	8	no	no	INTJ
cuesj-811	155	9	.	.	NOUN
cuesj-811	155	10	3	3	NUM
cuesj-811	155	11	,	,	PUNCT
cuesj-811	155	12	pp	pp	ADJ
cuesj-811	155	13	.	.	PUNCT
cuesj-811	156	1	542	542	NUM
cuesj-811	156	2	-	-	SYM
cuesj-811	156	3	550	550	NUM
cuesj-811	156	4	,	,	PUNCT
cuesj-811	156	5	2014	2014	NUM
cuesj-811	156	6	.	.	PUNCT
cuesj-811	157	1	8	8	X
cuesj-811	157	2	.	.	X
cuesj-811	157	3	m.	m.	NOUN
cuesj-811	157	4	u.	u.	PROPN
cuesj-811	157	5	ceran	ceran	PROPN
cuesj-811	157	6	,	,	PUNCT
cuesj-811	157	7	u.	u.	PROPN
cuesj-811	157	8	tasdemir	tasdemir	PROPN
cuesj-811	157	9	,	,	PUNCT
cuesj-811	157	10	e.	e.	PROPN
cuesj-811	157	11	colak	colak	PROPN
cuesj-811	157	12	and	and	CCONJ
cuesj-811	157	13	t.	t.	PROPN
cuesj-811	157	14	güngör	güngör	PROPN
cuesj-811	157	15	.	.	PUNCT
cuesj-811	158	1	can	can	AUX
cuesj-811	158	2	complete	complete	VERB
cuesj-811	158	3	blood	blood	NOUN
cuesj-811	158	4	count	count	NOUN
cuesj-811	158	5	inflammatory	inflammatory	ADJ
cuesj-811	158	6	parameters	parameter	NOUN
cuesj-811	158	7	in	in	ADP
cuesj-811	158	8	epithelial	epithelial	ADJ
cuesj-811	158	9	ovarian	ovarian	ADJ
cuesj-811	158	10	cancer	cancer	NOUN
cuesj-811	158	11	contribute	contribute	VERB
cuesj-811	158	12	to	to	ADP
cuesj-811	158	13	prognosis?-a	prognosis?-a	PROPN
cuesj-811	158	14	survival	survival	NOUN
cuesj-811	158	15	analysis	analysis	NOUN
cuesj-811	158	16	.	.	PUNCT
cuesj-811	159	1	journal	journal	NOUN
cuesj-811	159	2	of	of	ADP
cuesj-811	159	3	ovarian	ovarian	ADJ
cuesj-811	159	4	research	research	NOUN
cuesj-811	159	5	,	,	PUNCT
cuesj-811	159	6	vol	vol	NOUN
cuesj-811	159	7	.	.	PROPN
cuesj-811	159	8	12	12	NUM
cuesj-811	159	9	,	,	PUNCT
cuesj-811	159	10	no	no	INTJ
cuesj-811	159	11	.	.	NOUN
cuesj-811	159	12	1	1	NUM
cuesj-811	159	13	,	,	PUNCT
cuesj-811	159	14	p.	p.	NOUN
cuesj-811	159	15	16	16	NUM
cuesj-811	159	16	,	,	PUNCT
cuesj-811	159	17	2019	2019	NUM
cuesj-811	159	18	.	.	PUNCT
cuesj-811	160	1	9	9	NUM
cuesj-811	160	2	.	.	PUNCT
cuesj-811	160	3	a.	a.	NOUN
cuesj-811	160	4	g.	g.	PROPN
cuesj-811	160	5	van	van	PROPN
cuesj-811	160	6	der	der	PROPN
cuesj-811	160	7	zee	zee	PROPN
cuesj-811	160	8	,	,	PUNCT
cuesj-811	160	9	h.	h.	PROPN
cuesj-811	160	10	w.	w.	PROPN
cuesj-811	160	11	de	de	PROPN
cuesj-811	160	12	bruijn	bruijn	PROPN
cuesj-811	160	13	,	,	PUNCT
cuesj-811	160	14	m.	m.	PROPN
cuesj-811	160	15	krans	krans	PROPN
cuesj-811	160	16	,	,	PUNCT
cuesj-811	160	17	e.	e.	PROPN
cuesj-811	160	18	m.	m.	PROPN
cuesj-811	160	19	de	de	PROPN
cuesj-811	160	20	cuyper	cuyper	PROPN
cuesj-811	160	21	,	,	PUNCT
cuesj-811	160	22	h.	h.	PROPN
cuesj-811	160	23	hollema	hollema	PROPN
cuesj-811	160	24	,	,	PUNCT
cuesj-811	160	25	p.	p.	PROPN
cuesj-811	160	26	c.	c.	PROPN
cuesj-811	160	27	limburg	limburg	PROPN
cuesj-811	160	28	,	,	PUNCT
cuesj-811	160	29	h.	h.	PROPN
cuesj-811	160	30	w	w	PROPN
cuesj-811	160	31	de	de	PROPN
cuesj-811	160	32	bruijn	bruijn	PROPN
cuesj-811	160	33	,	,	PUNCT
cuesj-811	160	34	h.	h.	PROPN
cuesj-811	160	35	hollema	hollema	PROPN
cuesj-811	160	36	,	,	PUNCT
cuesj-811	160	37	j.	j.	PROPN
cuesj-811	160	38	bijzet	bijzet	PROPN
cuesj-811	160	39	,	,	PUNCT
cuesj-811	160	40	m.	m.	NOUN
cuesj-811	160	41	krans	krans	PROPN
cuesj-811	160	42	and	and	CCONJ
cuesj-811	160	43	e.	e.	PROPN
cuesj-811	160	44	g.	g.	PROPN
cuesj-811	160	45	de	de	PROPN
cuesj-811	160	46	vries	vries	PROPN
cuesj-811	160	47	.	.	PUNCT
cuesj-811	161	1	higher	high	ADJ
cuesj-811	161	2	levels	level	NOUN
cuesj-811	161	3	of	of	ADP
cuesj-811	161	4	interleukin‐6	interleukin‐6	NOUN
cuesj-811	161	5	in	in	ADP
cuesj-811	161	6	cystic	cystic	ADJ
cuesj-811	161	7	fluids	fluid	NOUN
cuesj-811	161	8	from	from	ADP
cuesj-811	161	9	patients	patient	NOUN
cuesj-811	161	10	with	with	ADP
cuesj-811	161	11	malignant	malignant	ADJ
cuesj-811	161	12	versus	versus	ADP
cuesj-811	161	13	benign	benign	ADJ
cuesj-811	161	14	ovarian	ovarian	ADJ
cuesj-811	161	15	tumors	tumor	NOUN
cuesj-811	161	16	correlate	correlate	VERB
cuesj-811	161	17	with	with	ADP
cuesj-811	161	18	decreased	decrease	VERB
cuesj-811	161	19	hemoglobin	hemoglobin	NOUN
cuesj-811	161	20	levels	level	NOUN
cuesj-811	161	21	and	and	CCONJ
cuesj-811	161	22	increased	increase	VERB
cuesj-811	161	23	platelet	platelet	NOUN
cuesj-811	161	24	counts	count	NOUN
cuesj-811	161	25	.	.	PUNCT
cuesj-811	162	1	cancer	cancer	NOUN
cuesj-811	162	2	,	,	PUNCT
cuesj-811	162	3	vol	vol	NOUN
cuesj-811	162	4	.	.	PROPN
cuesj-811	162	5	75	75	NUM
cuesj-811	162	6	,	,	PUNCT
cuesj-811	162	7	no	no	INTJ
cuesj-811	162	8	.	.	NOUN
cuesj-811	162	9	4	4	NUM
cuesj-811	162	10	,	,	PUNCT
cuesj-811	162	11	pp	pp	ADJ
cuesj-811	162	12	.	.	PUNCT
cuesj-811	163	1	1004	1004	NUM
cuesj-811	163	2	-	-	SYM
cuesj-811	163	3	1009	1009	NUM
cuesj-811	163	4	,	,	PUNCT
cuesj-811	163	5	1995	1995	NUM
cuesj-811	163	6	.	.	PUNCT
cuesj-811	164	1	10	10	NUM
cuesj-811	164	2	.	.	PUNCT
cuesj-811	164	3	a.	a.	NOUN
cuesj-811	164	4	maccio	maccio	PROPN
cuesj-811	164	5	,	,	PUNCT
cuesj-811	164	6	c.	c.	PROPN
cuesj-811	164	7	madeddu	madeddu	PROPN
cuesj-811	164	8	,	,	PUNCT
cuesj-811	164	9	d.	d.	PROPN
cuesj-811	164	10	massa	massa	PROPN
cuesj-811	164	11	,	,	PUNCT
cuesj-811	164	12	m.	m.	PROPN
cuesj-811	164	13	c.	c.	PROPN
cuesj-811	164	14	mudu	mudu	PROPN
cuesj-811	164	15	,	,	PUNCT
cuesj-811	164	16	m.	m.	PROPN
cuesj-811	164	17	r.	r.	PROPN
cuesj-811	164	18	lusso	lusso	PROPN
cuesj-811	164	19	,	,	PUNCT
cuesj-811	164	20	g.	g.	PROPN
cuesj-811	164	21	gramignano	gramignano	PROPN
cuesj-811	164	22	,	,	PUNCT
cuesj-811	164	23	r.	r.	PROPN
cuesj-811	164	24	serpe	serpe	PROPN
cuesj-811	164	25	,	,	PUNCT
cuesj-811	164	26	g.	g.	PROPN
cuesj-811	164	27	b.	b.	PROPN
cuesj-811	164	28	melis	melis	PROPN
cuesj-811	164	29	and	and	CCONJ
cuesj-811	164	30	g.	g.	PROPN
cuesj-811	164	31	mantovani	mantovani	PROPN
cuesj-811	164	32	.	.	PUNCT
cuesj-811	165	1	hemoglobin	hemoglobin	NOUN
cuesj-811	165	2	levels	level	NOUN
cuesj-811	165	3	correlate	correlate	VERB
cuesj-811	165	4	with	with	ADP
cuesj-811	165	5	interleukin-6	interleukin-6	NUM
cuesj-811	165	6	levels	level	NOUN
cuesj-811	165	7	in	in	ADP
cuesj-811	165	8	patients	patient	NOUN
cuesj-811	165	9	with	with	ADP
cuesj-811	165	10	advanced	advanced	ADJ
cuesj-811	165	11	untreated	untreated	ADJ
cuesj-811	165	12	epithelial	epithelial	ADJ
cuesj-811	165	13	ovarian	ovarian	ADJ
cuesj-811	165	14	cancer	cancer	NOUN
cuesj-811	165	15	:	:	PUNCT
cuesj-811	165	16	role	role	NOUN
cuesj-811	165	17	of	of	ADP
cuesj-811	165	18	inflammation	inflammation	NOUN
cuesj-811	165	19	in	in	ADP
cuesj-811	165	20	cancer	cancer	NOUN
cuesj-811	165	21	-	-	PUNCT
cuesj-811	165	22	related	relate	VERB
cuesj-811	165	23	anemia	anemia	NOUN
cuesj-811	165	24	.	.	PUNCT
cuesj-811	166	1	blood	blood	NOUN
cuesj-811	166	2	,	,	PUNCT
cuesj-811	166	3	vol	vol	NOUN
cuesj-811	166	4	.	.	PROPN
cuesj-811	166	5	106	106	NUM
cuesj-811	166	6	,	,	PUNCT
cuesj-811	166	7	no	no	INTJ
cuesj-811	166	8	.	.	NOUN
cuesj-811	166	9	1	1	NUM
cuesj-811	166	10	,	,	PUNCT
cuesj-811	166	11	pp	pp	ADJ
cuesj-811	166	12	.	.	PUNCT
cuesj-811	167	1	362	362	NUM
cuesj-811	167	2	-	-	SYM
cuesj-811	167	3	367	367	NUM
cuesj-811	167	4	,	,	PUNCT
cuesj-811	167	5	2005	2005	NUM
cuesj-811	167	6	.	.	PUNCT
cuesj-811	168	1	11	11	NUM
cuesj-811	168	2	.	.	PUNCT
cuesj-811	168	3	e.	e.	PROPN
cuesj-811	168	4	lengyel	lengyel	PROPN
cuesj-811	168	5	.	.	PUNCT
cuesj-811	169	1	ovarian	ovarian	ADJ
cuesj-811	169	2	cancer	cancer	NOUN
cuesj-811	169	3	development	development	NOUN
cuesj-811	169	4	and	and	CCONJ
cuesj-811	169	5	metastasis	metastasis	NOUN
cuesj-811	169	6	.	.	PUNCT
cuesj-811	170	1	the	the	DET
cuesj-811	170	2	american	american	PROPN
cuesj-811	170	3	journal	journal	PROPN
cuesj-811	170	4	of	of	ADP
cuesj-811	170	5	pathology	pathology	PROPN
cuesj-811	170	6	,	,	PUNCT
cuesj-811	170	7	vol	vol	NOUN
cuesj-811	170	8	.	.	PROPN
cuesj-811	170	9	177	177	NUM
cuesj-811	170	10	,	,	PUNCT
cuesj-811	170	11	no	no	INTJ
cuesj-811	170	12	.	.	NOUN
cuesj-811	170	13	3	3	NUM
cuesj-811	170	14	,	,	PUNCT
cuesj-811	170	15	pp	pp	ADJ
cuesj-811	170	16	.	.	PUNCT
cuesj-811	171	1	1053	1053	NUM
cuesj-811	171	2	-	-	SYM
cuesj-811	171	3	1064	1064	NUM
cuesj-811	171	4	,	,	PUNCT
cuesj-811	171	5	2010	2010	NUM
cuesj-811	171	6	.	.	PUNCT
cuesj-811	172	1	12	12	NUM
cuesj-811	172	2	.	.	PUNCT
cuesj-811	173	1	c.	c.	PROPN
cuesj-811	173	2	h.	h.	PROPN
cuesj-811	173	3	holschneider	holschneider	PROPN
cuesj-811	173	4	and	and	CCONJ
cuesj-811	173	5	j.	j.	PROPN
cuesj-811	173	6	s.	s.	PROPN
cuesj-811	173	7	berek	berek	PROPN
cuesj-811	173	8	.	.	PUNCT
cuesj-811	174	1	ovarian	ovarian	ADJ
cuesj-811	174	2	cancer	cancer	NOUN
cuesj-811	174	3	:	:	PUNCT
cuesj-811	174	4	epidemiology	epidemiology	NOUN
cuesj-811	174	5	,	,	PUNCT
cuesj-811	174	6	biology	biology	NOUN
cuesj-811	174	7	,	,	PUNCT
cuesj-811	174	8	and	and	CCONJ
cuesj-811	174	9	prognostic	prognostic	ADJ
cuesj-811	174	10	factors	factor	NOUN
cuesj-811	174	11	.	.	PUNCT
cuesj-811	175	1	in	in	ADP
cuesj-811	175	2	:	:	PUNCT
cuesj-811	175	3	seminars	seminar	NOUN
cuesj-811	175	4	in	in	ADP
cuesj-811	175	5	surgical	surgical	ADJ
cuesj-811	175	6	oncology	oncology	NOUN
cuesj-811	175	7	,	,	PUNCT
cuesj-811	175	8	springer	springer	NOUN
cuesj-811	175	9	,	,	PUNCT
cuesj-811	175	10	berlin	berlin	PROPN
cuesj-811	175	11	,	,	PUNCT
cuesj-811	175	12	pp	pp	ADJ
cuesj-811	175	13	.	.	PUNCT
cuesj-811	176	1	3	3	NUM
cuesj-811	176	2	-	-	SYM
cuesj-811	176	3	10	10	NUM
cuesj-811	176	4	,	,	PUNCT
cuesj-811	176	5	2000	2000	NUM
cuesj-811	176	6	.	.	PUNCT
cuesj-811	177	1	13	13	NUM
cuesj-811	177	2	.	.	PUNCT
cuesj-811	178	1	f.	f.	PROPN
cuesj-811	178	2	salehi	salehi	PROPN
cuesj-811	178	3	,	,	PUNCT
cuesj-811	178	4	l.	l.	PROPN
cuesj-811	178	5	dunfield	dunfield	PROPN
cuesj-811	178	6	,	,	PUNCT
cuesj-811	178	7	k.	k.	PROPN
cuesj-811	178	8	p.	p.	PROPN
cuesj-811	178	9	phillips	phillips	PROPN
cuesj-811	178	10	,	,	PUNCT
cuesj-811	178	11	d.	d.	PROPN
cuesj-811	178	12	krewski	krewski	PROPN
cuesj-811	178	13	and	and	CCONJ
cuesj-811	178	14	b.	b.	PROPN
cuesj-811	178	15	c.	c.	PROPN
cuesj-811	178	16	vanderhyden	vanderhyden	PROPN
cuesj-811	178	17	.	.	PUNCT
cuesj-811	179	1	risk	risk	NOUN
cuesj-811	179	2	factors	factor	NOUN
cuesj-811	179	3	for	for	ADP
cuesj-811	179	4	ovarian	ovarian	ADJ
cuesj-811	179	5	cancer	cancer	NOUN
cuesj-811	179	6	:	:	PUNCT
cuesj-811	179	7	an	an	DET
cuesj-811	179	8	overview	overview	NOUN
cuesj-811	179	9	with	with	ADP
cuesj-811	179	10	emphasis	emphasis	NOUN
cuesj-811	179	11	on	on	ADP
cuesj-811	179	12	hormonal	hormonal	ADJ
cuesj-811	179	13	factors	factor	NOUN
cuesj-811	179	14	.	.	PUNCT
cuesj-811	180	1	journal	journal	NOUN
cuesj-811	180	2	of	of	ADP
cuesj-811	180	3	toxicology	toxicology	NOUN
cuesj-811	180	4	and	and	CCONJ
cuesj-811	180	5	environmental	environmental	ADJ
cuesj-811	180	6	health	health	NOUN
cuesj-811	180	7	,	,	PUNCT
cuesj-811	180	8	part	part	NOUN
cuesj-811	180	9	b	b	NOUN
cuesj-811	180	10	,	,	PUNCT
cuesj-811	180	11	vol	vol	NOUN
cuesj-811	180	12	.	.	PROPN
cuesj-811	180	13	11	11	NUM
cuesj-811	180	14	,	,	PUNCT
cuesj-811	180	15	pp	pp	ADJ
cuesj-811	180	16	.	.	PUNCT
cuesj-811	181	1	301	301	NUM
cuesj-811	181	2	-	-	SYM
cuesj-811	181	3	321	321	NUM
cuesj-811	181	4	,	,	PUNCT
cuesj-811	181	5	2008	2008	NUM
cuesj-811	181	6	.	.	PUNCT
cuesj-811	182	1	14	14	NUM
cuesj-811	182	2	.	.	PUNCT
cuesj-811	182	3	a.	a.	PROPN
cuesj-811	182	4	s.	s.	PROPN
cuesj-811	182	5	m.	m.	PROPN
cuesj-811	182	6	j.	j.	PROPN
cuesj-811	182	7	homady	homady	PROPN
cuesj-811	182	8	m.	m.	PROPN
cuesj-811	182	9	h.	h.	PROPN
cuesj-811	182	10	,	,	PUNCT
cuesj-811	182	11	m.	m.	PROPN
cuesj-811	182	12	h.	h.	PROPN
cuesj-811	182	13	ubeid	ubeid	PROPN
cuesj-811	182	14	,	,	PUNCT
cuesj-811	182	15	m.	m.	NOUN
cuesj-811	182	16	salih	salih	PROPN
cuesj-811	182	17	,	,	PUNCT
cuesj-811	182	18	t.	t.	PROPN
cuesj-811	182	19	s.	s.	PROPN
cuesj-811	182	20	and	and	CCONJ
cuesj-811	182	21	al	al	PROPN
cuesj-811	182	22	-	-	PUNCT
cuesj-811	182	23	jubori	jubori	PROPN
cuesj-811	182	24	,	,	PUNCT
cuesj-811	182	25	m.	m.	NOUN
cuesj-811	182	26	age	age	NOUN
cuesj-811	182	27	and	and	CCONJ
cuesj-811	182	28	gender	gender	NOUN
cuesj-811	182	29	in	in	ADP
cuesj-811	182	30	relation	relation	NOUN
cuesj-811	182	31	to	to	ADP
cuesj-811	182	32	colorectal	colorectal	ADJ
cuesj-811	182	33	cancer	cancer	NOUN
cuesj-811	182	34	in	in	ADP
cuesj-811	182	35	najef	najef	PROPN
cuesj-811	182	36	province	province	PROPN
cuesj-811	182	37	:	:	PUNCT
cuesj-811	182	38	a	a	DET
cuesj-811	182	39	histopathological	histopathological	ADJ
cuesj-811	182	40	study	study	NOUN
cuesj-811	182	41	.	.	PUNCT
cuesj-811	183	1	acta	acta	PROPN
cuesj-811	183	2	scientific	scientific	ADJ
cuesj-811	183	3	pharmaceutical	pharmaceutical	ADJ
cuesj-811	183	4	sciences	science	NOUN
cuesj-811	183	5	,	,	PUNCT
cuesj-811	183	6	vol	vol	NOUN
cuesj-811	183	7	.	.	PROPN
cuesj-811	183	8	5	5	NUM
cuesj-811	183	9	,	,	PUNCT
cuesj-811	183	10	pp	pp	ADJ
cuesj-811	183	11	.	.	PUNCT
cuesj-811	184	1	21	21	NUM
cuesj-811	184	2	-	-	SYM
cuesj-811	184	3	27	27	NUM
cuesj-811	184	4	,	,	PUNCT
cuesj-811	184	5	2021	2021	NUM
cuesj-811	184	6	.	.	PUNCT
cuesj-811	185	1	15	15	NUM
cuesj-811	185	2	.	.	PUNCT
cuesj-811	186	1	w.	w.	PROPN
cuesj-811	186	2	k.	k.	PROPN
cuesj-811	186	3	eo	eo	PROPN
cuesj-811	186	4	,	,	PUNCT
cuesj-811	186	5	k.	k.	PROPN
cuesj-811	186	6	h.	h.	PROPN
cuesj-811	186	7	kim	kim	PROPN
cuesj-811	186	8	,	,	PUNCT
cuesj-811	186	9	e.	e.	PROPN
cuesj-811	186	10	j.	j.	PROPN
cuesj-811	186	11	park	park	PROPN
cuesj-811	186	12	,	,	PUNCT
cuesj-811	186	13	h.	h.	PROPN
cuesj-811	186	14	y.	y.	PROPN
cuesj-811	186	15	kim	kim	PROPN
cuesj-811	186	16	,	,	PUNCT
cuesj-811	186	17	h.	h.	PROPN
cuesj-811	186	18	b.	b.	PROPN
cuesj-811	186	19	kim	kim	PROPN
cuesj-811	186	20	,	,	PUNCT
cuesj-811	186	21	s.	s.	PROPN
cuesj-811	186	22	b.	b.	PROPN
cuesj-811	186	23	koh	koh	PROPN
cuesj-811	186	24	and	and	CCONJ
cuesj-811	186	25	j.	j.	PROPN
cuesj-811	186	26	namkung	namkung	PROPN
cuesj-811	186	27	.	.	PUNCT
cuesj-811	187	1	diagnostic	diagnostic	ADJ
cuesj-811	187	2	accuracy	accuracy	NOUN
cuesj-811	187	3	of	of	ADP
cuesj-811	187	4	inflammatory	inflammatory	ADJ
cuesj-811	187	5	markers	marker	NOUN
cuesj-811	187	6	for	for	ADP
cuesj-811	187	7	distinguishing	distinguish	VERB
cuesj-811	187	8	malignant	malignant	ADJ
cuesj-811	187	9	and	and	CCONJ
cuesj-811	187	10	benign	benign	ADJ
cuesj-811	187	11	ovarian	ovarian	ADJ
cuesj-811	187	12	masses	masse	NOUN
cuesj-811	187	13	.	.	PUNCT
cuesj-811	188	1	journal	journal	NOUN
cuesj-811	188	2	of	of	ADP
cuesj-811	188	3	cancer	cancer	NOUN
cuesj-811	188	4	,	,	PUNCT
cuesj-811	188	5	vol	vol	NOUN
cuesj-811	188	6	.	.	NOUN
cuesj-811	188	7	9	9	NUM
cuesj-811	188	8	,	,	PUNCT
cuesj-811	188	9	pp	pp	ADJ
cuesj-811	188	10	.	.	PUNCT
cuesj-811	189	1	1165	1165	NUM
cuesj-811	189	2	-	-	SYM
cuesj-811	189	3	1172	1172	NUM
cuesj-811	189	4	,	,	PUNCT
cuesj-811	189	5	2018	2018	NUM
cuesj-811	189	6	.	.	PUNCT
cuesj-811	190	1	16	16	NUM
cuesj-811	190	2	.	.	PUNCT
cuesj-811	191	1	committee	committee	NOUN
cuesj-811	191	2	on	on	ADP
cuesj-811	191	3	the	the	DET
cuesj-811	191	4	state	state	NOUN
cuesj-811	191	5	of	of	ADP
cuesj-811	191	6	the	the	DET
cuesj-811	191	7	science	science	NOUN
cuesj-811	191	8	in	in	ADP
cuesj-811	191	9	ovarian	ovarian	ADJ
cuesj-811	191	10	cancer	cancer	NOUN
cuesj-811	191	11	research	research	NOUN
cuesj-811	191	12	;	;	PUNCT
cuesj-811	191	13	board	board	NOUN
cuesj-811	191	14	on	on	ADP
cuesj-811	191	15	health	health	NOUN
cuesj-811	191	16	care	care	NOUN
cuesj-811	191	17	services	services	PROPN
cuesj-811	191	18	;	;	PUNCT
cuesj-811	191	19	institute	institute	NOUN
cuesj-811	191	20	of	of	ADP
cuesj-811	191	21	medicine	medicine	NOUN
cuesj-811	191	22	;	;	PUNCT
cuesj-811	191	23	national	national	ADJ
cuesj-811	191	24	academies	academy	NOUN
cuesj-811	191	25	of	of	ADP
cuesj-811	191	26	sciences	science	NOUN
cuesj-811	191	27	,	,	PUNCT
cuesj-811	191	28	engineering	engineering	NOUN
cuesj-811	191	29	,	,	PUNCT
cuesj-811	191	30	and	and	CCONJ
cuesj-811	191	31	medicine	medicine	NOUN
cuesj-811	191	32	.	.	PUNCT
cuesj-811	192	1	ovarian	ovarian	ADJ
cuesj-811	192	2	cancers	cancer	NOUN
cuesj-811	192	3	:	:	PUNCT
cuesj-811	192	4	evolving	evolve	VERB
cuesj-811	192	5	paradigms	paradigm	NOUN
cuesj-811	192	6	in	in	ADP
cuesj-811	192	7	research	research	NOUN
cuesj-811	192	8	and	and	CCONJ
cuesj-811	192	9	care	care	NOUN
cuesj-811	192	10	.	.	PUNCT
cuesj-811	193	1	national	national	ADJ
cuesj-811	193	2	academies	academies	PROPN
cuesj-811	193	3	press	press	PROPN
cuesj-811	193	4	,	,	PUNCT
cuesj-811	193	5	washington	washington	PROPN
cuesj-811	193	6	,	,	PUNCT
cuesj-811	193	7	dc	dc	PROPN
cuesj-811	193	8	,	,	PUNCT
cuesj-811	193	9	2016	2016	NUM
cuesj-811	193	10	.	.	PUNCT
cuesj-811	194	1	17	17	NUM
cuesj-811	194	2	.	.	PUNCT
cuesj-811	195	1	j.	j.	PROPN
cuesj-811	195	2	a.	a.	PROPN
cuesj-811	195	3	rauh	rauh	PROPN
cuesj-811	195	4	-	-	PUNCT
cuesj-811	195	5	hain	hain	PROPN
cuesj-811	195	6	,	,	PUNCT
cuesj-811	195	7	t.	t.	PROPN
cuesj-811	195	8	c.	c.	PROPN
cuesj-811	195	9	krivak	krivak	PROPN
cuesj-811	195	10	,	,	PUNCT
cuesj-811	195	11	m.	m.	NOUN
cuesj-811	195	12	g.	g.	PROPN
cuesj-811	195	13	del	del	PROPN
cuesj-811	195	14	carmen	carmen	PROPN
cuesj-811	195	15	and	and	CCONJ
cuesj-811	195	16	a.	a.	PROPN
cuesj-811	195	17	b.	b.	PROPN
cuesj-811	195	18	olawaiye	olawaiye	PROPN
cuesj-811	195	19	.	.	PUNCT
cuesj-811	196	1	ovarian	ovarian	ADJ
cuesj-811	196	2	cancer	cancer	NOUN
cuesj-811	196	3	screening	screening	NOUN
cuesj-811	196	4	and	and	CCONJ
cuesj-811	196	5	early	early	ADJ
cuesj-811	196	6	detection	detection	NOUN
cuesj-811	196	7	in	in	ADP
cuesj-811	196	8	the	the	DET
cuesj-811	196	9	general	general	ADJ
cuesj-811	196	10	population	population	NOUN
cuesj-811	196	11	.	.	PUNCT
cuesj-811	197	1	reviews	review	NOUN
cuesj-811	197	2	in	in	ADP
cuesj-811	197	3	obstetrics	obstetric	NOUN
cuesj-811	197	4	and	and	CCONJ
cuesj-811	197	5	gynecology	gynecology	NOUN
cuesj-811	197	6	,	,	PUNCT
cuesj-811	197	7	vol	vol	NOUN
cuesj-811	197	8	.	.	PROPN
cuesj-811	197	9	4	4	NUM
cuesj-811	197	10	,	,	PUNCT
cuesj-811	197	11	no	no	INTJ
cuesj-811	197	12	.	.	NOUN
cuesj-811	197	13	1	1	NUM
cuesj-811	197	14	,	,	PUNCT
cuesj-811	197	15	pp	pp	ADJ
cuesj-811	197	16	.	.	PUNCT
cuesj-811	198	1	15	15	NUM
cuesj-811	198	2	-	-	SYM
cuesj-811	198	3	21	21	NUM
cuesj-811	198	4	,	,	PUNCT
cuesj-811	198	5	2011	2011	NUM
cuesj-811	198	6	.	.	PUNCT
cuesj-811	199	1	18	18	NUM
cuesj-811	199	2	.	.	PUNCT
cuesj-811	199	3	m.	m.	PROPN
cuesj-811	199	4	thun	thun	PROPN
cuesj-811	199	5	,	,	PUNCT
cuesj-811	199	6	m.	m.	NOUN
cuesj-811	199	7	s.	s.	PROPN
cuesj-811	199	8	linet	linet	PROPN
cuesj-811	199	9	,	,	PUNCT
cuesj-811	199	10	j.	j.	PROPN
cuesj-811	199	11	r.	r.	PROPN
cuesj-811	199	12	cerhan	cerhan	PROPN
cuesj-811	199	13	,	,	PUNCT
cuesj-811	199	14	c.	c.	PROPN
cuesj-811	199	15	a.	a.	NOUN
cuesj-811	199	16	haiman	haiman	PROPN
cuesj-811	199	17	and	and	CCONJ
cuesj-811	199	18	d.	d.	PROPN
cuesj-811	199	19	schottenfeld	schottenfeld	PROPN
cuesj-811	199	20	.	.	PUNCT
cuesj-811	200	1	cancer	cancer	NOUN
cuesj-811	200	2	epidemiology	epidemiology	NOUN
cuesj-811	200	3	and	and	CCONJ
cuesj-811	200	4	prevention	prevention	NOUN
cuesj-811	200	5	:	:	PUNCT
cuesj-811	200	6	oxford	oxford	PROPN
cuesj-811	200	7	university	university	PROPN
cuesj-811	200	8	press	press	NOUN
cuesj-811	200	9	,	,	PUNCT
cuesj-811	200	10	oxford	oxford	NOUN
cuesj-811	200	11	,	,	PUNCT
cuesj-811	200	12	2017	2017	NUM
cuesj-811	200	13	.	.	PUNCT
cuesj-811	201	1	19	19	NUM
cuesj-811	201	2	.	.	PUNCT
cuesj-811	201	3	n.	n.	PROPN
cuesj-811	201	4	mahdavifar	mahdavifar	PROPN
cuesj-811	201	5	,	,	PUNCT
cuesj-811	201	6	r.	r.	PROPN
cuesj-811	201	7	pakzad	pakzad	PROPN
cuesj-811	201	8	,	,	PUNCT
cuesj-811	201	9	m.	m.	NOUN
cuesj-811	201	10	ghoncheh	ghoncheh	PROPN
cuesj-811	201	11	,	,	PUNCT
cuesj-811	201	12	h.	h.	PROPN
cuesj-811	201	13	s.	s.	PROPN
cuesj-811	201	14	gandomani	gandomani	PROPN
cuesj-811	201	15	and	and	CCONJ
cuesj-811	201	16	h.	h.	PROPN
cuesj-811	201	17	salehiniya	salehiniya	PROPN
cuesj-811	201	18	.	.	PUNCT
cuesj-811	202	1	epidemiology	epidemiology	NOUN
cuesj-811	202	2	,	,	PUNCT
cuesj-811	202	3	incidence	incidence	NOUN
cuesj-811	202	4	,	,	PUNCT
cuesj-811	202	5	and	and	CCONJ
cuesj-811	202	6	mortality	mortality	NOUN
cuesj-811	202	7	of	of	ADP
cuesj-811	202	8	gallbladder	gallbladder	NOUN
cuesj-811	202	9	cancer	cancer	NOUN
cuesj-811	202	10	and	and	CCONJ
cuesj-811	202	11	its	its	PRON
cuesj-811	202	12	relation	relation	NOUN
cuesj-811	202	13	with	with	ADP
cuesj-811	202	14	development	development	NOUN
cuesj-811	202	15	in	in	ADP
cuesj-811	202	16	the	the	DET
cuesj-811	202	17	world	world	NOUN
cuesj-811	202	18	.	.	PUNCT
cuesj-811	203	1	annals	annal	NOUN
cuesj-811	203	2	of	of	ADP
cuesj-811	203	3	tropical	tropical	ADJ
cuesj-811	203	4	medicine	medicine	NOUN
cuesj-811	203	5	and	and	CCONJ
cuesj-811	203	6	public	public	ADJ
cuesj-811	203	7	health	health	NOUN
cuesj-811	203	8	,	,	PUNCT
cuesj-811	203	9	vol	vol	NOUN
cuesj-811	203	10	.	.	PROPN
cuesj-811	203	11	10	10	NUM
cuesj-811	203	12	,	,	PUNCT
cuesj-811	203	13	pp	pp	ADJ
cuesj-811	203	14	.	.	PUNCT
cuesj-811	204	1	563	563	NUM
cuesj-811	204	2	-	-	SYM
cuesj-811	204	3	517	517	NUM
cuesj-811	204	4	,	,	PUNCT
cuesj-811	204	5	2017	2017	NUM
cuesj-811	204	6	.	.	PUNCT
cuesj-811	205	1	20	20	NUM
cuesj-811	205	2	.	.	PUNCT
cuesj-811	206	1	y.	y.	NOUN
cuesj-811	206	2	moradi	moradi	PROPN
cuesj-811	206	3	,	,	PUNCT
cuesj-811	206	4	m.	m.	NOUN
cuesj-811	206	5	jafari	jafari	PROPN
cuesj-811	206	6	,	,	PUNCT
cuesj-811	206	7	s.	s.	PROPN
cuesj-811	206	8	chaichian	chaichian	PROPN
cuesj-811	206	9	,	,	PUNCT
cuesj-811	206	10	s.	s.	PROPN
cuesj-811	206	11	khateri	khateri	PROPN
cuesj-811	206	12	,	,	PUNCT
cuesj-811	206	13	a.	a.	NOUN
cuesj-811	206	14	akbarian	akbarian	PROPN
cuesj-811	206	15	,	,	PUNCT
cuesj-811	206	16	b.	b.	PROPN
cuesj-811	206	17	moazzami	moazzami	PROPN
cuesj-811	206	18	,	,	PUNCT
cuesj-811	206	19	k.	k.	PROPN
cuesj-811	206	20	mansori	mansori	PROPN
cuesj-811	206	21	,	,	PUNCT
cuesj-811	206	22	y.	y.	PROPN
cuesj-811	206	23	mahmodi	mahmodi	PROPN
cuesj-811	206	24	and	and	CCONJ
cuesj-811	206	25	s.	s.	PROPN
cuesj-811	206	26	samie	samie	PROPN
cuesj-811	206	27	.	.	PUNCT
cuesj-811	207	1	trends	trend	NOUN
cuesj-811	207	2	in	in	ADP
cuesj-811	207	3	ovarian	ovarian	ADJ
cuesj-811	207	4	cancer	cancer	NOUN
cuesj-811	207	5	incidence	incidence	NOUN
cuesj-811	207	6	in	in	ADP
cuesj-811	207	7	iran	iran	PROPN
cuesj-811	207	8	.	.	PUNCT
cuesj-811	208	1	international	international	ADJ
cuesj-811	208	2	journal	journal	PROPN
cuesj-811	208	3	of	of	ADP
cuesj-811	208	4	cancer	cancer	NOUN
cuesj-811	208	5	management	management	NOUN
cuesj-811	208	6	,	,	PUNCT
cuesj-811	208	7	vol	vol	NOUN
cuesj-811	208	8	.	.	NOUN
cuesj-811	208	9	9	9	NUM
cuesj-811	208	10	,	,	PUNCT
cuesj-811	208	11	p.	p.	PROPN
cuesj-811	208	12	e5452	e5452	PROPN
cuesj-811	208	13	,	,	PUNCT
cuesj-811	208	14	2016	2016	NUM
cuesj-811	208	15	.	.	PUNCT
cuesj-811	209	1	21	21	NUM
cuesj-811	209	2	.	.	PUNCT
cuesj-811	209	3	n.	n.	NOUN
cuesj-811	209	4	bhatla	bhatla	PROPN
cuesj-811	209	5	and	and	CCONJ
cuesj-811	209	6	a.	a.	NOUN
cuesj-811	209	7	jones	jones	PROPN
cuesj-811	209	8	.	.	PUNCT
cuesj-811	210	1	the	the	DET
cuesj-811	210	2	world	world	NOUN
cuesj-811	210	3	ovarian	ovarian	ADJ
cuesj-811	210	4	cancer	cancer	NOUN
cuesj-811	210	5	coalition	coalition	NOUN
cuesj-811	210	6	atlas	atlas	PROPN
cuesj-811	210	7	.	.	PUNCT
cuesj-811	211	1	global	global	ADJ
cuesj-811	211	2	trends	trend	NOUN
cuesj-811	211	3	in	in	ADP
cuesj-811	211	4	incidence	incidence	NOUN
cuesj-811	211	5	,	,	PUNCT
cuesj-811	211	6	mortality	mortality	NOUN
cuesj-811	211	7	and	and	CCONJ
cuesj-811	211	8	survival	survival	NOUN
cuesj-811	211	9	.	.	PUNCT
cuesj-811	212	1	the	the	DET
cuesj-811	212	2	world	world	NOUN
cuesj-811	212	3	ovarian	ovarian	ADJ
cuesj-811	212	4	cancer	cancer	NOUN
cuesj-811	212	5	coalition	coalition	NOUN
cuesj-811	212	6	,	,	PUNCT
cuesj-811	212	7	toronto	toronto	PROPN
cuesj-811	212	8	,	,	PUNCT
cuesj-811	212	9	on	on	ADP
cuesj-811	212	10	.	.	PROPN
cuesj-811	212	11	2018	2018	NUM
cuesj-811	212	12	.	.	PUNCT
cuesj-811	213	1	22	22	NUM
cuesj-811	213	2	.	.	PUNCT
cuesj-811	213	3	r.	r.	PROPN
cuesj-811	213	4	bast	bast	PROPN
cuesj-811	213	5	,	,	PUNCT
cuesj-811	213	6	m.	m.	NOUN
cuesj-811	213	7	feeney	feeney	PROPN
cuesj-811	213	8	,	,	PUNCT
cuesj-811	213	9	h.	h.	PROPN
cuesj-811	213	10	lazarus	lazarus	PROPN
cuesj-811	213	11	,	,	PUNCT
cuesj-811	213	12	l.	l.	PROPN
cuesj-811	213	13	m.	m.	PROPN
cuesj-811	213	14	nadler	nadler	PROPN
cuesj-811	213	15	,	,	PUNCT
cuesj-811	213	16	r.	r.	PROPN
cuesj-811	213	17	b.	b.	PROPN
cuesj-811	213	18	colvin	colvin	PROPN
cuesj-811	213	19	and	and	CCONJ
cuesj-811	213	20	r.	r.	PROPN
cuesj-811	213	21	c.	c.	PROPN
cuesj-811	213	22	knapp	knapp	PROPN
cuesj-811	213	23	.	.	PROPN
cuesj-811	214	1	reactivity	reactivity	NOUN
cuesj-811	214	2	of	of	ADP
cuesj-811	214	3	a	a	DET
cuesj-811	214	4	monoclonal	monoclonal	NOUN
cuesj-811	214	5	antibody	antibody	NOUN
cuesj-811	214	6	with	with	ADP
cuesj-811	214	7	human	human	ADJ
cuesj-811	214	8	ovarian	ovarian	ADJ
cuesj-811	214	9	carcinoma	carcinoma	NOUN
cuesj-811	214	10	.	.	PUNCT
cuesj-811	215	1	the	the	DET
cuesj-811	215	2	journal	journal	NOUN
cuesj-811	215	3	of	of	ADP
cuesj-811	215	4	clinical	clinical	ADJ
cuesj-811	215	5	investigation	investigation	NOUN
cuesj-811	215	6	,	,	PUNCT
cuesj-811	215	7	vol	vol	NOUN
cuesj-811	215	8	.	.	PROPN
cuesj-811	215	9	68	68	NUM
cuesj-811	215	10	,	,	PUNCT
cuesj-811	215	11	no	no	INTJ
cuesj-811	215	12	.	.	NOUN
cuesj-811	215	13	5	5	NUM
cuesj-811	215	14	,	,	PUNCT
cuesj-811	215	15	pp	pp	ADJ
cuesj-811	215	16	.	.	PUNCT
cuesj-811	215	17	1331	1331	NUM
cuesj-811	215	18	-	-	SYM
cuesj-811	215	19	1337	1337	NUM
cuesj-811	215	20	,	,	PUNCT
cuesj-811	215	21	1981	1981	NUM
cuesj-811	215	22	.	.	PUNCT
cuesj-811	216	1	23	23	NUM
cuesj-811	216	2	.	.	PUNCT
cuesj-811	217	1	n.	n.	NOUN
cuesj-811	217	2	scholler	scholler	PROPN
cuesj-811	217	3	and	and	CCONJ
cuesj-811	217	4	n.	n.	NOUN
cuesj-811	217	5	urban	urban	NOUN
cuesj-811	217	6	.	.	PUNCT
cuesj-811	218	1	ca125	ca125	X
cuesj-811	219	1	in	in	ADP
cuesj-811	219	2	ovarian	ovarian	ADJ
cuesj-811	219	3	cancer	cancer	NOUN
cuesj-811	219	4	.	.	PUNCT
cuesj-811	220	1	biomarkers	biomarker	NOUN
cuesj-811	220	2	in	in	ADP
cuesj-811	220	3	medicine	medicine	NOUN
cuesj-811	220	4	,	,	PUNCT
cuesj-811	220	5	vol	vol	NOUN
cuesj-811	220	6	.	.	PROPN
cuesj-811	220	7	1	1	NUM
cuesj-811	220	8	,	,	PUNCT
cuesj-811	220	9	no	no	INTJ
cuesj-811	220	10	.	.	NOUN
cuesj-811	220	11	4	4	NUM
cuesj-811	220	12	,	,	PUNCT
cuesj-811	220	13	pp	pp	ADJ
cuesj-811	220	14	.	.	PUNCT
cuesj-811	221	1	513	513	NUM
cuesj-811	221	2	-	-	SYM
cuesj-811	221	3	523	523	NUM
cuesj-811	221	4	,	,	PUNCT
cuesj-811	221	5	2007	2007	NUM
cuesj-811	221	6	.	.	PUNCT
cuesj-811	222	1	24	24	NUM
cuesj-811	222	2	.	.	PUNCT
cuesj-811	222	3	h.	h.	PROPN
cuesj-811	222	4	yesilyurt	yesilyurt	PROPN
cuesj-811	222	5	,	,	PUNCT
cuesj-811	222	6	b.	b.	PROPN
cuesj-811	222	7	seckin	seckin	PROPN
cuesj-811	222	8	,	,	PUNCT
cuesj-811	222	9	a.	a.	NOUN
cuesj-811	222	10	aktulay	aktulay	NOUN
cuesj-811	222	11	and	and	CCONJ
cuesj-811	222	12	s.	s.	PROPN
cuesj-811	222	13	ozyer	ozyer	PROPN
cuesj-811	222	14	.	.	PUNCT
cuesj-811	223	1	age	age	NOUN
cuesj-811	223	2	-	-	PUNCT
cuesj-811	223	3	stratified	stratify	VERB
cuesj-811	223	4	analysis	analysis	NOUN
cuesj-811	223	5	of	of	ADP
cuesj-811	223	6	tumor	tumor	NOUN
cuesj-811	223	7	markers	marker	NOUN
cuesj-811	223	8	and	and	CCONJ
cuesj-811	223	9	tumor	tumor	NOUN
cuesj-811	223	10	characteristics	characteristic	NOUN
cuesj-811	223	11	in	in	ADP
cuesj-811	223	12	adolescents	adolescent	NOUN
cuesj-811	223	13	and	and	CCONJ
cuesj-811	223	14	young	young	ADJ
cuesj-811	223	15	women	woman	NOUN
cuesj-811	223	16	with	with	ADP
cuesj-811	223	17	mature	mature	ADJ
cuesj-811	223	18	cystic	cystic	ADJ
cuesj-811	223	19	teratoma	teratoma	NOUN
cuesj-811	223	20	.	.	PUNCT
cuesj-811	224	1	journal	journal	NOUN
cuesj-811	224	2	of	of	ADP
cuesj-811	224	3	the	the	DET
cuesj-811	224	4	chinese	chinese	PROPN
cuesj-811	224	5	medical	medical	PROPN
cuesj-811	224	6	association	association	PROPN
cuesj-811	224	7	,	,	PUNCT
cuesj-811	224	8	vol	vol	NOUN
cuesj-811	224	9	.	.	PROPN
cuesj-811	224	10	81	81	NUM
cuesj-811	224	11	,	,	PUNCT
cuesj-811	224	12	pp	pp	ADJ
cuesj-811	224	13	.	.	PUNCT
cuesj-811	225	1	499	499	NUM
cuesj-811	225	2	-	-	SYM
cuesj-811	225	3	504	504	NUM
cuesj-811	225	4	,	,	PUNCT
cuesj-811	225	5	2018	2018	NUM
cuesj-811	225	6	.	.	PUNCT
cuesj-811	226	1	25	25	NUM
cuesj-811	226	2	.	.	PUNCT
cuesj-811	226	3	k.	k.	PROPN
cuesj-811	226	4	a.	a.	PROPN
cuesj-811	226	5	habib	habib	PROPN
cuesj-811	226	6	,	,	PUNCT
cuesj-811	226	7	m.	m.	NOUN
cuesj-811	226	8	g.	g.	PROPN
cuesj-811	226	9	jumaa	jumaa	PROPN
cuesj-811	226	10	and	and	CCONJ
cuesj-811	226	11	m.	m.	PROPN
cuesj-811	226	12	j.	j.	PROPN
cuesj-811	226	13	hussein	hussein	PROPN
cuesj-811	226	14	.	.	PUNCT
cuesj-811	227	1	determination	determination	NOUN
cuesj-811	227	2	of	of	ADP
cuesj-811	227	3	serum	serum	NOUN
cuesj-811	227	4	ca125	ca125	NOUN
cuesj-811	227	5	and	and	CCONJ
cuesj-811	227	6	evaluate	evaluate	VERB
cuesj-811	227	7	its	its	PRON
cuesj-811	227	8	efficiency	efficiency	NOUN
cuesj-811	227	9	as	as	ADP
cuesj-811	227	10	screening	screen	VERB
cuesj-811	227	11	tool	tool	NOUN
cuesj-811	227	12	for	for	ADP
cuesj-811	227	13	early	early	ADJ
cuesj-811	227	14	detection	detection	NOUN
cuesj-811	227	15	of	of	ADP
cuesj-811	227	16	ovarian	ovarian	ADJ
cuesj-811	227	17	tumors	tumor	NOUN
cuesj-811	227	18	.	.	PUNCT
cuesj-811	228	1	baghdad	baghdad	PROPN
cuesj-811	228	2	science	science	PROPN
cuesj-811	228	3	journal	journal	PROPN
cuesj-811	228	4	,	,	PUNCT
cuesj-811	228	5	vol	vol	NOUN
cuesj-811	228	6	.	.	PROPN
cuesj-811	228	7	12	12	NUM
cuesj-811	228	8	,	,	PUNCT
cuesj-811	228	9	pp	pp	ADJ
cuesj-811	228	10	.	.	PUNCT
cuesj-811	229	1	55	55	NUM
cuesj-811	229	2	-	-	SYM
cuesj-811	229	3	62	62	NUM
cuesj-811	229	4	,	,	PUNCT
cuesj-811	229	5	2015	2015	NUM
cuesj-811	229	6	.	.	PUNCT
cuesj-811	230	1	26	26	NUM
cuesj-811	230	2	.	.	PUNCT
cuesj-811	230	3	m.	m.	NOUN
cuesj-811	230	4	h.	h.	PROPN
cuesj-811	230	5	ubeid	ubeid	PROPN
cuesj-811	230	6	.	.	PUNCT
cuesj-811	231	1	prevalence	prevalence	NOUN
cuesj-811	231	2	of	of	ADP
cuesj-811	231	3	leukocytes	leukocyte	NOUN
cuesj-811	231	4	in	in	ADP
cuesj-811	231	5	type	type	NOUN
cuesj-811	231	6	2	2	NUM
cuesj-811	231	7	diabetic	diabetic	ADJ
cuesj-811	231	8	patients	patient	NOUN
cuesj-811	231	9	in	in	ADP
cuesj-811	231	10	erbil	erbil	PROPN
cuesj-811	231	11	city	city	PROPN
cuesj-811	231	12	.	.	PUNCT
cuesj-811	232	1	medical	medical	ADJ
cuesj-811	232	2	journal	journal	PROPN
cuesj-811	232	3	of	of	ADP
cuesj-811	232	4	babylon	babylon	PROPN
cuesj-811	232	5	,	,	PUNCT
cuesj-811	232	6	vol	vol	NOUN
cuesj-811	232	7	.	.	PROPN
cuesj-811	232	8	17	17	NUM
cuesj-811	232	9	,	,	PUNCT
cuesj-811	232	10	p.	p.	NOUN
cuesj-811	232	11	19	19	NUM
cuesj-811	232	12	,	,	PUNCT
cuesj-811	232	13	2020	2020	NUM
cuesj-811	232	14	.	.	PUNCT
cuesj-811	233	1	27	27	NUM
cuesj-811	233	2	.	.	PUNCT
cuesj-811	233	3	c.	c.	PROPN
cuesj-811	233	4	l.	l.	PROPN
cuesj-811	233	5	gyftaki	gyftaki	PROPN
cuesj-811	233	6	,	,	PUNCT
cuesj-811	233	7	e.	e.	PROPN
cuesj-811	233	8	politi	politi	PROPN
cuesj-811	233	9	,	,	PUNCT
cuesj-811	233	10	m.	m.	NOUN
cuesj-811	233	11	liontos	liontos	PROPN
cuesj-811	233	12	,	,	PUNCT
cuesj-811	233	13	k.	k.	PROPN
cuesj-811	233	14	saltiki	saltiki	PROPN
cuesj-811	233	15	,	,	PUNCT
cuesj-811	233	16	n.	n.	PROPN
cuesj-811	233	17	theocharis	theocharis	PROPN
cuesj-811	233	18	papageorgiou	papageorgiou	PROPN
cuesj-811	233	19	,	,	PUNCT
cuesj-811	233	20	d.	d.	PROPN
cuesj-811	233	21	h.	h.	PROPN
cuesj-811	233	22	thomakos	thomakos	PROPN
cuesj-811	233	23	,	,	PUNCT
cuesj-811	233	24	d.	d.	PROPN
cuesj-811	233	25	haidopoulos	haidopoulos	PROPN
cuesj-811	233	26	,	,	PUNCT
cuesj-811	233	27	a.	a.	NOUN
cuesj-811	233	28	rodolakis	rodolakis	PROPN
cuesj-811	233	29	,	,	PUNCT
cuesj-811	233	30	m.	m.	NOUN
cuesj-811	233	31	alevizaki	alevizaki	PROPN
cuesj-811	233	32	,	,	PUNCT
cuesj-811	233	33	a.	a.	PROPN
cuesj-811	233	34	bamias	bamias	PROPN
cuesj-811	233	35	and	and	CCONJ
cuesj-811	233	36	a.	a.	NOUN
cuesj-811	233	37	dimopoulos	dimopoulo	NOUN
cuesj-811	233	38	.	.	PUNCT
cuesj-811	234	1	differential	differential	ADJ
cuesj-811	234	2	transcriptional	transcriptional	NOUN
cuesj-811	234	3	and	and	CCONJ
cuesj-811	234	4	protein	protein	NOUN
cuesj-811	234	5	expression	expression	NOUN
cuesj-811	234	6	of	of	ADP
cuesj-811	234	7	thyroidstimulating	thyroidstimulating	ADJ
cuesj-811	234	8	hormone	hormone	NOUN
cuesj-811	234	9	receptor	receptor	NOUN
cuesj-811	234	10	in	in	ADP
cuesj-811	234	11	ovarian	ovarian	ADJ
cuesj-811	234	12	carcinomas	carcinoma	NOUN
cuesj-811	234	13	.	.	PUNCT
cuesj-811	235	1	international	international	ADJ
cuesj-811	235	2	journal	journal	NOUN
cuesj-811	235	3	of	of	ADP
cuesj-811	235	4	gynecological	gynecological	ADJ
cuesj-811	235	5	cancer	cancer	NOUN
cuesj-811	235	6	,	,	PUNCT
cuesj-811	235	7	vol	vol	NOUN
cuesj-811	235	8	.	.	PROPN
cuesj-811	235	9	24	24	NUM
cuesj-811	235	10	,	,	PUNCT
cuesj-811	235	11	no	no	INTJ
cuesj-811	235	12	.	.	NOUN
cuesj-811	235	13	5	5	NUM
cuesj-811	235	14	,	,	PUNCT
cuesj-811	235	15	pp	pp	ADJ
cuesj-811	235	16	.	.	PUNCT
cuesj-811	235	17	851	851	NUM
cuesj-811	235	18	-	-	SYM
cuesj-811	235	19	856	856	NUM
cuesj-811	235	20	,	,	PUNCT
cuesj-811	235	21	2014	2014	NUM
cuesj-811	235	22	.	.	PUNCT
cuesj-811	236	1	28	28	NUM
cuesj-811	236	2	.	.	PUNCT
cuesj-811	236	3	m.	m.	PROPN
cuesj-811	236	4	rae	rae	PROPN
cuesj-811	236	5	,	,	PUNCT
cuesj-811	236	6	o.	o.	PROPN
cuesj-811	236	7	gubbay	gubbay	PROPN
cuesj-811	236	8	,	,	PUNCT
cuesj-811	236	9	a.	a.	NOUN
cuesj-811	236	10	kostogiannou	kostogiannou	PROPN
cuesj-811	236	11	,	,	PUNCT
cuesj-811	236	12	d.	d.	PROPN
cuesj-811	236	13	price	price	PROPN
cuesj-811	236	14	,	,	PUNCT
cuesj-811	236	15	h.	h.	PROPN
cuesj-811	236	16	critchley	critchley	PROPN
cuesj-811	236	17	and	and	CCONJ
cuesj-811	236	18	s.	s.	PROPN
cuesj-811	236	19	hillier	hillier	PROPN
cuesj-811	236	20	.	.	PUNCT
cuesj-811	237	1	thyroid	thyroid	NOUN
cuesj-811	237	2	hormone	hormone	NOUN
cuesj-811	237	3	signaling	signal	VERB
cuesj-811	237	4	in	in	ADP
cuesj-811	237	5	human	human	ADJ
cuesj-811	237	6	ovarian	ovarian	ADJ
cuesj-811	237	7	surface	surface	NOUN
cuesj-811	237	8	epithelial	epithelial	ADJ
cuesj-811	237	9	cells	cell	NOUN
cuesj-811	237	10	.	.	PUNCT
cuesj-811	238	1	the	the	DET
cuesj-811	238	2	journal	journal	NOUN
cuesj-811	238	3	of	of	ADP
cuesj-811	238	4	clinical	clinical	ADJ
cuesj-811	238	5	endocrinology	endocrinology	NOUN
cuesj-811	238	6	and	and	CCONJ
cuesj-811	238	7	metabolism	metabolism	NOUN
cuesj-811	238	8	,	,	PUNCT
cuesj-811	238	9	vol	vol	NOUN
cuesj-811	238	10	.	.	PROPN
cuesj-811	238	11	92	92	NUM
cuesj-811	238	12	,	,	PUNCT
cuesj-811	238	13	pp	pp	ADJ
cuesj-811	238	14	.	.	PUNCT
cuesj-811	239	1	322	322	NUM
cuesj-811	239	2	-	-	SYM
cuesj-811	239	3	327	327	NUM
cuesj-811	239	4	,	,	PUNCT
cuesj-811	239	5	2007	2007	NUM
cuesj-811	239	6	.	.	PUNCT
cuesj-811	240	1	29	29	NUM
cuesj-811	240	2	.	.	PUNCT
cuesj-811	240	3	m.	m.	NOUN
cuesj-811	240	4	rasool	rasool	PROPN
cuesj-811	240	5	,	,	PUNCT
cuesj-811	240	6	m.	m.	NOUN
cuesj-811	240	7	i.	i.	PROPN
cuesj-811	240	8	naseer	naseer	PROPN
cuesj-811	240	9	,	,	PUNCT
cuesj-811	240	10	k.	k.	PROPN
cuesj-811	240	11	zaigham	zaigham	PROPN
cuesj-811	240	12	,	,	PUNCT
cuesj-811	240	13	a.	a.	PROPN
cuesj-811	240	14	malik	malik	PROPN
cuesj-811	240	15	,	,	PUNCT
cuesj-811	240	16	n.	n.	PROPN
cuesj-811	240	17	riaz	riaz	PROPN
cuesj-811	240	18	,	,	PUNCT
cuesj-811	240	19	r.	r.	PROPN
cuesj-811	240	20	alam	alam	PROPN
cuesj-811	240	21	,	,	PUNCT
cuesj-811	240	22	a.	a.	PROPN
cuesj-811	240	23	manan	manan	PROPN
cuesj-811	240	24	,	,	PUNCT
cuesj-811	240	25	i.	i.	PROPN
cuesj-811	240	26	a.	a.	PROPN
cuesj-811	240	27	sheikh	sheikh	PROPN
cuesj-811	240	28	,	,	PUNCT
cuesj-811	240	29	m.	m.	NOUN
cuesj-811	240	30	asif	asif	PROPN
cuesj-811	240	31	.	.	PUNCT
cuesj-811	240	32	comparative	comparative	ADJ
cuesj-811	240	33	study	study	NOUN
cuesj-811	240	34	of	of	ADP
cuesj-811	240	35	alterations	alteration	NOUN
cuesj-811	240	36	in	in	ADP
cuesj-811	240	37	tri	tri	ADJ
cuesj-811	240	38	-	-	ADJ
cuesj-811	240	39	iodothyronine	iodothyronine	ADJ
cuesj-811	240	40	(	(	PUNCT
cuesj-811	240	41	t3	t3	PROPN
cuesj-811	240	42	)	)	PUNCT
cuesj-811	240	43	and	and	CCONJ
cuesj-811	240	44	thyroxine	thyroxine	NOUN
cuesj-811	240	45	(	(	PUNCT
cuesj-811	240	46	t4	t4	PROPN
cuesj-811	240	47	)	)	PUNCT
cuesj-811	240	48	hormone	hormone	NOUN
cuesj-811	240	49	levels	level	NOUN
cuesj-811	240	50	in	in	ADP
cuesj-811	240	51	breast	breast	NOUN
cuesj-811	240	52	and	and	CCONJ
cuesj-811	240	53	ovarian	ovarian	ADJ
cuesj-811	240	54	cancer	cancer	NOUN
cuesj-811	240	55	.	.	PUNCT
cuesj-811	241	1	pakistan	pakistan	PROPN
cuesj-811	241	2	journal	journal	PROPN
cuesj-811	241	3	of	of	ADP
cuesj-811	241	4	medical	medical	ADJ
cuesj-811	241	5	sciences	science	NOUN
cuesj-811	241	6	,	,	PUNCT
cuesj-811	241	7	vol	vol	NOUN
cuesj-811	241	8	.	.	PROPN
cuesj-811	241	9	30	30	NUM
cuesj-811	241	10	,	,	PUNCT
cuesj-811	241	11	p.	p.	NOUN
cuesj-811	241	12	1356	1356	NUM
cuesj-811	241	13	,	,	PUNCT
cuesj-811	241	14	2014	2014	NUM
cuesj-811	241	15	.	.	PUNCT
cuesj-811	242	1	30	30	NUM
cuesj-811	242	2	.	.	PUNCT
cuesj-811	243	1	k.	k.	PROPN
cuesj-811	243	2	żak	żak	PROPN
cuesj-811	243	3	,	,	PUNCT
cuesj-811	243	4	s.	s.	PROPN
cuesj-811	243	5	niedobylski	niedobylski	PROPN
cuesj-811	243	6	,	,	PUNCT
cuesj-811	243	7	m.	m.	NOUN
cuesj-811	243	8	leziak	leziak	PROPN
cuesj-811	243	9	,	,	PUNCT
cuesj-811	243	10	k.	k.	PROPN
cuesj-811	243	11	maliszewska	maliszewska	PROPN
cuesj-811	243	12	,	,	PUNCT
cuesj-811	243	13	m.	m.	NOUN
cuesj-811	243	14	czapska	czapska	PROPN
cuesj-811	243	15	and	and	CCONJ
cuesj-811	243	16	k.	k.	PROPN
cuesj-811	243	17	skórzyńska	skórzyńska	PROPN
cuesj-811	243	18	-	-	PUNCT
cuesj-811	243	19	dziduszko	dziduszko	PROPN
cuesj-811	243	20	.	.	PROPN
cuesj-811	244	1	have	have	AUX
cuesj-811	244	2	thyroid	thyroid	NOUN
cuesj-811	244	3	hormones	hormone	NOUN
cuesj-811	244	4	an	an	DET
cuesj-811	244	5	impact	impact	NOUN
cuesj-811	244	6	ubeid	ubeid	NOUN
cuesj-811	244	7	,	,	PUNCT
cuesj-811	244	8	et	et	PROPN
cuesj-811	244	9	al	al	PROPN
cuesj-811	244	10	.	.	PUNCT
cuesj-811	244	11	:	:	PUNCT
cuesj-811	245	1	parameter	parameter	PROPN
cuesj-811	245	2	affecting	affect	VERB
cuesj-811	245	3	ca-125	ca-125	PROPN
cuesj-811	245	4	,	,	PUNCT
cuesj-811	245	5	tsh	tsh	NOUN
cuesj-811	245	6	,	,	PUNCT
cuesj-811	245	7	and	and	CCONJ
cuesj-811	245	8	cbc	cbc	NOUN
cuesj-811	245	9	7	7	NUM
cuesj-811	245	10	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-811	245	11	cuesj	cuesj	NOUN
cuesj-811	245	12	2023	2023	NUM
cuesj-811	245	13	,	,	PUNCT
cuesj-811	245	14	7	7	NUM
cuesj-811	245	15	(	(	PUNCT
cuesj-811	245	16	1	1	NUM
cuesj-811	245	17	):	):	PUNCT
cuesj-811	245	18	1	1	NUM
cuesj-811	245	19	-	-	SYM
cuesj-811	245	20	7	7	NUM
cuesj-811	245	21	author	author	NOUN
cuesj-811	245	22	queries	query	VERB
cuesj-811	245	23	?	?	PUNCT
cuesj-811	245	24	?	?	PUNCT
cuesj-811	245	25	?	?	PUNCT
cuesj-811	246	1	aq1	aq1	VERB
cuesj-811	246	2	:	:	PUNCT
cuesj-811	246	3	kindly	kindly	ADV
cuesj-811	246	4	provide	provide	VERB
cuesj-811	246	5	running	running	NOUN
cuesj-811	246	6	title	title	NOUN
cuesj-811	246	7	aq2	aq2	PROPN
cuesj-811	246	8	:	:	PUNCT
cuesj-811	246	9	kindly	kindly	ADV
cuesj-811	246	10	check	check	VERB
cuesj-811	246	11	the	the	DET
cuesj-811	246	12	author	author	NOUN
cuesj-811	246	13	name	name	NOUN
cuesj-811	246	14	does	do	AUX
cuesj-811	246	15	not	not	PART
cuesj-811	246	16	match	match	VERB
cuesj-811	246	17	with	with	ADP
cuesj-811	246	18	reference	reference	NOUN
cuesj-811	246	19	list	list	NOUN
cuesj-811	246	20	aq3	aq3	PROPN
cuesj-811	246	21	:	:	PUNCT
cuesj-811	246	22	kindly	kindly	ADV
cuesj-811	246	23	provide	provide	VERB
cuesj-811	246	24	complete	complete	ADJ
cuesj-811	246	25	reference	reference	NOUN
cuesj-811	246	26	aq4	aq4	ADV
cuesj-811	246	27	:	:	PUNCT
cuesj-811	246	28	kindly	kindly	ADV
cuesj-811	246	29	provide	provide	VERB
cuesj-811	246	30	foot	foot	NOUN
cuesj-811	246	31	note	note	NOUN
cuesj-811	246	32	for	for	ADP
cuesj-811	246	33	significant	significant	ADJ
cuesj-811	246	34	symbol	symbol	NOUN
cuesj-811	246	35	of	of	ADP
cuesj-811	246	36	“	"	PUNCT
cuesj-811	246	37	*	*	PROPN
cuesj-811	246	38	*	*	NOUN
cuesj-811	246	39	”	"	PUNCT
cuesj-811	246	40	aq5	aq5	NOUN
cuesj-811	246	41	:	:	PUNCT
cuesj-811	246	42	kindly	kindly	ADV
cuesj-811	246	43	provide	provide	VERB
cuesj-811	246	44	foot	foot	NOUN
cuesj-811	246	45	note	note	NOUN
cuesj-811	246	46	for	for	ADP
cuesj-811	246	47	significant	significant	ADJ
cuesj-811	246	48	symbol	symbol	NOUN
cuesj-811	246	49	of	of	ADP
cuesj-811	246	50	“	"	PUNCT
cuesj-811	246	51	*	*	NOUN
cuesj-811	246	52	”	"	PUNCT
cuesj-811	246	53	on	on	ADP
cuesj-811	246	54	ovarian	ovarian	ADJ
cuesj-811	246	55	cancer	cancer	NOUN
cuesj-811	246	56	?	?	PUNCT
cuesj-811	247	1	journal	journal	NOUN
cuesj-811	247	2	of	of	ADP
cuesj-811	247	3	education	education	NOUN
cuesj-811	247	4	,	,	PUNCT
cuesj-811	247	5	health	health	NOUN
cuesj-811	247	6	and	and	CCONJ
cuesj-811	247	7	sport	sport	NOUN
cuesj-811	247	8	,	,	PUNCT
cuesj-811	247	9	vol	vol	NOUN
cuesj-811	247	10	.	.	PROPN
cuesj-811	247	11	8	8	NUM
cuesj-811	247	12	,	,	PUNCT
cuesj-811	247	13	pp	pp	ADJ
cuesj-811	247	14	.	.	PUNCT
cuesj-811	247	15	803	803	NUM
cuesj-811	247	16	-	-	SYM
cuesj-811	247	17	809	809	NUM
cuesj-811	247	18	,	,	PUNCT
cuesj-811	247	19	2018	2018	NUM
cuesj-811	247	20	.	.	PUNCT
cuesj-811	248	1	31	31	NUM
cuesj-811	248	2	.	.	PUNCT
cuesj-811	248	3	m.	m.	NOUN
cuesj-811	248	4	den	den	PROPN
cuesj-811	248	5	ouden	ouden	PROPN
cuesj-811	248	6	,	,	PUNCT
cuesj-811	248	7	j.	j.	PROPN
cuesj-811	248	8	ubachs	ubachs	PROPN
cuesj-811	248	9	,	,	PUNCT
cuesj-811	248	10	j.	j.	PROPN
cuesj-811	248	11	stoot	stoot	PROPN
cuesj-811	248	12	and	and	CCONJ
cuesj-811	248	13	j.	j.	PROPN
cuesj-811	248	14	van	van	PROPN
cuesj-811	248	15	wersch	wersch	PROPN
cuesj-811	248	16	.	.	PUNCT
cuesj-811	249	1	whole	whole	ADJ
cuesj-811	249	2	blood	blood	NOUN
cuesj-811	249	3	cell	cell	NOUN
cuesj-811	249	4	counts	count	NOUN
cuesj-811	249	5	and	and	CCONJ
cuesj-811	249	6	leucocyte	leucocyte	NOUN
cuesj-811	249	7	differentials	differential	NOUN
cuesj-811	249	8	in	in	ADP
cuesj-811	249	9	patients	patient	NOUN
cuesj-811	249	10	with	with	ADP
cuesj-811	249	11	benign	benign	ADJ
cuesj-811	249	12	or	or	CCONJ
cuesj-811	249	13	malignant	malignant	ADJ
cuesj-811	249	14	ovarian	ovarian	ADJ
cuesj-811	249	15	tumours	tumour	NOUN
cuesj-811	249	16	.	.	PUNCT
cuesj-811	250	1	european	european	ADJ
cuesj-811	250	2	journal	journal	PROPN
cuesj-811	250	3	of	of	ADP
cuesj-811	250	4	obstetrics	obstetric	NOUN
cuesj-811	250	5	and	and	CCONJ
cuesj-811	250	6	gynecology	gynecology	NOUN
cuesj-811	250	7	and	and	CCONJ
cuesj-811	250	8	reproductive	reproductive	ADJ
cuesj-811	250	9	biology	biology	NOUN
cuesj-811	250	10	,	,	PUNCT
cuesj-811	250	11	vol	vol	NOUN
cuesj-811	250	12	.	.	PROPN
cuesj-811	250	13	72	72	NUM
cuesj-811	250	14	,	,	PUNCT
cuesj-811	250	15	pp	pp	ADJ
cuesj-811	250	16	.	.	PUNCT
cuesj-811	251	1	73	73	NUM
cuesj-811	251	2	-	-	SYM
cuesj-811	251	3	77	77	NUM
cuesj-811	251	4	,	,	PUNCT
cuesj-811	251	5	1997	1997	NUM
cuesj-811	251	6	.	.	PUNCT
cuesj-811	252	1	32	32	NUM
cuesj-811	252	2	.	.	PUNCT
cuesj-811	252	3	a.	a.	PROPN
cuesj-811	252	4	s.	s.	PROPN
cuesj-811	252	5	juma	juma	PROPN
cuesj-811	252	6	,	,	PUNCT
cuesj-811	252	7	m.	m.	PROPN
cuesj-811	252	8	h.	h.	PROPN
cuesj-811	252	9	ubeid	ubeid	PROPN
cuesj-811	252	10	and	and	CCONJ
cuesj-811	252	11	t.	t.	PROPN
cuesj-811	252	12	s.	s.	PROPN
cuesj-811	252	13	salih	salih	PROPN
cuesj-811	252	14	.	.	PUNCT
cuesj-811	253	1	anti	anti	PROPN
cuesj-811	253	2	-	-	ADJ
cuesj-811	253	3	toxoplasma	toxoplasma	ADJ
cuesj-811	253	4	,	,	PUNCT
cuesj-811	253	5	anti	anti	ADJ
cuesj-811	253	6	-	-	NOUN
cuesj-811	253	7	rubella	rubella	NOUN
cuesj-811	253	8	,	,	PUNCT
cuesj-811	253	9	and	and	CCONJ
cuesj-811	253	10	anti	anti	ADJ
cuesj-811	253	11	-	-	ADJ
cuesj-811	253	12	cytomegalovirus	cytomegalovirus	NOUN
cuesj-811	253	13	antibodies	antibodie	VERB
cuesj-811	253	14	in	in	ADP
cuesj-811	253	15	dumpsite	dumpsite	ADJ
cuesj-811	253	16	workers	worker	NOUN
cuesj-811	253	17	of	of	ADP
cuesj-811	253	18	erbil	erbil	PROPN
cuesj-811	253	19	governorate	governorate	PROPN
cuesj-811	253	20	.	.	PUNCT
cuesj-811	254	1	cihan	cihan	VERB
cuesj-811	254	2	university	university	NOUN
cuesj-811	254	3	-	-	PUNCT
cuesj-811	254	4	erbil	erbil	PROPN
cuesj-811	254	5	scientific	scientific	ADJ
cuesj-811	254	6	journal	journal	NOUN
cuesj-811	254	7	,	,	PUNCT
cuesj-811	254	8	vol	vol	NOUN
cuesj-811	254	9	.	.	PROPN
cuesj-811	255	1	3	3	NUM
cuesj-811	255	2	,	,	PUNCT
cuesj-811	255	3	pp	pp	ADJ
cuesj-811	255	4	.	.	PUNCT
cuesj-811	256	1	85	85	NUM
cuesj-811	256	2	-	-	SYM
cuesj-811	256	3	89	89	NUM
cuesj-811	256	4	,	,	PUNCT
cuesj-811	256	5	2019	2019	NUM
cuesj-811	256	6	.	.	PUNCT
cuesj-811	257	1	33	33	NUM
cuesj-811	257	2	.	.	PUNCT
cuesj-811	257	3	a.	a.	PROPN
cuesj-811	257	4	s.	s.	PROPN
cuesj-811	257	5	juma	juma	PROPN
cuesj-811	257	6	,	,	PUNCT
cuesj-811	257	7	m.	m.	PROPN
cuesj-811	257	8	h.	h.	PROPN
cuesj-811	257	9	ubeid	ubeid	PROPN
cuesj-811	257	10	,	,	PUNCT
cuesj-811	257	11	s.	s.	PROPN
cuesj-811	257	12	s.	s.	PROPN
cuesj-811	257	13	haydar	haydar	PROPN
cuesj-811	257	14	and	and	CCONJ
cuesj-811	257	15	t.	t.	PROPN
cuesj-811	257	16	s.	s.	PROPN
cuesj-811	257	17	salih	salih	PROPN
cuesj-811	257	18	.	.	PUNCT
cuesj-811	258	1	some	some	DET
cuesj-811	258	2	immunological	immunological	ADJ
cuesj-811	258	3	and	and	CCONJ
cuesj-811	258	4	hematological	hematological	ADJ
cuesj-811	258	5	parameters	parameter	NOUN
cuesj-811	258	6	among	among	ADP
cuesj-811	258	7	refugees	refugee	NOUN
cuesj-811	258	8	in	in	ADP
cuesj-811	258	9	kawergosk	kawergosk	ADJ
cuesj-811	258	10	camp	camp	PROPN
cuesj-811	258	11	-	-	PUNCT
cuesj-811	258	12	erbil	erbil	PROPN
cuesj-811	258	13	governorate	governorate	PROPN
cuesj-811	258	14	.	.	PUNCT
cuesj-811	259	1	cihan	cihan	VERB
cuesj-811	259	2	university	university	NOUN
cuesj-811	259	3	-	-	PUNCT
cuesj-811	259	4	erbil	erbil	PROPN
cuesj-811	259	5	scientific	scientific	ADJ
cuesj-811	259	6	journal	journal	NOUN
cuesj-811	259	7	,	,	PUNCT
cuesj-811	259	8	vol	vol	NOUN
cuesj-811	259	9	.	.	PROPN
cuesj-811	260	1	3	3	NUM
cuesj-811	260	2	,	,	PUNCT
cuesj-811	260	3	pp	pp	ADJ
cuesj-811	260	4	.	.	PUNCT
cuesj-811	261	1	80	80	NUM
cuesj-811	261	2	-	-	SYM
cuesj-811	261	3	84	84	NUM
cuesj-811	261	4	,	,	PUNCT
cuesj-811	261	5	2019	2019	NUM
cuesj-811	261	6	.	.	PUNCT
cuesj-811	262	1	34	34	NUM
cuesj-811	262	2	.	.	PUNCT
cuesj-811	262	3	r.	r.	PROPN
cuesj-811	262	4	s.	s.	PROPN
cuesj-811	262	5	nomelini	nomelini	PROPN
cuesj-811	262	6	,	,	PUNCT
cuesj-811	262	7	t.	t.	PROPN
cuesj-811	262	8	m.	m.	NOUN
cuesj-811	262	9	da	da	PROPN
cuesj-811	262	10	silva	silva	PROPN
cuesj-811	262	11	,	,	PUNCT
cuesj-811	262	12	b.	b.	PROPN
cuesj-811	262	13	m.	m.	PROPN
cuesj-811	262	14	t.	t.	PROPN
cuesj-811	262	15	murta	murta	PROPN
cuesj-811	262	16	and	and	CCONJ
cuesj-811	262	17	e.	e.	PROPN
cuesj-811	262	18	f.	f.	PROPN
cuesj-811	262	19	c.	c.	PROPN
cuesj-811	262	20	murta	murta	PROPN
cuesj-811	262	21	.	.	PUNCT
cuesj-811	263	1	parameters	parameter	NOUN
cuesj-811	263	2	of	of	ADP
cuesj-811	263	3	blood	blood	NOUN
cuesj-811	263	4	count	count	NOUN
cuesj-811	263	5	and	and	CCONJ
cuesj-811	263	6	tumor	tumor	NOUN
cuesj-811	263	7	markers	marker	NOUN
cuesj-811	263	8	in	in	ADP
cuesj-811	263	9	patients	patient	NOUN
cuesj-811	263	10	with	with	ADP
cuesj-811	263	11	borderline	borderline	NOUN
cuesj-811	263	12	ovarian	ovarian	ADJ
cuesj-811	263	13	tumors	tumor	NOUN
cuesj-811	263	14	:	:	PUNCT
cuesj-811	263	15	a	a	DET
cuesj-811	263	16	retrospective	retrospective	ADJ
cuesj-811	263	17	analysis	analysis	NOUN
cuesj-811	263	18	and	and	CCONJ
cuesj-811	263	19	relation	relation	NOUN
cuesj-811	263	20	to	to	ADP
cuesj-811	263	21	staging	stage	VERB
cuesj-811	263	22	.	.	PUNCT
cuesj-811	264	1	international	international	ADJ
cuesj-811	264	2	scholarly	scholarly	ADJ
cuesj-811	264	3	research	research	NOUN
cuesj-811	264	4	notices	notice	NOUN
cuesj-811	264	5	,	,	PUNCT
cuesj-811	264	6	vol	vol	NOUN
cuesj-811	264	7	.	.	PROPN
cuesj-811	264	8	2012	2012	NUM
cuesj-811	264	9	,	,	PUNCT
cuesj-811	264	10	p.	p.	NOUN
cuesj-811	264	11	947831	947831	NUM
cuesj-811	264	12	,	,	PUNCT
cuesj-811	264	13	2012	2012	NUM
cuesj-811	264	14	.	.	PUNCT
cuesj-811	265	1	35	35	NUM
cuesj-811	265	2	.	.	PUNCT
cuesj-811	266	1	g.	g.	PROPN
cuesj-811	266	2	e.	e.	PROPN
cuesj-811	266	3	krassas	krassas	PROPN
cuesj-811	266	4	.	.	PUNCT
cuesj-811	267	1	thyroid	thyroid	NOUN
cuesj-811	267	2	disease	disease	NOUN
cuesj-811	267	3	and	and	CCONJ
cuesj-811	267	4	female	female	ADJ
cuesj-811	267	5	reproduction	reproduction	NOUN
cuesj-811	267	6	.	.	PUNCT
cuesj-811	268	1	fertility	fertility	NOUN
cuesj-811	268	2	and	and	CCONJ
cuesj-811	268	3	sterility	sterility	NOUN
cuesj-811	268	4	,	,	PUNCT
cuesj-811	268	5	vol	vol	NOUN
cuesj-811	268	6	.	.	PROPN
cuesj-811	268	7	74	74	NUM
cuesj-811	268	8	,	,	PUNCT
cuesj-811	268	9	pp	pp	ADJ
cuesj-811	268	10	.	.	PUNCT
cuesj-811	269	1	1063	1063	NUM
cuesj-811	269	2	-	-	SYM
cuesj-811	269	3	1070	1070	NUM
cuesj-811	269	4	,	,	PUNCT
cuesj-811	269	5	2000	2000	NUM
cuesj-811	269	6	.	.	PUNCT
cuesj-811	270	1	36	36	NUM
cuesj-811	270	2	.	.	PUNCT
cuesj-811	271	1	j.	j.	PROPN
cuesj-811	271	2	h.	h.	PROPN
cuesj-811	271	3	kang	kang	PROPN
cuesj-811	271	4	,	,	PUNCT
cuesj-811	271	5	a.	a.	PROPN
cuesj-811	271	6	s.	s.	PROPN
cuesj-811	271	7	kueck	kueck	PROPN
cuesj-811	271	8	,	,	PUNCT
cuesj-811	271	9	r.	r.	PROPN
cuesj-811	271	10	stevens	stevens	PROPN
cuesj-811	271	11	,	,	PUNCT
cuesj-811	271	12	g.	g.	PROPN
cuesj-811	271	13	curhan	curhan	PROPN
cuesj-811	271	14	,	,	PUNCT
cuesj-811	271	15	i.	i.	PROPN
cuesj-811	271	16	de	de	PROPN
cuesj-811	271	17	vivo	vivo	PROPN
cuesj-811	271	18	,	,	PUNCT
cuesj-811	271	19	b.	b.	PROPN
cuesj-811	271	20	rosner	rosner	PROPN
cuesj-811	271	21	,	,	PUNCT
cuesj-811	271	22	erik	erik	PROPN
cuesj-811	271	23	alexander	alexander	PROPN
cuesj-811	271	24	,	,	PUNCT
cuesj-811	271	25	s.	s.	PROPN
cuesj-811	271	26	s.	s.	PROPN
cuesj-811	271	27	tworoger	tworoger	PROPN
cuesj-811	271	28	.	.	PUNCT
cuesj-811	272	1	a	a	DET
cuesj-811	272	2	large	large	ADJ
cuesj-811	272	3	cohort	cohort	NOUN
cuesj-811	272	4	study	study	NOUN
cuesj-811	272	5	of	of	ADP
cuesj-811	272	6	hypothyroidism	hypothyroidism	NOUN
cuesj-811	272	7	and	and	CCONJ
cuesj-811	272	8	hyperthyroidism	hyperthyroidism	NOUN
cuesj-811	272	9	in	in	ADP
cuesj-811	272	10	relation	relation	NOUN
cuesj-811	272	11	to	to	ADP
cuesj-811	272	12	gynecologic	gynecologic	ADJ
cuesj-811	272	13	cancers	cancer	NOUN
cuesj-811	272	14	.	.	PUNCT
cuesj-811	273	1	obstetrics	obstetric	NOUN
cuesj-811	273	2	and	and	CCONJ
cuesj-811	273	3	gynecology	gynecology	NOUN
cuesj-811	273	4	international	international	ADJ
cuesj-811	273	5	,	,	PUNCT
cuesj-811	273	6	vol	vol	NOUN
cuesj-811	273	7	.	.	PROPN
cuesj-811	273	8	2013	2013	NUM
cuesj-811	273	9	,	,	PUNCT
cuesj-811	273	10	p.	p.	NOUN
cuesj-811	273	11	743721	743721	NUM
cuesj-811	273	12	,	,	PUNCT
cuesj-811	273	13	2013	2013	NUM
cuesj-811	273	14	.	.	PUNCT
cuesj-811	274	1	37	37	NUM
cuesj-811	274	2	.	.	PUNCT
cuesj-811	275	1	t.	t.	PROPN
cuesj-811	275	2	m.	m.	PROPN
cuesj-811	275	3	markman	markman	PROPN
cuesj-811	275	4	,	,	PUNCT
cuesj-811	275	5	m.	m.	NOUN
cuesj-811	275	6	markman	markman	NOUN
cuesj-811	275	7	and	and	CCONJ
cuesj-811	275	8	b.	b.	PROPN
cuesj-811	275	9	w.	w.	PROPN
cuesj-811	275	10	clark	clark	PROPN
cuesj-811	275	11	.	.	PUNCT
cuesj-811	276	1	case	case	NOUN
cuesj-811	276	2	of	of	ADP
cuesj-811	276	3	ovarian	ovarian	ADJ
cuesj-811	276	4	cancer	cancer	NOUN
cuesj-811	276	5	in	in	ADP
cuesj-811	276	6	a	a	DET
cuesj-811	276	7	woman	woman	NOUN
cuesj-811	276	8	with	with	ADP
cuesj-811	276	9	undiagnosed	undiagnosed	ADJ
cuesj-811	276	10	graves	grave	NOUN
cuesj-811	276	11	’	’	PART
cuesj-811	276	12	disease	disease	NOUN
cuesj-811	276	13	:	:	PUNCT
cuesj-811	276	14	a	a	DET
cuesj-811	276	15	case	case	NOUN
cuesj-811	276	16	report	report	NOUN
cuesj-811	276	17	and	and	CCONJ
cuesj-811	276	18	review	review	NOUN
cuesj-811	276	19	of	of	ADP
cuesj-811	276	20	the	the	DET
cuesj-811	276	21	literature	literature	NOUN
cuesj-811	276	22	.	.	PUNCT
cuesj-811	277	1	case	case	NOUN
cuesj-811	277	2	reports	report	VERB
cuesj-811	277	3	in	in	ADP
cuesj-811	277	4	oncology	oncology	NOUN
cuesj-811	277	5	,	,	PUNCT
cuesj-811	277	6	vol	vol	NOUN
cuesj-811	277	7	.	.	PROPN
cuesj-811	277	8	10	10	NUM
cuesj-811	277	9	,	,	PUNCT
cuesj-811	277	10	pp	pp	ADJ
cuesj-811	277	11	.	.	PUNCT
cuesj-811	278	1	452	452	NUM
cuesj-811	278	2	-	-	SYM
cuesj-811	278	3	454	454	NUM
cuesj-811	278	4	,	,	PUNCT
cuesj-811	278	5	2017	2017	NUM
cuesj-811	278	6	.	.	PUNCT
cuesj-811	279	1	38	38	NUM
cuesj-811	279	2	.	.	PUNCT
cuesj-811	279	3	m.	m.	NOUN
cuesj-811	279	4	bekmezci	bekmezci	NOUN
cuesj-811	279	5	and	and	CCONJ
cuesj-811	279	6	o.	o.	PROPN
cuesj-811	279	7	gunenc	gunenc	PROPN
cuesj-811	279	8	.	.	PUNCT
cuesj-811	280	1	the	the	DET
cuesj-811	280	2	role	role	NOUN
cuesj-811	280	3	of	of	ADP
cuesj-811	280	4	neutrophil	neutrophil	ADJ
cuesj-811	280	5	/	/	SYM
cuesj-811	280	6	lymphocyte	lymphocyte	ADJ
cuesj-811	280	7	ratio	ratio	NOUN
cuesj-811	280	8	(	(	PUNCT
cuesj-811	280	9	nlr	nlr	PROPN
cuesj-811	280	10	)	)	PUNCT
cuesj-811	280	11	with	with	ADP
cuesj-811	280	12	ca	ca	NOUN
cuesj-811	280	13	125	125	NUM
cuesj-811	280	14	in	in	ADP
cuesj-811	280	15	preoperative	preoperative	ADJ
cuesj-811	280	16	predictıon	predictıon	NOUN
cuesj-811	280	17	of	of	ADP
cuesj-811	280	18	malignancy	malignancy	NOUN
cuesj-811	280	19	in	in	ADP
cuesj-811	280	20	adnexial	adnexial	PROPN
cuesj-811	280	21	mass	mass	PROPN
cuesj-811	280	22	.	.	PUNCT
cuesj-811	281	1	medicine	medicine	NOUN
cuesj-811	281	2	,	,	PUNCT
cuesj-811	281	3	vol	vol	NOUN
cuesj-811	281	4	.	.	PROPN
cuesj-811	281	5	7	7	NUM
cuesj-811	281	6	,	,	PUNCT
cuesj-811	281	7	pp	pp	ADJ
cuesj-811	281	8	.	.	PUNCT
cuesj-811	282	1	857	857	NUM
cuesj-811	282	2	-	-	SYM
cuesj-811	282	3	60	60	NUM
cuesj-811	282	4	,	,	PUNCT
cuesj-811	282	5	2018	2018	NUM
cuesj-811	282	6	.	.	PUNCT
cuesj-811	283	1	39	39	NUM
cuesj-811	283	2	.	.	PUNCT
cuesj-811	284	1	s.	s.	PROPN
cuesj-811	284	2	bishara	bishara	PROPN
cuesj-811	284	3	,	,	PUNCT
cuesj-811	284	4	m.	m.	NOUN
cuesj-811	284	5	griffin	griffin	PROPN
cuesj-811	284	6	,	,	PUNCT
cuesj-811	284	7	a.	a.	PROPN
cuesj-811	284	8	cargill	cargill	PROPN
cuesj-811	284	9	,	,	PUNCT
cuesj-811	284	10	a.	a.	PROPN
cuesj-811	284	11	bali	bali	PROPN
cuesj-811	284	12	,	,	PUNCT
cuesj-811	284	13	m.	m.	PROPN
cuesj-811	284	14	gore	gore	PROPN
cuesj-811	284	15	,	,	PUNCT
cuesj-811	284	16	s.	s.	PROPN
cuesj-811	284	17	kaye	kaye	PROPN
cuesj-811	284	18	,	,	PUNCT
cuesj-811	284	19	j.	j.	PROPN
cuesj-811	284	20	h.	h.	PROPN
cuesj-811	284	21	shepherd	shepherd	PROPN
cuesj-811	284	22	,	,	PUNCT
cuesj-811	284	23	p.	p.	NOUN
cuesj-811	284	24	o.	o.	PROPN
cuesj-811	285	1	van	van	PROPN
cuesj-811	285	2	trappen	trappen	PROPN
cuesj-811	285	3	.	.	PUNCT
cuesj-811	286	1	pre	pre	ADJ
cuesj-811	286	2	-	-	ADJ
cuesj-811	286	3	treatment	treatment	ADJ
cuesj-811	286	4	white	white	ADJ
cuesj-811	286	5	blood	blood	NOUN
cuesj-811	286	6	cell	cell	NOUN
cuesj-811	286	7	subtypes	subtype	NOUN
cuesj-811	286	8	as	as	ADP
cuesj-811	286	9	prognostic	prognostic	ADJ
cuesj-811	286	10	indicators	indicator	NOUN
cuesj-811	286	11	in	in	ADP
cuesj-811	286	12	ovarian	ovarian	ADJ
cuesj-811	286	13	cancer	cancer	NOUN
cuesj-811	286	14	.	.	PUNCT
cuesj-811	287	1	european	european	ADJ
cuesj-811	287	2	journal	journal	PROPN
cuesj-811	287	3	of	of	ADP
cuesj-811	287	4	obstetrics	obstetric	NOUN
cuesj-811	287	5	and	and	CCONJ
cuesj-811	287	6	gynecology	gynecology	NOUN
cuesj-811	287	7	and	and	CCONJ
cuesj-811	287	8	reproductive	reproductive	ADJ
cuesj-811	287	9	biology	biology	NOUN
cuesj-811	287	10	,	,	PUNCT
cuesj-811	287	11	vol	vol	NOUN
cuesj-811	287	12	.	.	PROPN
cuesj-811	287	13	138	138	NUM
cuesj-811	287	14	,	,	PUNCT
cuesj-811	287	15	pp	pp	ADJ
cuesj-811	287	16	.	.	PUNCT
cuesj-811	288	1	71	71	NUM
cuesj-811	288	2	-	-	SYM
cuesj-811	288	3	75	75	NUM
cuesj-811	288	4	,	,	PUNCT
cuesj-811	288	5	2008	2008	NUM
cuesj-811	288	6	.	.	PUNCT
cuesj-811	289	1	40	40	NUM
cuesj-811	289	2	.	.	PUNCT
cuesj-811	289	3	m.	m.	PROPN
cuesj-811	289	4	yildirim	yildirim	PROPN
cuesj-811	289	5	,	,	PUNCT
cuesj-811	289	6	b.	b.	PROPN
cuesj-811	289	7	d.	d.	PROPN
cuesj-811	289	8	cendek	cendek	PROPN
cuesj-811	289	9	and	and	CCONJ
cuesj-811	289	10	a.	a.	PROPN
cuesj-811	289	11	f.	f.	PROPN
cuesj-811	289	12	avsar	avsar	PROPN
cuesj-811	289	13	.	.	PUNCT
cuesj-811	290	1	differentiation	differentiation	NOUN
cuesj-811	290	2	between	between	ADP
cuesj-811	290	3	benign	benign	ADJ
cuesj-811	290	4	and	and	CCONJ
cuesj-811	290	5	malignant	malignant	ADJ
cuesj-811	290	6	ovarian	ovarian	ADJ
cuesj-811	290	7	masses	masse	NOUN
cuesj-811	290	8	in	in	ADP
cuesj-811	290	9	the	the	DET
cuesj-811	290	10	preoperative	preoperative	ADJ
cuesj-811	290	11	period	period	NOUN
cuesj-811	290	12	using	use	VERB
cuesj-811	290	13	neutrophil	neutrophil	NOUN
cuesj-811	290	14	-	-	PUNCT
cuesj-811	290	15	to	to	ADP
cuesj-811	290	16	-	-	PUNCT
cuesj-811	290	17	lymphocyte	lymphocyte	ADJ
cuesj-811	290	18	and	and	CCONJ
cuesj-811	290	19	platelet	platelet	NOUN
cuesj-811	290	20	-	-	PUNCT
cuesj-811	290	21	to	to	ADP
cuesj-811	290	22	-	-	PUNCT
cuesj-811	290	23	lymphocyte	lymphocyte	ADJ
cuesj-811	290	24	ratios	ratio	NOUN
cuesj-811	290	25	.	.	PUNCT
cuesj-811	291	1	molecular	molecular	ADJ
cuesj-811	291	2	and	and	CCONJ
cuesj-811	291	3	clinical	clinical	ADJ
cuesj-811	291	4	oncology	oncology	NOUN
cuesj-811	291	5	,	,	PUNCT
cuesj-811	291	6	vol	vol	NOUN
cuesj-811	291	7	.	.	PROPN
cuesj-811	291	8	3	3	NUM
cuesj-811	291	9	,	,	PUNCT
cuesj-811	291	10	pp	pp	ADJ
cuesj-811	291	11	.	.	PUNCT
cuesj-811	292	1	317	317	NUM
cuesj-811	292	2	-	-	SYM
cuesj-811	292	3	321	321	NUM
cuesj-811	292	4	,	,	PUNCT
cuesj-811	292	5	2015	2015	NUM
cuesj-811	292	6	.	.	PUNCT
cuesj-811	293	1	41	41	NUM
cuesj-811	293	2	.	.	PUNCT
cuesj-811	294	1	t.	t.	PROPN
cuesj-811	294	2	s.	s.	PROPN
cuesj-811	294	3	salih	salih	PROPN
cuesj-811	294	4	,	,	PUNCT
cuesj-811	294	5	a.	a.	PROPN
cuesj-811	294	6	s.	s.	PROPN
cuesj-811	294	7	juma	juma	PROPN
cuesj-811	294	8	and	and	CCONJ
cuesj-811	294	9	m.	m.	PROPN
cuesj-811	294	10	h.	h.	PROPN
cuesj-811	294	11	ubeid	ubeid	PROPN
cuesj-811	294	12	.	.	PUNCT
cuesj-811	295	1	occupational	occupational	ADJ
cuesj-811	295	2	exposures	exposure	NOUN
cuesj-811	295	3	and	and	CCONJ
cuesj-811	295	4	associated	associated	ADJ
cuesj-811	295	5	health	health	NOUN
cuesj-811	295	6	effects	effect	NOUN
cuesj-811	295	7	among	among	ADP
cuesj-811	295	8	dumpsite	dumpsite	ADJ
cuesj-811	295	9	workers	worker	NOUN
cuesj-811	295	10	.	.	PUNCT
cuesj-811	296	1	cihan	cihan	VERB
cuesj-811	296	2	university	university	NOUN
cuesj-811	296	3	-	-	PUNCT
cuesj-811	296	4	erbil	erbil	PROPN
cuesj-811	296	5	scientific	scientific	ADJ
cuesj-811	296	6	journal	journal	NOUN
cuesj-811	296	7	,	,	PUNCT
cuesj-811	296	8	vol	vol	NOUN
cuesj-811	296	9	.	.	PROPN
cuesj-811	296	10	5	5	NUM
cuesj-811	296	11	,	,	PUNCT
cuesj-811	296	12	pp	pp	ADJ
cuesj-811	296	13	.	.	PUNCT
cuesj-811	297	1	1	1	NUM
cuesj-811	297	2	-	-	SYM
cuesj-811	297	3	5	5	NUM
cuesj-811	297	4	,	,	PUNCT
cuesj-811	297	5	2021	2021	NUM
cuesj-811	297	6	.	.	PUNCT
cuesj-811	298	1	42	42	NUM
cuesj-811	298	2	.	.	PUNCT
cuesj-811	299	1	y.	y.	PROPN
cuesj-811	299	2	qin	qin	PROPN
cuesj-811	299	3	,	,	PUNCT
cuesj-811	299	4	p.	p.	PROPN
cuesj-811	299	5	wang	wang	PROPN
cuesj-811	299	6	,	,	PUNCT
cuesj-811	299	7	z.	z.	PROPN
cuesj-811	299	8	huang	huang	PROPN
cuesj-811	299	9	,	,	PUNCT
cuesj-811	299	10	g.	g.	PROPN
cuesj-811	299	11	huang	huang	PROPN
cuesj-811	299	12	,	,	PUNCT
cuesj-811	299	13	j.	j.	PROPN
cuesj-811	299	14	tang	tang	PROPN
cuesj-811	299	15	,	,	PUNCT
cuesj-811	299	16	y.	y.	PROPN
cuesj-811	299	17	guo	guo	PROPN
cuesj-811	299	18	,	,	PUNCT
cuesj-811	299	19	p.	p.	PROPN
cuesj-811	299	20	huang	huang	PROPN
cuesj-811	299	21	,	,	PUNCT
cuesj-811	299	22	z.	z.	PROPN
cuesj-811	299	23	lai	lai	PROPN
cuesj-811	299	24	and	and	CCONJ
cuesj-811	299	25	f.	f.	PROPN
cuesj-811	299	26	lin	lin	PROPN
cuesj-811	299	27	.	.	PUNCT
cuesj-811	300	1	the	the	DET
cuesj-811	300	2	value	value	NOUN
cuesj-811	300	3	of	of	ADP
cuesj-811	300	4	red	red	ADJ
cuesj-811	300	5	cell	cell	NOUN
cuesj-811	300	6	distribution	distribution	NOUN
cuesj-811	300	7	width	width	NOUN
cuesj-811	300	8	in	in	ADP
cuesj-811	300	9	patients	patient	NOUN
cuesj-811	300	10	with	with	ADP
cuesj-811	300	11	ovarian	ovarian	ADJ
cuesj-811	300	12	cancer	cancer	NOUN
cuesj-811	300	13	.	.	PUNCT
cuesj-811	301	1	medicine	medicine	NOUN
cuesj-811	301	2	,	,	PUNCT
cuesj-811	301	3	vol	vol	NOUN
cuesj-811	301	4	.	.	PROPN
cuesj-811	301	5	96	96	NUM
cuesj-811	301	6	,	,	PUNCT
cuesj-811	301	7	p.	p.	NOUN
cuesj-811	301	8	e6752	e6752	NOUN
cuesj-811	301	9	,	,	PUNCT
cuesj-811	301	10	2017	2017	NUM
cuesj-811	301	11	.	.	PUNCT
cuesj-811	302	1	43	43	NUM
cuesj-811	302	2	.	.	PUNCT
cuesj-811	302	3	a.	a.	NOUN
cuesj-811	302	4	obermair	obermair	PROPN
cuesj-811	302	5	,	,	PUNCT
cuesj-811	302	6	a.	a.	NOUN
cuesj-811	302	7	handisurya	handisurya	NOUN
cuesj-811	302	8	,	,	PUNCT
cuesj-811	302	9	a.	a.	NOUN
cuesj-811	302	10	kaider	kaider	NOUN
cuesj-811	302	11	,	,	PUNCT
cuesj-811	302	12	p.	p.	NOUN
cuesj-811	302	13	sevelda	sevelda	NOUN
cuesj-811	302	14	,	,	PUNCT
cuesj-811	302	15	h.	h.	PROPN
cuesj-811	302	16	kölbl	kölbl	PROPN
cuesj-811	302	17	and	and	CCONJ
cuesj-811	302	18	g.	g.	PROPN
cuesj-811	302	19	gitsch	gitsch	PROPN
cuesj-811	302	20	.	.	PUNCT
cuesj-811	303	1	the	the	DET
cuesj-811	303	2	relationship	relationship	NOUN
cuesj-811	303	3	of	of	ADP
cuesj-811	303	4	pretreatment	pretreatment	NOUN
cuesj-811	303	5	serum	serum	NOUN
cuesj-811	303	6	hemoglobin	hemoglobin	NOUN
cuesj-811	303	7	level	level	NOUN
cuesj-811	303	8	to	to	ADP
cuesj-811	303	9	the	the	DET
cuesj-811	303	10	survival	survival	NOUN
cuesj-811	303	11	of	of	ADP
cuesj-811	303	12	epithelial	epithelial	ADJ
cuesj-811	303	13	ovarian	ovarian	ADJ
cuesj-811	303	14	carcinoma	carcinoma	NOUN
cuesj-811	303	15	patients	patient	NOUN
cuesj-811	303	16	:	:	PUNCT
cuesj-811	303	17	a	a	DET
cuesj-811	303	18	prospective	prospective	ADJ
cuesj-811	303	19	review	review	NOUN
cuesj-811	303	20	.	.	PUNCT
cuesj-811	304	1	cancer	cancer	NOUN
cuesj-811	304	2	,	,	PUNCT
cuesj-811	304	3	vol	vol	NOUN
cuesj-811	304	4	.	.	PROPN
cuesj-811	304	5	83	83	NUM
cuesj-811	304	6	,	,	PUNCT
cuesj-811	304	7	pp	pp	ADJ
cuesj-811	304	8	.	.	PUNCT
cuesj-811	305	1	726	726	NUM
cuesj-811	305	2	-	-	SYM
cuesj-811	305	3	731	731	NUM
cuesj-811	305	4	,	,	PUNCT
cuesj-811	305	5	1998	1998	NUM
cuesj-811	305	6	.	.	PUNCT
cuesj-811	306	1	44	44	NUM
cuesj-811	306	2	.	.	PUNCT
cuesj-811	307	1	z.	z.	PROPN
cuesj-811	307	2	förhécz	förhécz	PROPN
cuesj-811	307	3	,	,	PUNCT
cuesj-811	307	4	t.	t.	PROPN
cuesj-811	307	5	gombos	gombos	PROPN
cuesj-811	307	6	,	,	PUNCT
cuesj-811	307	7	g.	g.	PROPN
cuesj-811	307	8	borgulya	borgulya	PROPN
cuesj-811	307	9	,	,	PUNCT
cuesj-811	307	10	z.	z.	PROPN
cuesj-811	307	11	pozsonyi	pozsonyi	PROPN
cuesj-811	307	12	,	,	PUNCT
cuesj-811	307	13	z.	z.	PROPN
cuesj-811	307	14	prohászka	prohászka	PROPN
cuesj-811	307	15	and	and	CCONJ
cuesj-811	307	16	l.	l.	PROPN
cuesj-811	307	17	jánoskuti	jánoskuti	PROPN
cuesj-811	307	18	.	.	PUNCT
cuesj-811	308	1	red	red	ADJ
cuesj-811	308	2	cell	cell	NOUN
cuesj-811	308	3	distribution	distribution	NOUN
cuesj-811	308	4	width	width	NOUN
cuesj-811	308	5	in	in	ADP
cuesj-811	308	6	heart	heart	NOUN
cuesj-811	308	7	failure	failure	NOUN
cuesj-811	308	8	:	:	PUNCT
cuesj-811	308	9	prediction	prediction	NOUN
cuesj-811	308	10	of	of	ADP
cuesj-811	308	11	clinical	clinical	ADJ
cuesj-811	308	12	events	event	NOUN
cuesj-811	308	13	and	and	CCONJ
cuesj-811	308	14	relationship	relationship	NOUN
cuesj-811	308	15	with	with	ADP
cuesj-811	308	16	markers	marker	NOUN
cuesj-811	308	17	of	of	ADP
cuesj-811	308	18	ineffective	ineffective	ADJ
cuesj-811	308	19	erythropoiesis	erythropoiesis	NOUN
cuesj-811	308	20	,	,	PUNCT
cuesj-811	308	21	inflammation	inflammation	NOUN
cuesj-811	308	22	,	,	PUNCT
cuesj-811	308	23	renal	renal	ADJ
cuesj-811	308	24	function	function	NOUN
cuesj-811	308	25	,	,	PUNCT
cuesj-811	308	26	and	and	CCONJ
cuesj-811	308	27	nutritional	nutritional	ADJ
cuesj-811	308	28	state	state	NOUN
cuesj-811	308	29	.	.	PUNCT
cuesj-811	309	1	american	american	ADJ
cuesj-811	309	2	heart	heart	PROPN
cuesj-811	309	3	journal	journal	PROPN
cuesj-811	309	4	,	,	PUNCT
cuesj-811	309	5	vol	vol	NOUN
cuesj-811	309	6	.	.	PROPN
cuesj-811	309	7	158	158	NUM
cuesj-811	309	8	,	,	PUNCT
cuesj-811	309	9	pp	pp	ADJ
cuesj-811	309	10	.	.	PUNCT
cuesj-811	310	1	659666	659666	NUM
cuesj-811	310	2	,	,	PUNCT
cuesj-811	310	3	2009	2009	NUM
cuesj-811	310	4	.	.	PUNCT
cuesj-811	311	1	45	45	NUM
cuesj-811	311	2	.	.	PUNCT
cuesj-811	312	1	p.	p.	NOUN
cuesj-811	312	2	lehtovirta	lehtovirta	PROPN
cuesj-811	312	3	,	,	PUNCT
cuesj-811	312	4	d.	d.	PROPN
cuesj-811	312	5	apter	apter	ADV
cuesj-811	312	6	and	and	CCONJ
cuesj-811	312	7	u.	u.	PROPN
cuesj-811	312	8	h.	h.	PROPN
cuesj-811	312	9	stenman	stenman	PROPN
cuesj-811	312	10	.	.	PUNCT
cuesj-811	313	1	serum	serum	PROPN
cuesj-811	313	2	ca	ca	PROPN
cuesj-811	313	3	125	125	NUM
cuesj-811	313	4	levels	level	NOUN
cuesj-811	313	5	during	during	ADP
cuesj-811	313	6	the	the	DET
cuesj-811	313	7	menstrual	menstrual	ADJ
cuesj-811	313	8	cycle	cycle	NOUN
cuesj-811	313	9	.	.	PUNCT
cuesj-811	314	1	british	british	ADJ
cuesj-811	314	2	journal	journal	PROPN
cuesj-811	314	3	of	of	ADP
cuesj-811	314	4	obstetrics	obstetric	NOUN
cuesj-811	314	5	and	and	CCONJ
cuesj-811	314	6	gynaecology	gynaecology	NOUN
cuesj-811	314	7	,	,	PUNCT
cuesj-811	314	8	vol	vol	NOUN
cuesj-811	314	9	.	.	PROPN
cuesj-811	314	10	97	97	NUM
cuesj-811	314	11	,	,	PUNCT
cuesj-811	314	12	pp	pp	ADJ
cuesj-811	314	13	.	.	PUNCT
cuesj-811	315	1	930	930	NUM
cuesj-811	315	2	-	-	SYM
cuesj-811	315	3	933	933	NUM
cuesj-811	315	4	,	,	PUNCT
cuesj-811	315	5	1990	1990	NUM
cuesj-811	315	6	.	.	PUNCT
cuesj-811	316	1	46	46	NUM
cuesj-811	316	2	.	.	PUNCT
cuesj-811	316	3	a.	a.	PROPN
cuesj-811	316	4	s.	s.	PROPN
cuesj-811	316	5	juma	juma	PROPN
cuesj-811	316	6	and	and	CCONJ
cuesj-811	316	7	m.	m.	PROPN
cuesj-811	316	8	h.	h.	PROPN
cuesj-811	316	9	ubeid	ubeid	PROPN
cuesj-811	316	10	.	.	PUNCT
cuesj-811	317	1	a	a	DET
cuesj-811	317	2	microbiological	microbiological	ADJ
cuesj-811	317	3	survey	survey	NOUN
cuesj-811	317	4	of	of	ADP
cuesj-811	317	5	ear	ear	NOUN
cuesj-811	317	6	infections	infection	NOUN
cuesj-811	317	7	in	in	ADP
cuesj-811	317	8	inhabitants	inhabitant	NOUN
cuesj-811	317	9	of	of	ADP
cuesj-811	317	10	erbil	erbil	PROPN
cuesj-811	317	11	city	city	PROPN
cuesj-811	317	12	.	.	PUNCT
cuesj-811	318	1	cihan	cihan	VERB
cuesj-811	318	2	university	university	NOUN
cuesj-811	318	3	-	-	PUNCT
cuesj-811	318	4	erbil	erbil	PROPN
cuesj-811	318	5	scientific	scientific	ADJ
cuesj-811	318	6	journal	journal	NOUN
cuesj-811	318	7	,	,	PUNCT
cuesj-811	318	8	vol	vol	NOUN
cuesj-811	318	9	.	.	PROPN
cuesj-811	318	10	6	6	NUM
cuesj-811	318	11	,	,	PUNCT
cuesj-811	318	12	pp	pp	ADJ
cuesj-811	318	13	.	.	PUNCT
cuesj-811	319	1	62	62	NUM
cuesj-811	319	2	-	-	SYM
cuesj-811	319	3	67	67	NUM
cuesj-811	319	4	,	,	PUNCT
cuesj-811	319	5	2022	2022	NUM
cuesj-811	319	6	.	.	PUNCT
cuesj-811	320	1	47	47	NUM
cuesj-811	320	2	.	.	PUNCT
cuesj-811	321	1	c.	c.	PROPN
cuesj-811	321	2	c.	c.	PROPN
cuesj-811	321	3	johnson	johnson	PROPN
cuesj-811	321	4	,	,	PUNCT
cuesj-811	321	5	b.	b.	PROPN
cuesj-811	321	6	kessel	kessel	PROPN
cuesj-811	321	7	,	,	PUNCT
cuesj-811	321	8	t.	t.	PROPN
cuesj-811	321	9	l.	l.	PROPN
cuesj-811	321	10	riley	riley	PROPN
cuesj-811	321	11	,	,	PUNCT
cuesj-811	321	12	l.	l.	PROPN
cuesj-811	321	13	r.	r.	PROPN
cuesj-811	321	14	ragard	ragard	PROPN
cuesj-811	321	15	,	,	PUNCT
cuesj-811	321	16	c.	c.	PROPN
cuesj-811	321	17	r.	r.	PROPN
cuesj-811	321	18	williams	williams	PROPN
cuesj-811	321	19	,	,	PUNCT
cuesj-811	321	20	j.	j.	PROPN
cuesj-811	321	21	l.	l.	PROPN
cuesj-811	321	22	xu	xu	PROPN
cuesj-811	321	23	,	,	PUNCT
cuesj-811	321	24	s.	s.	PROPN
cuesj-811	321	25	s.	s.	PROPN
cuesj-811	321	26	buys	buy	VERB
cuesj-811	321	27	and	and	CCONJ
cuesj-811	321	28	prostate	prostate	NOUN
cuesj-811	321	29	,	,	PUNCT
cuesj-811	321	30	lung	lung	NOUN
cuesj-811	321	31	,	,	PUNCT
cuesj-811	321	32	colorectal	colorectal	ADJ
cuesj-811	321	33	and	and	CCONJ
cuesj-811	321	34	ovarian	ovarian	ADJ
cuesj-811	321	35	cancer	cancer	NOUN
cuesj-811	321	36	project	project	NOUN
cuesj-811	321	37	team	team	NOUN
cuesj-811	321	38	.	.	PUNCT
cuesj-811	322	1	the	the	DET
cuesj-811	322	2	epidemiology	epidemiology	NOUN
cuesj-811	322	3	of	of	ADP
cuesj-811	322	4	ca-125	ca-125	NOUN
cuesj-811	322	5	in	in	ADP
cuesj-811	322	6	women	woman	NOUN
cuesj-811	322	7	without	without	ADP
cuesj-811	322	8	evidence	evidence	NOUN
cuesj-811	322	9	of	of	ADP
cuesj-811	322	10	ovarian	ovarian	ADJ
cuesj-811	322	11	cancer	cancer	NOUN
cuesj-811	322	12	in	in	ADP
cuesj-811	322	13	the	the	DET
cuesj-811	322	14	prostate	prostate	NOUN
cuesj-811	322	15	,	,	PUNCT
cuesj-811	322	16	lung	lung	NOUN
cuesj-811	322	17	,	,	PUNCT
cuesj-811	322	18	colorectal	colorectal	ADJ
cuesj-811	322	19	and	and	CCONJ
cuesj-811	322	20	ovarian	ovarian	ADJ
cuesj-811	322	21	cancer	cancer	NOUN
cuesj-811	322	22	(	(	PUNCT
cuesj-811	322	23	plco	plco	NOUN
cuesj-811	322	24	)	)	PUNCT
cuesj-811	322	25	screening	screen	VERB
cuesj-811	322	26	trial	trial	NOUN
cuesj-811	322	27	.	.	PUNCT
cuesj-811	323	1	gynecologic	gynecologic	ADJ
cuesj-811	323	2	oncology	oncology	NOUN
cuesj-811	323	3	,	,	PUNCT
cuesj-811	323	4	vol	vol	NOUN
cuesj-811	323	5	.	.	PROPN
cuesj-811	323	6	110	110	NUM
cuesj-811	323	7	,	,	PUNCT
cuesj-811	323	8	pp	pp	ADJ
cuesj-811	323	9	.	.	PUNCT
cuesj-811	324	1	383	383	NUM
cuesj-811	324	2	-	-	SYM
cuesj-811	324	3	389	389	NUM
cuesj-811	324	4	,	,	PUNCT
cuesj-811	324	5	2008	2008	NUM
cuesj-811	324	6	.	.	PUNCT
cuesj-811	325	1	48	48	NUM
cuesj-811	325	2	.	.	PUNCT
cuesj-811	326	1	n.	n.	PROPN
cuesj-811	326	2	s.	s.	PROPN
cuesj-811	326	3	joo	joo	PROPN
cuesj-811	326	4	,	,	PUNCT
cuesj-811	326	5	k.	k.	PROPN
cuesj-811	326	6	n.	n.	PROPN
cuesj-811	326	7	kim	kim	PROPN
cuesj-811	326	8	and	and	CCONJ
cuesj-811	326	9	k.	k.	PROPN
cuesj-811	326	10	s.	s.	PROPN
cuesj-811	326	11	kim	kim	PROPN
cuesj-811	326	12	.	.	PUNCT
cuesj-811	327	1	serum	serum	PROPN
cuesj-811	327	2	ca125	ca125	PROPN
cuesj-811	327	3	concentration	concentration	NOUN
cuesj-811	327	4	has	have	VERB
cuesj-811	327	5	inverse	inverse	NOUN
cuesj-811	327	6	correlation	correlation	NOUN
cuesj-811	327	7	with	with	ADP
cuesj-811	327	8	metabolic	metabolic	NOUN
cuesj-811	327	9	syndrome	syndrome	NOUN
cuesj-811	327	10	.	.	PUNCT
cuesj-811	328	1	journal	journal	NOUN
cuesj-811	328	2	of	of	ADP
cuesj-811	328	3	korean	korean	PROPN
cuesj-811	328	4	medical	medical	ADJ
cuesj-811	328	5	science	science	NOUN
cuesj-811	328	6	,	,	PUNCT
cuesj-811	328	7	vol	vol	NOUN
cuesj-811	328	8	.	.	PROPN
cuesj-811	328	9	26	26	NUM
cuesj-811	328	10	,	,	PUNCT
cuesj-811	328	11	pp	pp	ADJ
cuesj-811	328	12	.	.	PUNCT
cuesj-811	329	1	1328	1328	NUM
cuesj-811	329	2	-	-	SYM
cuesj-811	329	3	1332	1332	NUM
cuesj-811	329	4	,	,	PUNCT
cuesj-811	329	5	2011	2011	NUM
cuesj-811	329	6	.	.	PUNCT
cuesj-811	330	1	49	49	NUM
cuesj-811	330	2	.	.	PUNCT
cuesj-811	331	1	n.	n.	PROPN
cuesj-811	331	2	t.	t.	PROPN
cuesj-811	331	3	kouris	kouris	PROPN
cuesj-811	331	4	,	,	PUNCT
cuesj-811	331	5	i.	i.	PROPN
cuesj-811	331	6	d.	d.	PROPN
cuesj-811	331	7	zacharos	zacharos	PROPN
cuesj-811	331	8	,	,	PUNCT
cuesj-811	331	9	d.	d.	PROPN
cuesj-811	331	10	d.	d.	PROPN
cuesj-811	331	11	kontogianni	kontogianni	PROPN
cuesj-811	331	12	,	,	PUNCT
cuesj-811	331	13	g.	g.	PROPN
cuesj-811	331	14	s.	s.	PROPN
cuesj-811	331	15	goranitou	goranitou	PROPN
cuesj-811	331	16	,	,	PUNCT
cuesj-811	331	17	m.	m.	PROPN
cuesj-811	331	18	d.	d.	PROPN
cuesj-811	331	19	sifaki	sifaki	PROPN
cuesj-811	331	20	,	,	PUNCT
cuesj-811	331	21	h.	h.	PROPN
cuesj-811	331	22	e.	e.	PROPN
cuesj-811	331	23	grassos	grassos	PROPN
cuesj-811	331	24	,	,	PUNCT
cuesj-811	331	25	e.	e.	PROPN
cuesj-811	331	26	m.	m.	PROPN
cuesj-811	331	27	kalkandi	kalkandi	PROPN
cuesj-811	331	28	and	and	CCONJ
cuesj-811	331	29	d.	d.	PROPN
cuesj-811	331	30	k.	k.	PROPN
cuesj-811	332	1	babalis.the	babalis.the	DET
cuesj-811	332	2	significance	significance	NOUN
cuesj-811	332	3	of	of	ADP
cuesj-811	332	4	ca125	ca125	NOUN
cuesj-811	332	5	levels	level	NOUN
cuesj-811	332	6	in	in	ADP
cuesj-811	332	7	patients	patient	NOUN
cuesj-811	332	8	with	with	ADP
cuesj-811	332	9	chronic	chronic	ADJ
cuesj-811	332	10	congestive	congestive	ADJ
cuesj-811	332	11	heart	heart	NOUN
cuesj-811	332	12	failure	failure	NOUN
cuesj-811	332	13	.	.	PUNCT
cuesj-811	333	1	correlation	correlation	NOUN
cuesj-811	333	2	with	with	ADP
cuesj-811	333	3	clinical	clinical	ADJ
cuesj-811	333	4	and	and	CCONJ
cuesj-811	333	5	echocardiographic	echocardiographic	ADJ
cuesj-811	333	6	parameters	parameter	NOUN
cuesj-811	333	7	.	.	PUNCT
cuesj-811	334	1	european	european	PROPN
cuesj-811	334	2	journal	journal	PROPN
cuesj-811	334	3	of	of	ADP
cuesj-811	334	4	heart	heart	NOUN
cuesj-811	334	5	failure	failure	NOUN
cuesj-811	334	6	,	,	PUNCT
cuesj-811	334	7	vol	vol	NOUN
cuesj-811	334	8	.	.	PROPN
cuesj-811	334	9	7	7	NUM
cuesj-811	334	10	,	,	PUNCT
cuesj-811	334	11	pp	pp	ADJ
cuesj-811	334	12	.	.	PUNCT
cuesj-811	335	1	199	199	NUM
cuesj-811	335	2	-	-	SYM
cuesj-811	335	3	203	203	NUM
cuesj-811	335	4	,	,	PUNCT
cuesj-811	335	5	2005	2005	NUM
cuesj-811	335	6	.	.	PUNCT
cuesj-811	336	1	50	50	NUM
cuesj-811	336	2	.	.	PUNCT
cuesj-811	336	3	h.	h.	PROPN
cuesj-811	336	4	m.	m.	PROPN
cuesj-811	336	5	turk	turk	PROPN
cuesj-811	336	6	,	,	PUNCT
cuesj-811	336	7	h.	h.	PROPN
cuesj-811	336	8	pekdemir	pekdemir	PROPN
cuesj-811	336	9	,	,	PUNCT
cuesj-811	336	10	s.	s.	PROPN
cuesj-811	336	11	buyukberber	buyukberber	PROPN
cuesj-811	336	12	,	,	PUNCT
cuesj-811	336	13	a.	a.	PROPN
cuesj-811	336	14	sevinc	sevinc	PROPN
cuesj-811	336	15	,	,	PUNCT
cuesj-811	336	16	c.	c.	PROPN
cuesj-811	336	17	camci	camci	PROPN
cuesj-811	336	18	,	,	PUNCT
cuesj-811	336	19	r.	r.	PROPN
cuesj-811	336	20	kocabas	kocabas	PROPN
cuesj-811	336	21	,	,	PUNCT
cuesj-811	336	22	tarakcioglu	tarakcioglu	ADJ
cuesj-811	336	23	and	and	CCONJ
cuesj-811	336	24	n.	n.	NOUN
cuesj-811	336	25	m.	m.	NOUN
cuesj-811	336	26	buyukberbe	buyukberbe	NOUN
cuesj-811	336	27	.	.	PUNCT
cuesj-811	337	1	serum	serum	PROPN
cuesj-811	337	2	ca	can	AUX
cuesj-811	337	3	125	125	NUM
cuesj-811	337	4	levels	level	NOUN
cuesj-811	337	5	in	in	ADP
cuesj-811	337	6	patients	patient	NOUN
cuesj-811	337	7	with	with	ADP
cuesj-811	337	8	chronic	chronic	ADJ
cuesj-811	337	9	heart	heart	NOUN
cuesj-811	337	10	failure	failure	NOUN
cuesj-811	337	11	and	and	CCONJ
cuesj-811	337	12	accompanying	accompany	VERB
cuesj-811	337	13	pleural	pleural	ADJ
cuesj-811	337	14	fluid	fluid	NOUN
cuesj-811	337	15	.	.	PUNCT
cuesj-811	338	1	tumor	tumor	NOUN
cuesj-811	338	2	biology	biology	NOUN
cuesj-811	338	3	,	,	PUNCT
cuesj-811	338	4	vol	vol	NOUN
cuesj-811	338	5	.	.	PROPN
cuesj-811	339	1	24	24	NUM
cuesj-811	339	2	,	,	PUNCT
cuesj-811	339	3	pp	pp	ADJ
cuesj-811	339	4	.	.	PUNCT
cuesj-811	340	1	172	172	NUM
cuesj-811	340	2	-	-	SYM
cuesj-811	340	3	175	175	NUM
cuesj-811	340	4	,	,	PUNCT
cuesj-811	340	5	2003	2003	NUM
cuesj-811	340	6	.	.	PUNCT